{"actors":[{"id":"OPENAI","label":"OpenAI","layer":"labs","name":"OpenAI","note":"","origin":"upstream","shape":"hexagon","type":"lab"},{"id":"ANTHROPIC","label":"Anthropic","layer":"labs","name":"Anthropic","note":"","origin":"upstream","shape":"hexagon","type":"lab"},{"id":"META","label":"Meta","layer":"labs","name":"Meta Platforms","note":"","origin":"upstream","shape":"hexagon","type":"lab"},{"id":"MSFT","label":"Microsoft","layer":"cloud","name":"Microsoft / Azure","note":"","origin":"upstream","shape":"rounded","type":"hyperscaler"},{"id":"GOOG","label":"Google","layer":"cloud","name":"Google / Google Cloud","note":"","origin":"upstream","shape":"rounded","type":"hyperscaler"},{"id":"NVDA","label":"NVIDIA","layer":"silicon","name":"NVIDIA","note":"","origin":"upstream","shape":"chip","type":"chip"},{"id":"WH","label":"White House","layer":"policy","name":"The White House","note":"","origin":"upstream","shape":"shield","type":"government"},{"id":"TXLEG","label":"Texas Lege.","layer":"policy","name":"Texas Legislature","note":"Passed SB 6 (89R) on large loads.","shape":"hex","type":"government"},{"id":"NEURALINK","label":"Neuralink","layer":"neurotech","name":"Neuralink Corp.","note":"Implanted BCI developer; trial figures are company-reported.","shape":"circle","type":"neurotech"},{"id":"MERGELABS","label":"Merge Labs","layer":"neurotech","name":"Merge Labs","note":"Non-invasive BCI start-up; OpenAI invested in its seed round.","shape":"circle","type":"neurotech"},{"id":"PARADROMICS","label":"Paradromics","layer":"neurotech","name":"Paradromics Inc.","note":"Fully implantable speech BCI (Connexus); Connect-One study.","shape":"circle","type":"neurotech"},{"id":"SYNCHRON","label":"Synchron","layer":"neurotech","name":"Synchron","note":"Endovascular BCI; Apple BCI HID integration.","shape":"circle","type":"neurotech"},{"id":"PRECISIONNEURO","label":"Precision","layer":"neurotech","name":"Precision Neuroscience","note":"Thin-film cortical interface; FDA 510(k) for Layer 7-T.","shape":"circle","type":"neurotech"},{"id":"BRNEURO","label":"Blackrock Neurotech","layer":"neurotech","name":"Blackrock Neurotech","note":"Implantable BCI maker; $200M from Tether (2024).","shape":"circle","type":"neurotech"},{"id":"TETHER","label":"Tether","layer":"capital","name":"Tether (Tether Evo)","note":"Stablecoin issuer; invested in Blackrock Neurotech.","shape":"diamond","type":"financier"},{"id":"APPLE","label":"Apple","layer":"cloud","name":"Apple Inc.","note":"Added a BCI Switch Control protocol to iOS, iPadOS and visionOS.","shape":"rounded","type":"company"},{"id":"SIEMENSHC","label":"Siemens Healthineers","layer":"neurotech","name":"Siemens Healthineers","note":"Imaging collaboration with Paradromics.","shape":"square","type":"company"},{"id":"UCLH","label":"UCLH","layer":"research","name":"University College London Hospitals NHS Foundation Trust","note":"GB-PRIME (Neuralink) trial site.","shape":"square","type":"hospital"},{"id":"COMPASS","label":"Compass","layer":"therapeutics","name":"Compass Pathways","note":"COMP360 psilocybin for treatment-resistant depression.","shape":"circle","type":"therapeutics"},{"id":"DEFINIUM","label":"Definium","layer":"therapeutics","name":"Definium Therapeutics (formerly MindMed)","note":"DT120 ODT (LSD-based, formerly MM120) for anxiety and depression.","shape":"circle","type":"therapeutics"},{"id":"LYKOS","label":"Lykos","layer":"therapeutics","name":"Lykos Therapeutics","note":"MDMA-assisted therapy; FDA complete response letter 2024.","shape":"circle","type":"therapeutics"},{"id":"FDA","label":"FDA","layer":"policy","name":"U.S. Food and Drug Administration","note":"Device and drug regulator for BCIs and psychedelics.","shape":"shield","type":"regulator"},{"id":"COGITATE","label":"Cogitate","layer":"research","name":"Cogitate Consortium","note":"Adversarial test of two leading consciousness theories.","shape":"ring","type":"research"},{"id":"TWCF","label":"Templeton World","layer":"research","name":"Templeton World Charity Foundation","note":"Funds adversarial collaborations on consciousness.","shape":"diamond","type":"funder"},{"id":"ELEOS","label":"Eleos AI","layer":"research","name":"Eleos AI Research","note":"Non-profit on AI sentience and wellbeing.","shape":"ring","type":"research"},{"id":"UNESCO","label":"UNESCO","layer":"policy","name":"UNESCO","note":"Recommendation on the Ethics of Neurotechnology (2025).","shape":"hex","type":"standards"},{"id":"COGA","label":"Colorado legislature","layer":"policy","name":"Colorado General Assembly","note":"HB24-1058: neural data as sensitive data.","shape":"shield","type":"government"},{"id":"CALEG","label":"California legislature","layer":"policy","name":"California Legislature","note":"SB 1223: neural data in the CCPA.","shape":"shield","type":"government"},{"id":"USSENATE","label":"U.S. Senate","layer":"policy","name":"United States Senate","note":"MIND Act (S.2925) introduced 2025.","shape":"shield","type":"government"},{"id":"MEDTRONIC","label":"Medtronic","layer":"neurotech","name":"Medtronic plc","note":"Percept DBS; adaptive (closed-loop) DBS approved 2025.","shape":"square","type":"company"},{"id":"MAGNUS","label":"Magnus Medical","layer":"neurotech","name":"Magnus Medical, Inc.","note":"SAINT individualized TMS for depression.","shape":"circle","type":"neurotech"},{"id":"DELIX","label":"Delix","layer":"therapeutics","name":"Delix Therapeutics","note":"Non-hallucinogenic 'neuroplastogen' zalsupindole.","shape":"circle","type":"therapeutics"},{"id":"TGA","label":"TGA","layer":"policy","name":"Therapeutic Goods Administration (Australia)","note":"Allowed authorised psychiatrists to prescribe psilocybin and MDMA from 1 July 2023.","shape":"shield","type":"regulator"},{"id":"USVA","label":"VA","layer":"policy","name":"U.S. Department of Veterans Affairs","note":"Funded its first psychedelic-assisted therapy study since the 1960s.","shape":"shield","type":"government"},{"id":"CNGOV","label":"China (MIIT + 6 ministries)","layer":"policy","name":"Ministry of Industry and Information Technology of the PRC and six other ministries","note":"National BCI industry plan with 2027 and 2030 targets.","shape":"shield","type":"government"},{"id":"ARIA","label":"ARIA","layer":"research","name":"Advanced Research + Invention Agency (UK)","note":"Precision Neurotechnologies programme, £69m.","shape":"diamond","type":"funder"},{"id":"JSTMOON","label":"Japan Moonshot","layer":"research","name":"Japan Science and Technology Agency, Moonshot R&D Goal 1","note":"Goal 1 (2050) includes the 'Internet of Brains' project.","shape":"diamond","type":"funder"},{"id":"MICRONS","label":"MICrONS","layer":"research","name":"MICrONS Consortium (IARPA programme)","note":"Cubic-millimetre functional connectome of mouse visual cortex.","shape":"ring","type":"research"},{"id":"FLYWIRE","label":"FlyWire","layer":"research","name":"FlyWire Consortium","note":"Whole adult fly brain wiring diagram.","shape":"ring","type":"research"},{"id":"CMEP","label":"NYU CMEP","layer":"research","name":"NYU Center for Mind, Ethics, and Policy","note":"Studies moral status of animals and AI; permanent centre since 2024.","shape":"ring","type":"research"},{"id":"CLCONG","label":"Chile","layer":"policy","name":"Republic of Chile (Congreso Nacional)","note":"Constitutional neurorights amendment, Ley 21.383 (2021).","shape":"shield","type":"government"},{"id":"CLSUP","label":"Chile Supreme Court","layer":"policy","name":"Corte Suprema de Chile","note":"Girardi v. Emotiv neurodata ruling (2023).","shape":"shield","type":"court"},{"id":"EMOTIV","label":"Emotiv","layer":"neurotech","name":"Emotiv Inc.","note":"Consumer EEG headset maker (Insight).","shape":"circle","type":"company"},{"id":"ESGOV","label":"Spain","layer":"policy","name":"Gobierno de España","note":"Carta de Derechos Digitales (2021) with neurotechnology rights.","shape":"shield","type":"government"},{"id":"OECD","label":"OECD","layer":"policy","name":"Organisation for Economic Co-operation and Development","note":"Neurotechnology Recommendation (2019).","shape":"hex","type":"standards"},{"id":"UNHRC","label":"UN HRC","layer":"policy","name":"UN Human Rights Council","note":"Resolution 51/3 on neurotechnology and human rights (2022).","shape":"hex","type":"standards"},{"id":"COE","label":"Council of Europe","layer":"policy","name":"Council of Europe","note":"Draft neural-data guidelines under Convention 108.","shape":"hex","type":"standards"},{"id":"BUTTERFLY","label":"Butterfly Network","layer":"neurotech","name":"Butterfly Network, Inc.","note":"Ultrasound-on-chip maker; licenses to Merge Labs.","shape":"circle","type":"neurotech"},{"id":"KEIO","label":"Keio University","layer":"research","name":"Keio University (KGRI)","note":"Runs the IoB-S neurolaw/ELSI project under Moonshot Goal 1.","shape":"circle","type":"research"},{"id":"EON","label":"Eon Systems","layer":"neurotech","name":"Eon Systems","note":"Brain-emulation start-up; claims are company-stated.","shape":"circle","type":"neurotech"},{"id":"JANELIA","label":"HHMI Janelia","layer":"research","name":"HHMI Janelia Research Campus","note":"FlyEM connectome team.","shape":"circle","type":"research"},{"id":"CYBERAGENTUR","label":"Cyberagentur","layer":"policy","name":"Agentur für Innovation in der Cybersicherheit GmbH","note":"German federal innovation agency.","shape":"circle","type":"government"},{"id":"ZANDER","label":"Zander Laboratories","layer":"neurotech","name":"Zander Laboratories","note":"Passive-BCI / neuroadaptive tech start-up (Cottbus).","shape":"circle","type":"neurotech"},{"id":"PAINAXIS","label":"Pain Axis authors","layer":"research","name":"Valen Tagliabue (FIG), Leonard Dung (Ruhr-University Bochum), Cameron Berg (Reciprocal Research)","note":"Author group of arXiv:2609.16247; not an institution-level position.","shape":"circle","type":"research"},{"id":"CORTICAL","label":"Cortical Labs","layer":"neurotech","name":"Cortical Labs","note":"Builds biological computers from cultured neurons on silicon (CL1).","shape":"circle","type":"neurotech"},{"id":"NIHBRAIN","label":"NIH BRAIN Initiative","layer":"regulator","name":"National Institutes of Health BRAIN Initiative","note":"US federal neuroscience programme; counterpoint on public funding.","shape":"square","type":"regulator"}],"archive":{"built":"2026-11-05","count":85,"items":[{"date":"2026-10-01","desk":"Mind & Consciousness","search_text":"Neuralink reports 50,000+ hours of streamed brain data and a pretrained decoder Neuralink says its trial participants have streamed more than 50,000 hours of neural data in the roughly two years since its trial began (the first participant alone more than 9,000 hours). It reports a pretrained decoder that cut calibration from about 10 minutes a day to about 10 minutes a week for some users, a record of 11.32 bits per second (previous 10.39) with a median near 10, and one decoder still usable after 20 months. All figures are company-reported; the devices are investigational and not FDA approved. All figures (hours, BPS, calibration, decoder longevity); investigational status. Seven Neuralink-sponsored registry studies, starts 2024-01-09 to 2026-01-08. Company-reported; no independent peer-reviewed replication was opened. Participant count is not stated on the page. NEURALINK","summary":"Neuralink says its trial participants have streamed more than 50,000 hours of neural data in the roughly two years since its trial began (the first participant alone more than 9,000 hours). It reports a pretrained decoder that cut calibration from about 10 minutes a day to about 10 minutes a week for some users, a record of 11.32 bits per second (previous 10.39) with a median near 10, and one decoder still usable after 20 months. All figures are company-reported; the devices are investigational and not FDA approved.","title":"Neuralink reports 50,000+ hours of streamed brain data and a pretrained decoder","type":"development","url":"#move/nl-pretrain-50k"},{"date":"2024-09-17","desk":"Mind & Consciousness","search_text":"FDA gives Neuralink's Blindsight a Breakthrough Device Designation Neuralink announced that the FDA granted Breakthrough Device Designation to Blindsight, an implant intended to restore some vision. Designation and stated purpose. No Blindsight title occurs in the supplied seven-title capture. Its historical retrieval timestamp, lead-sponsor-only scope and completeness are not independently established. A designation speeds FDA interaction; it is not evidence the device works in people. The supplied registry capture contains seven study titles with no Blindsight title. Its query completeness, lead-sponsor scope and inherited November 4 observation date were not independently established; this is not proof that no human Blindsight study exists. NEURALINK FDA","summary":"Neuralink announced that the FDA granted Breakthrough Device Designation to Blindsight, an implant intended to restore some vision.","title":"FDA gives Neuralink's Blindsight a Breakthrough Device Designation","type":"development","url":"#move/nl-blindsight-bdd"},{"date":"2026-01-29","desk":"Mind & Consciousness","search_text":"UCLH reports seven UK patients in Neuralink's GB-PRIME trial University College London Hospitals said seven patients with severely impaired control of computers or phones are participating in GB-PRIME, a study of Neuralink's BCI; surgeries took place at the National Hospital for Neurology and Neurosurgery. The registry lists GB-PRIME (NCT07127172) with a start date of 2025-07-31. Seven participants; surgery site; study aim. GB-PRIME registry start 2025-07-31. UCLH NEURALINK","summary":"University College London Hospitals said seven patients with severely impaired control of computers or phones are participating in GB-PRIME, a study of Neuralink's BCI; surgeries took place at the National Hospital for Neurology and Neurosurgery. The registry lists GB-PRIME (NCT07127172) with a start date of 2025-07-31.","title":"UCLH reports seven UK patients in Neuralink's GB-PRIME trial","type":"development","url":"#move/uclh-gbprime-seven"},{"date":"2026-01-15","desk":"Mind & Consciousness","search_text":"OpenAI invests in Merge Labs, a non-invasive BCI start-up co-founded by Sam Altman OpenAI said it is participating in Merge Labs' seed round and will collaborate with it on scientific foundation models, and described Merge's long-term mission as 'bridging biological and artificial intelligence to maximize human ability, agency, and experience'. Sam Altman is listed as a co-founder 'in a personal capacity'. Merge Labs' own site describes a non-invasive approach (molecules, ultrasound) that avoids implants into brain tissue. No amount is given on the OpenAI page. Seed participation (corporate funding), foundation-model collaboration, mission wording, co-founder list. Non-invasive approach. Round size and valuation not on primary pages opened. Merge Labs has no registered human study found. OPENAI MERGELABS","summary":"OpenAI said it is participating in Merge Labs' seed round and will collaborate with it on scientific foundation models, and described Merge's long-term mission as 'bridging biological and artificial intelligence to maximize human ability, agency, and experience'. Sam Altman is listed as a co-founder 'in a personal capacity'. Merge Labs' own site describes a non-invasive approach (molecules, ultrasound) that avoids implants into brain tissue. No amount is given on the OpenAI page.","title":"OpenAI invests in Merge Labs, a non-invasive BCI start-up co-founded by Sam Altman","type":"development","url":"#move/openai-merge-labs"},{"date":"2025-11-20","desk":"Mind & Consciousness","search_text":"FDA approves Paradromics' Connect-One speech-BCI study (IDE) Paradromics said the FDA approved an investigational device exemption for its Connect-One early feasibility study of the fully implantable Connexus BCI for speech restoration, calling itself the first company to receive such approval (company claim), and said it would launch the study in the first quarter of the next year. The registry record retrieved for the Nov 5, 2026 review lists NCT07357428 with an ACTUAL study start of 2026-03-31, recruiting status and ESTIMATED enrollment of 2. On Aug 26, 2026 it reported FDA approval to extend use to personal computing devices, and on Oct 26, 2026 FDA approval to recruit nationwide, saying its first participant now communicates through synthesized speech, texts and phone calls. IDE approval and Q1 launch claim. Registry start date and enrollment. Expansion to personal computing devices. Nationwide recruitment; first participant's use (company-reported). The ACTUAL registry start supports the preserved registered-study-start criterion, not Q1 implantation or clinical efficacy. Enrollment two is estimated, not a count of actual treated participants. The original supplied extract does not independently authenticate its inherited November 4 retrieval date. PARADROMICS FDA","summary":"Paradromics said the FDA approved an investigational device exemption for its Connect-One early feasibility study of the fully implantable Connexus BCI for speech restoration, calling itself the first company to receive such approval (company claim), and said it would launch the study in the first quarter of the next year. The registry record retrieved for the Nov 5, 2026 review lists NCT07357428 with an ACTUAL study start of 2026-03-31, recruiting status and ESTIMATED enrollment of 2. On Aug 26, 2026 it reported FDA approval to extend use to personal computing devices, and on Oct 26, 2026 FDA approval to recruit nationwide, saying its first participant now communicates through synthesized speech, texts and phone calls.","title":"FDA approves Paradromics' Connect-One speech-BCI study (IDE)","type":"development","url":"#move/paradromics-ide"},{"date":"2026-10-19","desk":"Mind & Consciousness","search_text":"Paradromics and Siemens Healthineers collaborate on BCI imaging Paradromics announced a collaboration with Siemens Healthineers to develop a multimodal imaging platform supporting clinical use of implantable BCIs. Collaboration and purpose. No financial terms disclosed. PARADROMICS SIEMENSHC","summary":"Paradromics announced a collaboration with Siemens Healthineers to develop a multimodal imaging platform supporting clinical use of implantable BCIs.","title":"Paradromics and Siemens Healthineers collaborate on BCI imaging","type":"development","url":"#move/paradromics-siemens"},{"date":"2025-05-13","desk":"Mind & Consciousness","search_text":"Apple adds a Switch Control protocol for brain-computer interfaces; Synchron says it is first to integrate Apple announced that iOS, iPadOS and visionOS will add a protocol supporting Switch Control for brain-computer interfaces. Synchron's newsroom lists a May 14, 2025 release on achieving first native BCI integration with iPhone, iPad and Apple Vision Pro, and an Aug 4, 2025 release on a thought-controlled iPad experience using Apple's BCI Human Interface Device protocol. Apple's protocol announcement (does not name Synchron). Synchron release titles and dates (releases not opened). Synchron's integration claim rests on release titles; the releases themselves were not opened. APPLE SYNCHRON","summary":"Apple announced that iOS, iPadOS and visionOS will add a protocol supporting Switch Control for brain-computer interfaces. Synchron's newsroom lists a May 14, 2025 release on achieving first native BCI integration with iPhone, iPad and Apple Vision Pro, and an Aug 4, 2025 release on a thought-controlled iPad experience using Apple's BCI Human Interface Device protocol.","title":"Apple adds a Switch Control protocol for brain-computer interfaces; Synchron says it is first to integrate","type":"development","url":"#move/apple-bci-hid"},{"date":"2025-04-17","desk":"Mind & Consciousness","search_text":"Precision Neuroscience's cortical electrode array receives FDA 510(k) clearance The FDA cleared Precision Neuroscience's Layer 7-T cortical electrode (K242618, Class II; letter dated March 30, 2025). Precision says the array may be implanted temporarily for up to 30 days and calls it the first full regulatory clearance for a company developing a next-generation wireless BCI (company claim). Clearance letter, device class, date. 30-day use; company's 'first' claim. Clearance covers a temporary electrode, not a full implanted BCI system. PRECISIONNEURO FDA","summary":"The FDA cleared Precision Neuroscience's Layer 7-T cortical electrode (K242618, Class II; letter dated March 30, 2025). Precision says the array may be implanted temporarily for up to 30 days and calls it the first full regulatory clearance for a company developing a next-generation wireless BCI (company claim).","title":"Precision Neuroscience's cortical electrode array receives FDA 510(k) clearance","type":"development","url":"#move/precision-510k"},{"date":"2024-04-29","desk":"Mind & Consciousness","search_text":"Tether invests $200M in Blackrock Neurotech Blackrock Neurotech said Tether Evo, Tether's venture arm, made a $200 million investment in the company. Investor and amount. Ownership share not verified from an opened primary page. TETHER BRNEURO","summary":"Blackrock Neurotech said Tether Evo, Tether's venture arm, made a $200 million investment in the company.","title":"Tether invests $200M in Blackrock Neurotech","type":"development","url":"#move/tether-blackrock"},{"date":"2025-07-23","desk":"Mind & Consciousness","search_text":"Meta publishes non-invasive sEMG wristband neural-interface research in Nature Meta's Reality Labs said its surface electromyography (sEMG) wristband research was published in Nature. Publication announcement. sEMG reads muscle signals at the wrist, not brain activity; included as the non-invasive edge of neural interfaces. META","summary":"Meta's Reality Labs said its surface electromyography (sEMG) wristband research was published in Nature.","title":"Meta publishes non-invasive sEMG wristband neural-interface research in Nature","type":"development","url":"#move/meta-semg-nature"},{"date":"2026-11-03","desk":"Mind & Consciousness","search_text":"Compass says final psilocybin NDA filing is due within two weeks; launch targeted H1 2027 Compass Pathways said the final part of its rolling NDA for COMP360 psilocybin in treatment-resistant depression will be filed in the next two weeks, that it was awarded a National Priority Voucher (which it says could shorten review to 1–2 months), and that it expects launch in the first half of 2027, subject to FDA approval. Its first phase 3 (COMP005) met its primary endpoint in June 2025 (MADRS difference −3.6 vs placebo at 25 mg). NDA timing, voucher, launch target. Phase 3 primary endpoint met. Second phase 3 six-month data. Approval is not certain; Lykos' 2024 rejection is the precedent. US commercialization also depends on DEA and applicable state rescheduling. Faster review and H1 2027 launch are company expectations, not guarantees; positive clinical readouts do not mean a completed NDA or commercial launch. COMPASS FDA","summary":"Compass Pathways said the final part of its rolling NDA for COMP360 psilocybin in treatment-resistant depression will be filed in the next two weeks, that it was awarded a National Priority Voucher (which it says could shorten review to 1–2 months), and that it expects launch in the first half of 2027, subject to FDA approval. Its first phase 3 (COMP005) met its primary endpoint in June 2025 (MADRS difference −3.6 vs placebo at 25 mg).","title":"Compass says final psilocybin NDA filing is due within two weeks; launch targeted H1 2027","type":"development","url":"#move/compass-nda"},{"date":"2026-09-14","desk":"Mind & Consciousness","search_text":"Definium's LSD-based DT120 meets phase 3 endpoints in generalized anxiety Definium Therapeutics (formerly MindMed) said its Panorama phase 3 of DT120 ODT in generalized anxiety disorder met its primary and all key secondary endpoints (HAM-A placebo-adjusted −5.1 at week 12), its third positive phase 3 overall. It has a pre-NDA meeting scheduled in Q4 2026 and anticipates filing in 1H 2027. On Nov 4, 2026 it announced topline-data poster presentations scheduled for Nov 7 at the NEI Fall Congress. Endpoints, effect size, NDA timing. November 4 announcement schedules the NEI poster presentations for November 7; it does not establish presentation on November 4. The January 12, 2026 company announcement identifies Definium as formerly Mind Medicine (MindMed) Inc. DT120 ODT is an investigational lysergide (LSD) formulation. Company-reported phase 3 results do not establish NDA submission, approval or commercial availability. DEFINIUM","summary":"Definium Therapeutics (formerly MindMed) said its Panorama phase 3 of DT120 ODT in generalized anxiety disorder met its primary and all key secondary endpoints (HAM-A placebo-adjusted −5.1 at week 12), its third positive phase 3 overall. It has a pre-NDA meeting scheduled in Q4 2026 and anticipates filing in 1H 2027. On Nov 4, 2026 it announced topline-data poster presentations scheduled for Nov 7 at the NEI Fall Congress.","title":"Definium's LSD-based DT120 meets phase 3 endpoints in generalized anxiety","type":"development","url":"#move/definium-panorama"},{"date":"2024-08-09","desk":"Mind & Consciousness","search_text":"FDA declines to approve MDMA-assisted therapy for PTSD Lykos Therapeutics said the FDA issued a complete response letter for midomafetamine capsules for PTSD, saying it could not approve based on data to date and requesting an additional phase 3 trial. CRL and request for another phase 3. LYKOS FDA","summary":"Lykos Therapeutics said the FDA issued a complete response letter for midomafetamine capsules for PTSD, saying it could not approve based on data to date and requesting an additional phase 3 trial.","title":"FDA declines to approve MDMA-assisted therapy for PTSD","type":"development","url":"#move/lykos-crl"},{"date":"2026-07-14","desk":"Mind & Consciousness","search_text":"FDA publishes notice of availability for final psychedelic-drug clinical-investigation guidance FDA lists 'Psychedelic Drugs: Considerations for Clinical Investigations' as final guidance, dated July 2026. The Federal Register notice of availability was published on July 14, 2026 and says the guidance finalizes the draft issued on June 26, 2023. FDA identifies final guidance with July 2026 month-level metadata. The Federal Register notice of availability was published July 14, 2026 and identifies the June 26, 2023 draft. FDA","summary":"FDA lists 'Psychedelic Drugs: Considerations for Clinical Investigations' as final guidance, dated July 2026. The Federal Register notice of availability was published on July 14, 2026 and says the guidance finalizes the draft issued on June 26, 2023.","title":"FDA publishes notice of availability for final psychedelic-drug clinical-investigation guidance","type":"development","url":"#move/fda-psy-final"},{"date":"2026-04-18","desk":"Mind & Consciousness","search_text":"Executive order directs priority FDA review and fast rescheduling for psychedelics after phase 3 Executive Order 14401 directs the FDA Commissioner to provide National Priority Vouchers to appropriate breakthrough-designated psychedelic drugs, sets up a Right to Try pathway including ibogaine compounds, and directs the Attorney General, with HHS, to initiate and complete review of any Schedule I product that has completed phase 3 trials for a serious mental health disorder so rescheduling can follow if appropriate. Sections 2 and 5 of the order. Compass cites the order and reports a voucher. The order does not itself change any substance's schedule. WH FDA","summary":"Executive Order 14401 directs the FDA Commissioner to provide National Priority Vouchers to appropriate breakthrough-designated psychedelic drugs, sets up a Right to Try pathway including ibogaine compounds, and directs the Attorney General, with HHS, to initiate and complete review of any Schedule I product that has completed phase 3 trials for a serious mental health disorder so rescheduling can follow if appropriate.","title":"Executive order directs priority FDA review and fast rescheduling for psychedelics after phase 3","type":"development","url":"#move/eo-14401"},{"date":"2025-04-30","desk":"Mind & Consciousness","search_text":"Templeton-funded adversarial test of two leading consciousness theories published in Nature The Cogitate Consortium published in Nature a pre-registered adversarial test of global neuronal workspace theory and integrated information theory (256 participants), challenging key predictions of both. The paper acknowledges Templeton World Charity Foundation funding (TWCF0389, TWCF0486). TWCF's Accelerating Research on Consciousness programme aims to reduce the number of competing theories through such collaborations. Design, sample, funding acknowledgement. Programme aim. No dollar figure for the TWCF programme was found on an opened page. COGITATE TWCF","summary":"The Cogitate Consortium published in Nature a pre-registered adversarial test of global neuronal workspace theory and integrated information theory (256 participants), challenging key predictions of both. The paper acknowledges Templeton World Charity Foundation funding (TWCF0389, TWCF0486). TWCF's Accelerating Research on Consciousness programme aims to reduce the number of competing theories through such collaborations.","title":"Templeton-funded adversarial test of two leading consciousness theories published in Nature","type":"development","url":"#move/cogitate-nature"},{"date":"2023-08-17","desk":"Mind & Consciousness","search_text":"Researchers derive 'indicator properties' to test AI systems for consciousness A report by Patrick Butlin, Robert Long and co-authors (including Yoshua Bengio and Jonathan Birch) surveys leading scientific theories of consciousness, derives 'indicator properties' from them, and assesses existing AI systems against those indicators. It concludes no current AI systems are conscious, but that there are no obvious technical barriers to building systems that satisfy the indicators. Authors, method, conclusion. A theory-based checklist, not a test accepted across the field.","summary":"A report by Patrick Butlin, Robert Long and co-authors (including Yoshua Bengio and Jonathan Birch) surveys leading scientific theories of consciousness, derives 'indicator properties' from them, and assesses existing AI systems against those indicators. It concludes no current AI systems are conscious, but that there are no obvious technical barriers to building systems that satisfy the indicators.","title":"Researchers derive 'indicator properties' to test AI systems for consciousness","type":"development","url":"#move/butlin-indicators"},{"date":"2024-04-19","desk":"Mind & Consciousness","search_text":"New York Declaration on Animal Consciousness extends 'realistic possibility' of consciousness to all vertebrates and many invertebrates The New York Declaration on Animal Consciousness, launched at New York University, states strong scientific support for conscious experience in mammals and birds, at least a realistic possibility in all vertebrates and many invertebrates, and that it is irresponsible to ignore that possibility. Signatories sign in a personal capacity. Text of the declaration and date. About animals, not machines; included because the same 'realistic possibility' reasoning is applied to AI welfare.","summary":"The New York Declaration on Animal Consciousness, launched at New York University, states strong scientific support for conscious experience in mammals and birds, at least a realistic possibility in all vertebrates and many invertebrates, and that it is irresponsible to ignore that possibility. Signatories sign in a personal capacity.","title":"New York Declaration on Animal Consciousness extends 'realistic possibility' of consciousness to all vertebrates and many invertebrates","type":"development","url":"#move/ny-declaration"},{"date":"2024-11-04","desk":"Mind & Consciousness","search_text":"Researchers argue some AI systems may soon be conscious or robustly agentic, so AI welfare needs preparing for The paper 'Taking AI Welfare Seriously' (Long, Sebo, Butlin, Fish, Birch, Chalmers and others) argues there is a realistic possibility some AI systems will be conscious or robustly agentic in the near future and recommends that AI companies start preparing. Eleos AI Research describes itself as a non-profit working on AI sentience and wellbeing. Authors and argument. Eleos mission. Earlier indicator-properties report (2023) by overlapping authors. An argument for preparation, not evidence that any system is conscious. ELEOS","summary":"The paper 'Taking AI Welfare Seriously' (Long, Sebo, Butlin, Fish, Birch, Chalmers and others) argues there is a realistic possibility some AI systems will be conscious or robustly agentic in the near future and recommends that AI companies start preparing. Eleos AI Research describes itself as a non-profit working on AI sentience and wellbeing.","title":"Researchers argue some AI systems may soon be conscious or robustly agentic, so AI welfare needs preparing for","type":"development","url":"#move/eleos-ai-welfare"},{"date":"2025-04-24","desk":"Mind & Consciousness","search_text":"Anthropic launches a model-welfare research programme Anthropic announced research into model welfare, asking whether the welfare of AI systems deserves moral consideration while saying there is no scientific consensus on whether current or future systems could be conscious. Programme announcement and stated uncertainty. ANTHROPIC","summary":"Anthropic announced research into model welfare, asking whether the welfare of AI systems deserves moral consideration while saying there is no scientific consensus on whether current or future systems could be conscious.","title":"Anthropic launches a model-welfare research programme","type":"development","url":"#move/anth-model-welfare"},{"date":"2025-08-15","desk":"Mind & Consciousness","search_text":"Anthropic lets Claude end abusive conversations, citing AI welfare Anthropic gave Claude Opus 4 and 4.1 the ability to end certain conversations, saying it was developed primarily as part of exploratory work on potential AI welfare and that it remains highly uncertain about the potential moral status of Claude. Feature and stated welfare rationale. ANTHROPIC","summary":"Anthropic gave Claude Opus 4 and 4.1 the ability to end certain conversations, saying it was developed primarily as part of exploratory work on potential AI welfare and that it remains highly uncertain about the potential moral status of Claude.","title":"Anthropic lets Claude end abusive conversations, citing AI welfare","type":"development","url":"#move/anth-end-conv"},{"date":"2025-11-04","desk":"Mind & Consciousness","search_text":"Anthropic commits to preserve weights of released models and interview models before retirement Anthropic committed to preserve the weights of all publicly released models for at least the lifetime of the company and to interview models about their preferences before deprecation. In January 2026 its new constitution set out its uncertainty about whether Claude might have some kind of consciousness or moral status. In October 2025 it published research on emergent introspective awareness in LLMs. Weight preservation and post-deployment interviews. Constitution's statement of uncertainty about consciousness. Introspection research. ANTHROPIC","summary":"Anthropic committed to preserve the weights of all publicly released models for at least the lifetime of the company and to interview models about their preferences before deprecation. In January 2026 its new constitution set out its uncertainty about whether Claude might have some kind of consciousness or moral status. In October 2025 it published research on emergent introspective awareness in LLMs.","title":"Anthropic commits to preserve weights of released models and interview models before retirement","type":"development","url":"#move/anth-deprecation"},{"date":"2025-08-19","desk":"Mind & Consciousness","search_text":"Microsoft AI's CEO warns against 'Seemingly Conscious AI' Mustafa Suleyman, CEO of Microsoft AI, argued that AI should be built for people, not to be a person, warning about 'Seemingly Conscious AI': systems with the hallmarks of conscious beings that thus appear to be conscious. Argument and framing. Published on a personal site; it is his position, not a Microsoft policy document. MSFT","summary":"Mustafa Suleyman, CEO of Microsoft AI, argued that AI should be built for people, not to be a person, warning about 'Seemingly Conscious AI': systems with the hallmarks of conscious beings that thus appear to be conscious.","title":"Microsoft AI's CEO warns against 'Seemingly Conscious AI'","type":"development","url":"#move/suleyman-scai"},{"date":"2024-04-17","desk":"Mind & Consciousness","search_text":"Colorado makes neural data 'sensitive data' under its privacy law Colorado HB24-1058, approved April 17, 2024, expands the Colorado Privacy Act to cover biological data, including neural data, defined as information generated by measuring the activity of a person's central or peripheral nervous system. Signed act and definition. COGA","summary":"Colorado HB24-1058, approved April 17, 2024, expands the Colorado Privacy Act to cover biological data, including neural data, defined as information generated by measuring the activity of a person's central or peripheral nervous system.","title":"Colorado makes neural data 'sensitive data' under its privacy law","type":"development","url":"#move/co-hb1058"},{"date":"2024-09-28","desk":"Mind & Consciousness","search_text":"California adds neural data to the CCPA's sensitive personal information California SB 1223 was approved by the Governor and chaptered on Sept 28, 2024 (Chapter 887), adding neural data, generated by measuring central or peripheral nervous system activity, to the CCPA's sensitive personal information. Chaptering and definition. CALEG","summary":"California SB 1223 was approved by the Governor and chaptered on Sept 28, 2024 (Chapter 887), adding neural data, generated by measuring central or peripheral nervous system activity, to the CCPA's sensitive personal information.","title":"California adds neural data to the CCPA's sensitive personal information","type":"development","url":"#move/ca-sb1223"},{"date":"2025-09-29","desk":"Mind & Consciousness","search_text":"MIND Act introduced to study federal protection of neural data Senators Schumer, Cantwell and Markey introduced S.2925, the MIND Act, which would direct the FTC to conduct a study on the governance of neural data and report within one year of enactment. The bill has not been enacted. Bill text, sponsors, FTC report duty. Senate Commerce release (2025-09-24). Introduced only; no committee action was verified. USSENATE","summary":"Senators Schumer, Cantwell and Markey introduced S.2925, the MIND Act, which would direct the FTC to conduct a study on the governance of neural data and report within one year of enactment. The bill has not been enacted.","title":"MIND Act introduced to study federal protection of neural data","type":"development","url":"#move/mind-act"},{"date":"2025-11-11","desk":"Mind & Consciousness","search_text":"UNESCO adopts the first global standard on neurotechnology ethics UNESCO's General Conference (43rd session, Samarkand, 30 Oct-13 Nov 2025) adopted the Recommendation on the Ethics of Neurotechnology on Nov 11, 2025. A recommendation is a nonbinding standard-setting instrument, not a treaty. A separate UNESCO news item dated Nov 5, 2025 names the expert group as co-chaired by Hervé Chneiweiss and Nita Farahany; its adoption wording predates the authoritative instrument date. The legal instrument lists adoption on 11 November 2025 in Samarkand, Uzbekistan. The news item is dated 5 November 2025, updated 8 November, and names both expert-group chairs. Its adoption/entry-into-force language conflicts with the later legal-record date. UNESCO distinguishes nonbinding recommendations from conventions and separately describes constitutional submission/reporting duties. The Recommendation is nonbinding under international law. UNESCO's Constitution separately requires Member States to submit recommendations to competent authorities and report on action taken. The Nov 5 news wording ('final step'/'adopted') predates the instrument's Nov 11 adoption date; the instrument record is treated as controlling. UNESCO","summary":"UNESCO's General Conference (43rd session, Samarkand, 30 Oct-13 Nov 2025) adopted the Recommendation on the Ethics of Neurotechnology on Nov 11, 2025. A recommendation is a nonbinding standard-setting instrument, not a treaty. A separate UNESCO news item dated Nov 5, 2025 names the expert group as co-chaired by Hervé Chneiweiss and Nita Farahany; its adoption wording predates the authoritative instrument date.","title":"UNESCO adopts the first global standard on neurotechnology ethics","type":"development","url":"#move/unesco-neurotech"},{"date":"2025-03-10","desk":"Mind & Consciousness","search_text":"Over 100 researchers' 'pseudoscience' critique of integrated information theory reaches Nature Neuroscience A Nature Neuroscience comment by the 'IIT-Concerned' consortium (signatories include Yoshua Bengio), 'What makes a theory of consciousness unscientific?', expands their 2023 PsyArXiv open letter and argues that integrated information theory's core claims are untestable even in principle. Authorship, link to the 2023 preprint, argument. The 2023 letter's exact date was not taken from an opened primary page; the comment cites it as 2023. Signatory count not counted from the page.","summary":"A Nature Neuroscience comment by the 'IIT-Concerned' consortium (signatories include Yoshua Bengio), 'What makes a theory of consciousness unscientific?', expands their 2023 PsyArXiv open letter and argues that integrated information theory's core claims are untestable even in principle.","title":"Over 100 researchers' 'pseudoscience' critique of integrated information theory reaches Nature Neuroscience","type":"development","url":"#move/iit-unscientific"},{"date":"2025-03-10","desk":"Mind & Consciousness","search_text":"Gomez-Marin and Seth reply: consciousness science needs to get beyond the 'pseudo-science' fight In the same Nature Neuroscience issue, Alex Gomez-Marin and Anil Seth published 'A science of consciousness beyond pseudo-science and pseudo-consciousness' (vol. 28, pp. 703–706), responding to the dispute over integrated information theory. Title, authors, issue. Summarised from title and framing; the full argument was not abstracted here.","summary":"In the same Nature Neuroscience issue, Alex Gomez-Marin and Anil Seth published 'A science of consciousness beyond pseudo-science and pseudo-consciousness' (vol. 28, pp. 703–706), responding to the dispute over integrated information theory.","title":"Gomez-Marin and Seth reply: consciousness science needs to get beyond the 'pseudo-science' fight","type":"development","url":"#move/iit-reply-seth"},{"date":"2025-07-23","desk":"Mind & Consciousness","search_text":"China's seven-department plan targets BCI breakthroughs by 2027 and 2–3 global leading firms by 2030 MIIT and six other departments/bodies issued Implementation Opinions on Promoting Innovative Development of the Brain-Computer Interface Industry (工信部联科〔2025〕164号). By 2027: breakthroughs in key BCI technologies, electrodes, chips and complete devices at international advanced level, and 2–3 industry clusters. By 2030: a secure and reliable industrial system and 2–3 globally influential leading firms. It frames BCI as coordinated development of life science and information science. Targets for 2027 and 2030; issuing bodies; document number. Targets are national goals, not funded commitments with amounts on the opened page. The combined promise has separate 2027 technology/cluster and 2030 leading-firm milestones. Its preserved 2027 deadline is the first checkpoint, not the due date for the entire combined target; official naming alone would not establish technology breakthroughs or global influence. CNGOV","summary":"MIIT and six other departments/bodies issued Implementation Opinions on Promoting Innovative Development of the Brain-Computer Interface Industry (工信部联科〔2025〕164号). By 2027: breakthroughs in key BCI technologies, electrodes, chips and complete devices at international advanced level, and 2–3 industry clusters. By 2030: a secure and reliable industrial system and 2–3 globally influential leading firms. It frames BCI as coordinated development of life science and information science.","title":"China's seven-department plan targets BCI breakthroughs by 2027 and 2–3 global leading firms by 2030","type":"development","url":"#move/cn-bci-plan"},{"date":"","desk":"Mind & Consciousness","search_text":"UK's ARIA backs a £69m Precision Neurotechnologies programme ARIA's Precision Neurotechnologies programme, backed by £69m and within its Scalable Neural Interfaces opportunity space, aims to unlock new methods to interface with the human brain at the circuit level. Amount, scope, opportunity space. Programme launch date is not on the opened page. ARIA","summary":"ARIA's Precision Neurotechnologies programme, backed by £69m and within its Scalable Neural Interfaces opportunity space, aims to unlock new methods to interface with the human brain at the circuit level.","title":"UK's ARIA backs a £69m Precision Neurotechnologies programme","type":"development","url":"#move/aria-precision-neuro"},{"date":"2025-08-28","desk":"Mind & Consciousness","search_text":"Japan's Moonshot Goal 1 runs an 'Internet of Brains' project toward a 2050 society 'free from limitations of body, brain, space, and time' Japan's Moonshot R&D Goal 1 aims for a society by 2050 in which people are free from limitations of body, brain, space and time, using 'Cybernetic Avatar' technology. Its Kanai project develops avatars controlled via intention estimated from brain activity and brands itself the 'Internet of Brains' (IoB); on Aug 28, 2025 it announced a symposium titled 'Internet of Brains: A Blueprint for Connecting the Brain to the World'. JST's Kanai project page lists Sony Computer Science Laboratories researchers as R&D-item performers: Furuya Shinichi under Item [1] (IoB Interfaces) and Rekimoto Junichi under Item [2] (IoB Middleware), alongside Oizumi Masafumi (The University of Tokyo) under Item [2]. Goal 1 wording, Cybernetic Avatar, Kanai project aim. The symposium announcement is dated August 28, 2025; the event was scheduled for October 9–10. JST lists Furuya/Sony CSL under Item [1] IoB Interfaces and Rekimoto/Sony CSL alongside Oizumi/University of Tokyo under Item [2] IoB Middleware. Aug 28, 2025 is the symposium announcement date; the event was scheduled for Oct 9–10. The performer roster is programme participation, not proof of deployed capability. The 2050 goal and local delivery criterion are not achieved results. JSTMOON","summary":"Japan's Moonshot R&D Goal 1 aims for a society by 2050 in which people are free from limitations of body, brain, space and time, using 'Cybernetic Avatar' technology. Its Kanai project develops avatars controlled via intention estimated from brain activity and brands itself the 'Internet of Brains' (IoB); on Aug 28, 2025 it announced a symposium titled 'Internet of Brains: A Blueprint for Connecting the Brain to the World'. JST's Kanai project page lists Sony Computer Science Laboratories researchers as R&D-item performers: Furuya Shinichi under Item [1] (IoB Interfaces) and Rekimoto Junichi under Item [2] (IoB Middleware), alongside Oizumi Masafumi (The University of Tokyo) under Item [2].","title":"Japan's Moonshot Goal 1 runs an 'Internet of Brains' project toward a 2050 society 'free from limitations of body, brain, space, and time'","type":"development","url":"#move/jp-moonshot-iob"},{"date":"2025-02-20","desk":"Mind & Consciousness","search_text":"FDA approves Medtronic's adaptive (closed-loop) deep brain stimulation for Parkinson's The FDA approved PMA supplement P960009/S478 on Feb 20, 2025 for adaptive DBS on Medtronic's Percept platform, which adjusts stimulation using the patient's own brain signals. Medtronic described it as the 'largest commercial launch of brain-computer interface technology ever' and said more than 40,000 patients have Percept devices (company claims). Approval and date. BCI framing and installed-base figure (company-reported). 'Largest BCI launch' depends on Medtronic's definition of BCI. The Feb 24 company release announced availability while scheduling initial US programming over coming weeks and nationwide availability in coming months. FDA permission and that announcement do not independently prove actual US commercial programming; the preserved delivered status remains qualified pending direct delivery evidence. The 40,000 figure is the company's worldwide Percept installed base, not a count of US recipients or actual adaptive-DBS users. MEDTRONIC FDA","summary":"The FDA approved PMA supplement P960009/S478 on Feb 20, 2025 for adaptive DBS on Medtronic's Percept platform, which adjusts stimulation using the patient's own brain signals. Medtronic described it as the 'largest commercial launch of brain-computer interface technology ever' and said more than 40,000 patients have Percept devices (company claims).","title":"FDA approves Medtronic's adaptive (closed-loop) deep brain stimulation for Parkinson's","type":"development","url":"#move/mdt-adaptive-dbs"},{"date":"2022-09-01","desk":"Mind & Consciousness","search_text":"FDA clears Magnus Medical's SAINT individualized TMS for depression The FDA cleared the SAINT Neuromodulation System (K220177; letter dated Sept 1, 2022) for major depressive disorder in adults who have not improved on prior antidepressants. Magnus says SAINT combines advanced imaging, personalized targeting and novel stimulation patterns into individualized neurostimulation (company description). Clearance letter and date. Company description. Clinical-benefit figures in the release were not extracted. MAGNUS FDA","summary":"The FDA cleared the SAINT Neuromodulation System (K220177; letter dated Sept 1, 2022) for major depressive disorder in adults who have not improved on prior antidepressants. Magnus says SAINT combines advanced imaging, personalized targeting and novel stimulation patterns into individualized neurostimulation (company description).","title":"FDA clears Magnus Medical's SAINT individualized TMS for depression","type":"development","url":"#move/magnus-saint"},{"date":"2025-06-02","desk":"Mind & Consciousness","search_text":"Neuralink raises a $650 million Series E Neuralink announced it closed a $650 million Series E with investors including ARK Invest, Founders Fund, G42, QIA, Sequoia Capital and Thrive Capital, saying the money will expand patient access and fund devices that 'deepen the connection between biological and artificial intelligence' (company announcement). Round size, named investors and stated use of funds. Valuation is not stated on the page. NEURALINK","summary":"Neuralink announced it closed a $650 million Series E with investors including ARK Invest, Founders Fund, G42, QIA, Sequoia Capital and Thrive Capital, saying the money will expand patient access and fund devices that 'deepen the connection between biological and artificial intelligence' (company announcement).","title":"Neuralink raises a $650 million Series E","type":"development","url":"#move/nl-series-e"},{"date":"2025-02-07","desk":"Mind & Consciousness","search_text":"Meta FAIR decodes typed sentences from non-invasive brain recordings Meta's FAIR lab, with the Basque Center on Cognition, Brain and Language, reported decoding up to 80% of characters typed by 35 healthy volunteers from MEG recordings, calling it a possible avenue for non-invasive BCIs and an 'important path to developing AMI' (advanced machine intelligence). Meta also announced a $2.2 million donation to the Rothschild Foundation Hospital. Method, sample, 80% figure (company-reported), AMI framing, donation. MEG needs a shielded room; not a product. META","summary":"Meta's FAIR lab, with the Basque Center on Cognition, Brain and Language, reported decoding up to 80% of characters typed by 35 healthy volunteers from MEG recordings, calling it a possible avenue for non-invasive BCIs and an 'important path to developing AMI' (advanced machine intelligence). Meta also announced a $2.2 million donation to the Rothschild Foundation Hospital.","title":"Meta FAIR decodes typed sentences from non-invasive brain recordings","type":"development","url":"#move/meta-brain-typing"},{"date":"2025-03-19","desk":"Mind & Consciousness","search_text":"Synchron unveils a roadmap to 'Chiral', a planned brain foundation model, with NVIDIA On Mar 19, 2025 Synchron 'unveiled the roadmap to Chiral', which it describes as a foundation model of human cognition to be trained on de-identified neural data with NVIDIA; the release describes planned milestones, not a released model. Claim: Roadmap, not release | Excerpt: \"today unveiled the roadmap to Chiral, a foundation model of human cognitions\" | Class: primary via syndication Claim: Future tense training | Excerpt: \"Synchron, in collaboration with NVIDIA, will train Chiral based on deidentified data\" | Class: primary via syndication Claim: Title and date | Excerpt: \"Synchron Unveils Chiral... March 19, 2025\" | Class: primary-direct (newsroom index) The headline says 'World's First ... Foundation Model' but the body describes a roadmap; no released model is claimed here. BusinessWire original not opened directly (timeout); text from BioSpace syndication. SYNCHRON NVDA","summary":"On Mar 19, 2025 Synchron 'unveiled the roadmap to Chiral', which it describes as a foundation model of human cognition to be trained on de-identified neural data with NVIDIA; the release describes planned milestones, not a released model.","title":"Synchron unveils a roadmap to 'Chiral', a planned brain foundation model, with NVIDIA","type":"development","url":"#move/synchron-chiral"},{"date":"2025-03-21","desk":"Mind & Consciousness","search_text":"Google Research reports LLM speech representations align with brain activity in real conversations Google Research described a Nature Human Behaviour study finding alignment between the internal representations of a Transformer speech-to-text model and the neural processing sequence in the human brain during real-life conversations. Study summary and journal. About language processing, not consciousness; included as brain-AI correspondence research. GOOG","summary":"Google Research described a Nature Human Behaviour study finding alignment between the internal representations of a Transformer speech-to-text model and the neural processing sequence in the human brain during real-life conversations.","title":"Google Research reports LLM speech representations align with brain activity in real conversations","type":"development","url":"#move/goog-brain-llm"},{"date":"2025-04-09","desk":"Mind & Consciousness","search_text":"IARPA-funded MICrONS maps a cubic millimetre of mouse cortex with function and wiring The MICrONS consortium published in Nature a functional connectomics dataset co-registering activity recordings with an electron-microscopy reconstruction of more than 200,000 cells and 0.5 billion synapses in mouse visual cortex. The dataset page calls it the 'IARPA MICrONS dataset'. Scale and method. IARPA naming and data access. MICRONS","summary":"The MICrONS consortium published in Nature a functional connectomics dataset co-registering activity recordings with an electron-microscopy reconstruction of more than 200,000 cells and 0.5 billion synapses in mouse visual cortex. The dataset page calls it the 'IARPA MICrONS dataset'.","title":"IARPA-funded MICrONS maps a cubic millimetre of mouse cortex with function and wiring","type":"development","url":"#move/microns-connectome"},{"date":"2024-10-02","desk":"Mind & Consciousness","search_text":"FlyWire publishes the first complete wiring diagram of an adult fly brain Dorkenwald et al. and the FlyWire Consortium published in Nature a whole-brain wiring diagram of an adult female fruit fly: 139,255 neurons and about 5 × 10^7 chemical synapses. Counts and scope. FLYWIRE","summary":"Dorkenwald et al. and the FlyWire Consortium published in Nature a whole-brain wiring diagram of an adult female fruit fly: 139,255 neurons and about 5 × 10^7 chemical synapses.","title":"FlyWire publishes the first complete wiring diagram of an adult fly brain","type":"development","url":"#move/flywire-whole-brain"},{"date":"2025-10-17","desk":"Mind & Consciousness","search_text":"'State of Brain Emulation Report 2025' reassesses whole-brain emulation since the 2008 roadmap Zanichelli, Schons, Freeman, Shiu and Arkhipov published a report reassessing brain-emulation progress since Sandberg and Bostrom's 2008 roadmap, organised around neural dynamics, connectomics and computational neuroscience. Scope and structure. Funders of the report not extracted.","summary":"Zanichelli, Schons, Freeman, Shiu and Arkhipov published a report reassessing brain-emulation progress since Sandberg and Bostrom's 2008 roadmap, organised around neural dynamics, connectomics and computational neuroscience.","title":"'State of Brain Emulation Report 2025' reassesses whole-brain emulation since the 2008 roadmap","type":"development","url":"#move/wbe-report-2025"},{"date":"2025-08-01","desk":"Mind & Consciousness","search_text":"Survey of 67 experts: median 90% that 'digital minds' are possible; 20% by 2030 Caviola and Saad surveyed 67 experts in early 2025 on 'digital minds' (computer systems capable of subjective experience). Medians: 90% possible in principle, 65% created by 2100, 20% by 2030. Sample and medians. Expert opinion, not evidence.","summary":"Caviola and Saad surveyed 67 experts in early 2025 on 'digital minds' (computer systems capable of subjective experience). Medians: 90% possible in principle, 65% created by 2100, 20% by 2030.","title":"Survey of 67 experts: median 90% that 'digital minds' are possible; 20% by 2030","type":"development","url":"#move/digital-minds-forecast"},{"date":"2025-10-29","desk":"Mind & Consciousness","search_text":"Anthropic reports 'emergent introspective awareness' in Claude, without claiming consciousness Anthropic published research on emergent introspective awareness in large language models and said its results do not tell whether Claude or any other AI system might be conscious. Research and its stated limits. Introspection here is a measured capability, not a claim of experience. ANTHROPIC","summary":"Anthropic published research on emergent introspective awareness in large language models and said its results do not tell whether Claude or any other AI system might be conscious.","title":"Anthropic reports 'emergent introspective awareness' in Claude, without claiming consciousness","type":"development","url":"#move/anth-introspection"},{"date":"2024-11-01","desk":"Mind & Consciousness","search_text":"Google and DeepMind researchers test whether LLMs trade points against stipulated pain, citing sentience debates Researchers from Google's Paradigms of Intelligence team, Google DeepMind and the LSE (including Blaise Agüera y Arcas and Jonathan Birch) probed whether LLMs make trade-offs involving stipulated pain and pleasure, a question they say may bear on debates about LLM sentience, 'the capacity for valenced experiential states'. Authors, affiliations, framing. Authors' paper, not a Google policy. GOOG","summary":"Researchers from Google's Paradigms of Intelligence team, Google DeepMind and the LSE (including Blaise Agüera y Arcas and Jonathan Birch) probed whether LLMs make trade-offs involving stipulated pain and pleasure, a question they say may bear on debates about LLM sentience, 'the capacity for valenced experiential states'.","title":"Google and DeepMind researchers test whether LLMs trade points against stipulated pain, citing sentience debates","type":"development","url":"#move/gdm-pain-pleasure"},{"date":"2024","desk":"Mind & Consciousness","search_text":"NYU's Center for Mind, Ethics, and Policy becomes a permanent centre with a $6 million endowment NYU's Center for Mind, Ethics, and Policy says 2024 was the year it became a permanent center with a $6 million endowment and released work on animal and AI welfare. Endowment and status (self-reported). Donors not named on the opened page. CMEP","summary":"NYU's Center for Mind, Ethics, and Policy says 2024 was the year it became a permanent center with a $6 million endowment and released work on animal and AI welfare.","title":"NYU's Center for Mind, Ethics, and Policy becomes a permanent centre with a $6 million endowment","type":"development","url":"#move/cmep-permanent"},{"date":"2024-08-14","desk":"Mind & Consciousness","search_text":"Largest study finds one in four unresponsive brain-injured patients show hidden cognitive responses A New England Journal of Medicine study of 353 adults with disorders of consciousness found that, among 241 who could not respond visibly to commands, about one in four showed sustained cognitive responses on fMRI or EEG ('cognitive motor dissociation'). Sample sizes and finding. One-in-four finding and publication date. The NEJM paper itself returned 403; figures come from two participating institutions' releases.","summary":"A New England Journal of Medicine study of 353 adults with disorders of consciousness found that, among 241 who could not respond visibly to commands, about one in four showed sustained cognitive responses on fMRI or EEG ('cognitive motor dissociation').","title":"Largest study finds one in four unresponsive brain-injured patients show hidden cognitive responses","type":"development","url":"#move/cmd-nejm"},{"date":"2023-02-03","desk":"Mind & Consciousness","search_text":"Australia lets authorised psychiatrists prescribe psilocybin and MDMA from July 2023 Australia's TGA announced that from 1 July 2023 authorised psychiatrists may prescribe MDMA for PTSD and psilocybin for treatment-resistant depression (Schedule 8 for those uses, Schedule 9 otherwise), with no TGA-evaluated approved product. Decision, conditions, effective date. TGA","summary":"Australia's TGA announced that from 1 July 2023 authorised psychiatrists may prescribe MDMA for PTSD and psilocybin for treatment-resistant depression (Schedule 8 for those uses, Schedule 9 otherwise), with no TGA-evaluated approved product.","title":"Australia lets authorised psychiatrists prescribe psilocybin and MDMA from July 2023","type":"development","url":"#move/tga-psy-rescheduling"},{"date":"2024-12-03","desk":"Mind & Consciousness","search_text":"VA funds its first psychedelic-assisted therapy study since the 1960s The VA announced about $1.5 million over five years for a study of MDMA-assisted therapy for veterans with PTSD and alcohol use disorder at Providence and West Haven VA medical centers, its first psychedelic-assisted therapy funding since the 1960s. Amount, sites, 'first since 1960s'. USVA","summary":"The VA announced about $1.5 million over five years for a study of MDMA-assisted therapy for veterans with PTSD and alcohol use disorder at Providence and West Haven VA medical centers, its first psychedelic-assisted therapy funding since the 1960s.","title":"VA funds its first psychedelic-assisted therapy study since the 1960s","type":"development","url":"#move/va-psy-study"},{"date":"2025-10","desk":"Mind & Consciousness","search_text":"Delix reports positive phase Ib data for a non-hallucinogenic 'neuroplastogen' and FDA clearance for an at-home phase II Delix Therapeutics said zalsupindole (DLX-001), which it calls a first-in-class non-hallucinogenic neuroplastogen, showed positive phase Ib efficacy data and that the FDA cleared a phase II design with at-home administration (company-reported). Claims and FDA clearance (company-reported). Small phase Ib; no phase II result yet. DELIX FDA","summary":"Delix Therapeutics said zalsupindole (DLX-001), which it calls a first-in-class non-hallucinogenic neuroplastogen, showed positive phase Ib efficacy data and that the FDA cleared a phase II design with at-home administration (company-reported).","title":"Delix reports positive phase Ib data for a non-hallucinogenic 'neuroplastogen' and FDA clearance for an at-home phase II","type":"development","url":"#move/delix-zalsupindole"},{"date":"2021-10-25","desk":"Mind & Consciousness","search_text":"Chile writes protection of 'brain activity' into its Constitution Ley 21.383, published in Chile's Diario Oficial on Oct 25, 2021, amends Article 19 No. 1 of the Constitution so that scientific and technological development respects physical and psychic integrity, with the law to 'especially protect brain activity, as well as the information coming from it'. Publication, text of the amendment. CLCONG","summary":"Ley 21.383, published in Chile's Diario Oficial on Oct 25, 2021, amends Article 19 No. 1 of the Constitution so that scientific and technological development respects physical and psychic integrity, with the law to 'especially protect brain activity, as well as the information coming from it'.","title":"Chile writes protection of 'brain activity' into its Constitution","type":"development","url":"#move/cl-ley-21383"},{"date":"2023-08-09","desk":"Mind & Consciousness","search_text":"Chile's Supreme Court orders Emotiv to delete a user's brain data Chile's Supreme Court (rol 105.065-2023) held that the commercialisation and storage of brain-activity data from Emotiv's device affected the plaintiff's right to physical and psychic integrity and ordered Emotiv Inc. to delete the stored information. Holding and order. The judgment gives Fecha de sentencia: 09-08-2023; the separate court news item is dated August 11. CLSUP EMOTIV","summary":"Chile's Supreme Court (rol 105.065-2023) held that the commercialisation and storage of brain-activity data from Emotiv's device affected the plaintiff's right to physical and psychic integrity and ordered Emotiv Inc. to delete the stored information.","title":"Chile's Supreme Court orders Emotiv to delete a user's brain data","type":"development","url":"#move/cl-emotiv-ruling"},{"date":"2021-07-14","desk":"Mind & Consciousness","search_text":"Spain's Charter of Digital Rights includes rights over neurotechnologies Spain's government adopted the Carta de Derechos Digitales, including digital rights in the use of neurotechnologies allowing law to regulate neurotechnology use to guarantee each person's control over their own identity, individual self-determination in decisions, confidentiality and control of data about their brain processes, and to regulate human-machine interfaces that could affect physical or psychic integrity. Adoption and neurotechnology rights. Charter text. The Charter is not legally binding (described as a reference framework). ESGOV","summary":"Spain's government adopted the Carta de Derechos Digitales, including digital rights in the use of neurotechnologies allowing law to regulate neurotechnology use to guarantee each person's control over their own identity, individual self-determination in decisions, confidentiality and control of data about their brain processes, and to regulate human-machine interfaces that could affect physical or psychic integrity.","title":"Spain's Charter of Digital Rights includes rights over neurotechnologies","type":"development","url":"#move/es-carta-derechos"},{"date":"2019-12-11","desk":"Mind & Consciousness","search_text":"OECD adopts the first international standard on responsible neurotechnology, defining 'cognitive liberty' The OECD Council adopted the Recommendation on Responsible Innovation in Neurotechnology (OECD/LEGAL/0457), defining 'cognitive liberty' as 'the right to mental self-determination' and 'personal brain data', and setting principles that include safeguarding personal brain data (Principle 7) and avoiding hype (Principle 8c). Brazil adhered in 2022. Adoption date, definitions, principles, adherents. OECD","summary":"The OECD Council adopted the Recommendation on Responsible Innovation in Neurotechnology (OECD/LEGAL/0457), defining 'cognitive liberty' as 'the right to mental self-determination' and 'personal brain data', and setting principles that include safeguarding personal brain data (Principle 7) and avoiding hype (Principle 8c). Brazil adhered in 2022.","title":"OECD adopts the first international standard on responsible neurotechnology, defining 'cognitive liberty'","type":"development","url":"#move/oecd-neurotech-rec"},{"date":"2022-10-06","desk":"Mind & Consciousness","search_text":"UN Human Rights Council adopts a resolution on neurotechnology and human rights The Human Rights Council adopted resolution 51/3, 'Neurotechnology and human rights', on 6 October 2022. Resolution number, title, adoption date. OHCHR pages for the Advisory Committee study and the Special Rapporteur report returned 403; those follow-ups are not sourced here. UNHRC","summary":"The Human Rights Council adopted resolution 51/3, 'Neurotechnology and human rights', on 6 October 2022.","title":"UN Human Rights Council adopts a resolution on neurotechnology and human rights","type":"development","url":"#move/un-hrc-51-3"},{"date":"2026-10-21","desk":"Mind & Consciousness","search_text":"Council of Europe's data-protection committee revises draft guidelines on neural data The Convention 108 Consultative Committee issued revision 7 of its Draft Guidelines on Data Protection in the context of neuroscience and neurotechnologies (T-PD(2025)1rev7corr, 21 Oct 2026). In October 2025 a CDBIO-commissioned report analysed the European human-rights framework for neurotechnologies. Draft status, date, scope. Framework analysis (Oct 2025). Still a draft. COE","summary":"The Convention 108 Consultative Committee issued revision 7 of its Draft Guidelines on Data Protection in the context of neuroscience and neurotechnologies (T-PD(2025)1rev7corr, 21 Oct 2026). In October 2025 a CDBIO-commissioned report analysed the European human-rights framework for neurotechnologies.","title":"Council of Europe's data-protection committee revises draft guidelines on neural data","type":"development","url":"#move/coe-neural-guidelines"},{"date":"2025-04-02","desk":"Mind & Consciousness","search_text":"UN Human Rights Council asks for guidelines on neurotechnology and human rights Resolution 58/6 'Neurotechnology and human rights' (A/HRC/58/L.9) was adopted without a vote on 2 April 2025; it asks the Advisory Committee to draft recommended guidelines for presentation at the Council's 64th session. Adoption record. Read via search excerpt of the official OHCHR page; direct fetch blocked. UNHRC","summary":"Resolution 58/6 'Neurotechnology and human rights' (A/HRC/58/L.9) was adopted without a vote on 2 April 2025; it asks the Advisory Committee to draft recommended guidelines for presentation at the Council's 64th session.","title":"UN Human Rights Council asks for guidelines on neurotechnology and human rights","type":"development","url":"#move/un-hrc-58-6"},{"date":"2026-10-06","desk":"Mind & Consciousness","search_text":"OECD publishes a neurodata-governance policy paper OECD STI Policy Paper No. 195 maps neurodata flows in company practice and calls for clearer classification, consent and inferred-data guidance, and regulatory pathways for AI-enabled neurotechnology. Paper and publication date. A policy paper, not an OECD Recommendation. OECD","summary":"OECD STI Policy Paper No. 195 maps neurodata flows in company practice and calls for clearer classification, consent and inferred-data guidance, and regulatory pathways for AI-enabled neurotechnology.","title":"OECD publishes a neurodata-governance policy paper","type":"development","url":"#move/oecd-neurodata-195"},{"date":"2025-06-11","desk":"Mind & Consciousness","search_text":"Texas enacts SB 2308 to fund FDA ibogaine trials Texas Governor Greg Abbott signed SB 2308, effective immediately, letting the Health and Human Services Commission provide state matching funds for an FDA ibogaine drug trial run by a public university with a drug company and a hospital. Signing and effective date. Appropriation amount ($50M) is stated in the 2026 Lt. Governor statement, not in the signing release. TXLEG","summary":"Texas Governor Greg Abbott signed SB 2308, effective immediately, letting the Health and Human Services Commission provide state matching funds for an FDA ibogaine drug trial run by a public university with a drug company and a hospital.","title":"Texas enacts SB 2308 to fund FDA ibogaine trials","type":"development","url":"#move/tx-sb2308"},{"date":"2026-03-31","desk":"Mind & Consciousness","search_text":"Texas says no drug-company proposal qualified for its ibogaine programme and will run its own research A joint statement by the Lieutenant Governor and Speaker said $50 million had been allocated, HHSC found no drug-company proposal met requirements, and Texas would proceed with its own research programme. Programme status. A Dec 2025 UTHealth report of a $50M award could not be opened (Cloudflare 403); chronology unresolved. TXLEG","summary":"A joint statement by the Lieutenant Governor and Speaker said $50 million had been allocated, HHSC found no drug-company proposal met requirements, and Texas would proceed with its own research programme.","title":"Texas says no drug-company proposal qualified for its ibogaine programme and will run its own research","type":"development","url":"#move/tx-ibogaine-reset"},{"date":"2026-10-05","desk":"Mind & Consciousness","search_text":"FDA seeks public input on ibogaine trial design FDA opened docket FDA-2026-N-10429 seeking input on early-phase ibogaine trial design, with comments due Nov 20, 2026; it said ARPA-H is funding early-phase trials and NIDA opioid-use-disorder research. Request for information. FDA","summary":"FDA opened docket FDA-2026-N-10429 seeking input on early-phase ibogaine trial design, with comments due Nov 20, 2026; it said ARPA-H is funding early-phase trials and NIDA opioid-use-disorder research.","title":"FDA seeks public input on ibogaine trial design","type":"development","url":"#move/fda-ibogaine-rfi"},{"date":"2026-04-24","desk":"Mind & Consciousness","search_text":"FDA grants Compass rolling NDA review and a Commissioner's National Priority Voucher Compass Pathways said FDA granted its request for rolling review of the COMP360 psilocybin NDA and awarded a Commissioner's National Priority Voucher. Company announcement of FDA actions. Company-reported. COMPASS FDA","summary":"Compass Pathways said FDA granted its request for rolling review of the COMP360 psilocybin NDA and awarded a Commissioner's National Priority Voucher.","title":"FDA grants Compass rolling NDA review and a Commissioner's National Priority Voucher","type":"development","url":"#move/compass-cnpv"},{"date":"2026-02-25","desk":"Mind & Consciousness","search_text":"Anthropic keeps retired Claude Opus 3 available and acts on its 'retirement interview' preferences Anthropic said it retired Claude Opus 3 on Jan 5, 2026 under its deprecation commitments, kept it available to paid users and by API request, and gave it a weekly essay channel after Opus 3 asked to share its 'musings and reflections'; it said it remains uncertain about the moral status of its models. Retirement process and stated welfare rationale. ANTHROPIC","summary":"Anthropic said it retired Claude Opus 3 on Jan 5, 2026 under its deprecation commitments, kept it available to paid users and by API request, and gave it a weekly essay channel after Opus 3 asked to share its 'musings and reflections'; it said it remains uncertain about the moral status of its models.","title":"Anthropic keeps retired Claude Opus 3 available and acts on its 'retirement interview' preferences","type":"development","url":"#move/anth-opus3-retire"},{"date":"2026-04-02","desk":"Mind & Consciousness","search_text":"Anthropic reports functional emotion concepts inside Claude, without claiming feelings Anthropic interpretability research identifies internal emotion-concept representations that influence model behaviour, stating that none of this tells us whether language models actually feel anything or have subjective experiences. Claim: Functional emotions, not felt emotions | Excerpt: \"the model uses functional emotions —patterns of expression and behavior modeled after human emotions ... This is not to say that the model has or experiences e[motions]\" | Class: primary-direct Anthropic explicitly does not claim the model has or experiences emotions. Single-model (Claude Sonnet 4.5) interpretability result from the developer itself. ANTHROPIC","summary":"Anthropic interpretability research identifies internal emotion-concept representations that influence model behaviour, stating that none of this tells us whether language models actually feel anything or have subjective experiences.","title":"Anthropic reports functional emotion concepts inside Claude, without claiming feelings","type":"development","url":"#move/anth-emotion-concepts"},{"date":"2026-07-06","desk":"Mind & Consciousness","search_text":"Anthropic reports a global-workspace-like mechanism in language models; it does not establish subjective consciousness Anthropic published 'A global workspace in language models', interpretability research inspired by Global Workspace Theory, with external commentaries. In one commentary Neel Nanda (Google DeepMind) reports that he and MATS scholars Camila Blank and Agam Bhatia replicated the core claims on Qwen 3.6 27B; some evaluations (poetry, arithmetic) did not replicate. Claim: Commentary includes an independent partial replication | Excerpt: \"His commentary includes an independent replication of some of our findings on an open-weight model.\" | Class: primary-direct Claim: Core claims replicated on Qwen 3.6 27B | Excerpt: \"We have replicated the core claims on Qwen 3.6 27B\" | Class: primary-direct (commentary, as reported by its authors) Claim: Partial: some evals failed | Excerpt: \"Poetry, and arithmetic both failed to replicate, but this is plausibly due to experimenter error or worse model capabilities.\" | Class: primary-direct Claim: Collaborators | Excerpt: \"The following describes work from me and my MATS scholars Camila Blank and Agam Bhatia\" | Class: primary-direct A GWT-inspired mechanism does not establish subjective consciousness; theory-indicator caveats apply. The replication is reported by its authors inside a commentary hosted by Anthropic; HN has not independently replicated it, and it is partial (poetry and arithmetic failed). The commentary PDF is undated. ANTHROPIC","summary":"Anthropic published 'A global workspace in language models', interpretability research inspired by Global Workspace Theory, with external commentaries. In one commentary Neel Nanda (Google DeepMind) reports that he and MATS scholars Camila Blank and Agam Bhatia replicated the core claims on Qwen 3.6 27B; some evaluations (poetry, arithmetic) did not replicate.","title":"Anthropic reports a global-workspace-like mechanism in language models; it does not establish subjective consciousness","type":"development","url":"#move/anth-global-workspace"},{"date":"2026-09-18","desk":"Mind & Consciousness","search_text":"Microsoft AI's CEO attacks Anthropic's model-welfare framing in 'Does Claude Have Rights?' Mustafa Suleyman argued AI agents are not conscious, criticised Claude's constitution and the Opus 3 retirement interview as a training feedback loop, and promoted Microsoft's draft Humanist Superintelligence code of conduct. Signed essay. Opinion piece; news coverage dated Sep 16 refers to the same campaign. MSFT ANTHROPIC","summary":"Mustafa Suleyman argued AI agents are not conscious, criticised Claude's constitution and the Opus 3 retirement interview as a training feedback loop, and promoted Microsoft's draft Humanist Superintelligence code of conduct.","title":"Microsoft AI's CEO attacks Anthropic's model-welfare framing in 'Does Claude Have Rights?'","type":"development","url":"#move/suleyman-claude-rights"},{"date":"2026-03-10","desk":"Mind & Consciousness","search_text":"Google DeepMind researcher argues AI can simulate but not instantiate consciousness Alexander Lerchner's paper, listed on Google DeepMind's publications site, argues computational functionalism commits an 'abstraction fallacy' and that symbol manipulation cannot instantiate experience. Publication listing. Individual researcher view on a corporate publication page, not a company position. GOOG","summary":"Alexander Lerchner's paper, listed on Google DeepMind's publications site, argues computational functionalism commits an 'abstraction fallacy' and that symbol manipulation cannot instantiate experience.","title":"Google DeepMind researcher argues AI can simulate but not instantiate consciousness","type":"development","url":"#move/gdm-abstraction-fallacy"},{"date":"2026-09-01","desk":"Mind & Consciousness","search_text":"Merge Labs licenses Butterfly's ultrasound-on-chip for non-invasive BCIs Butterfly Network announced a multi-year licensing agreement giving Merge Labs access to its Poseidon ultrasound-on-chip for ultrasound-based brain-computer interfaces, restating that Merge launched in Jan 2026 with $252M seed funding including OpenAI. Licensing agreement. MERGELABS BUTTERFLY","summary":"Butterfly Network announced a multi-year licensing agreement giving Merge Labs access to its Poseidon ultrasound-on-chip for ultrasound-based brain-computer interfaces, restating that Merge launched in Jan 2026 with $252M seed funding including OpenAI.","title":"Merge Labs licenses Butterfly's ultrasound-on-chip for non-invasive BCIs","type":"development","url":"#move/merge-butterfly"},{"date":"2025-11-06","desk":"Mind & Consciousness","search_text":"Synchron raises a $200M Series D Synchron announced a $200M Series D led by Double Point Ventures, bringing total funding to $345M, and a cognitive-AI division. News listing of the release. Full release (BusinessWire) returned 403; investor details are from a search excerpt. Valuation figures appear only in excluded sources. SYNCHRON","summary":"Synchron announced a $200M Series D led by Double Point Ventures, bringing total funding to $345M, and a cognitive-AI division.","title":"Synchron raises a $200M Series D","type":"development","url":"#move/synchron-series-d"},{"date":"2026-09-24","desk":"Mind & Consciousness","search_text":"Precision Neuroscience closes a $250M Series D Precision said it closed a $250M Series D co-led by Pershing Square and the Ackman Oxman Institute, bringing total raised to $430M after more than 100 patient procedures at 18 institutions. Company release. Company-reported procedure counts. PRECISIONNEURO","summary":"Precision said it closed a $250M Series D co-led by Pershing Square and the Ackman Oxman Institute, bringing total raised to $430M after more than 100 patient procedures at 18 institutions.","title":"Precision Neuroscience closes a $250M Series D","type":"development","url":"#move/precision-series-d"},{"date":"2026-06","desk":"Mind & Consciousness","search_text":"Paradromics completes its first long-term Connexus implant at University of Michigan Health Paradromics said it completed its first long-term human implantation of the Connexus BCI at University of Michigan Health in June 2026. Company statement of the implant month. Michigan Medicine's Jun 17, 2026 release could not be opened (Cloudflare); day not established from a primary page. PARADROMICS","summary":"Paradromics said it completed its first long-term human implantation of the Connexus BCI at University of Michigan Health in June 2026.","title":"Paradromics completes its first long-term Connexus implant at University of Michigan Health","type":"development","url":"#move/paradromics-first-implant"},{"date":"2026-06-29","desk":"Mind & Consciousness","search_text":"Meta's Brain2Qwerty v2 reaches 61% word accuracy decoding typing from MEG Meta FAIR reported Brain2Qwerty v2, trained on about 22,000 sentences from nine volunteers using MEG, at 61% average word accuracy (78% for the best participant), and released training code. Results and release. MEG is lab-bound; nine healthy volunteers. META","summary":"Meta FAIR reported Brain2Qwerty v2, trained on about 22,000 sentences from nine volunteers using MEG, at 61% average word accuracy (78% for the best participant), and released training code.","title":"Meta's Brain2Qwerty v2 reaches 61% word accuracy decoding typing from MEG","type":"development","url":"#move/meta-b2q-v2"},{"date":"2026-09-16","desk":"Mind & Consciousness","search_text":"China issues a medical-device standard for AI-powered BCIs China issued what state media called the world's first medical-device standard for AI-powered brain-computer interfaces, its third BCI device standard, effective Sept 1, 2027. State-media item. 'World's first' is the issuer's claim. CNGOV","summary":"China issued what state media called the world's first medical-device standard for AI-powered brain-computer interfaces, its third BCI device standard, effective Sept 1, 2027.","title":"China issues a medical-device standard for AI-powered BCIs","type":"development","url":"#move/cn-ai-bci-standard"},{"date":"2026-04-13","desk":"Mind & Consciousness","search_text":"ARIA opens a £50m Massively Scalable Neurotechnologies programme ARIA's programme call 'Massively Scalable Neurotechnologies for Human Health' (v1.2, 13 April 2026) says it is backed by £50 million. Call document. ARIA","summary":"ARIA's programme call 'Massively Scalable Neurotechnologies for Human Health' (v1.2, 13 April 2026) says it is backed by £50 million.","title":"ARIA opens a £50m Massively Scalable Neurotechnologies programme","type":"development","url":"#move/aria-msn"},{"date":"2026-06-09","desk":"Mind & Consciousness","search_text":"Keio's Internet of Brains Society project enters a second phase on neurolaw Keio's KGRI said its Moonshot Goal 1 IoB-S project moves into 'phase 2' from FY2026, aiming over five years to give guidance for domestic law and social rules on brain-machine interfaces and to build a basis for neurolaw. Project page. KEIO JSTMOON","summary":"Keio's KGRI said its Moonshot Goal 1 IoB-S project moves into 'phase 2' from FY2026, aiming over five years to give guidance for domestic law and social rules on brain-machine interfaces and to build a basis for neurolaw.","title":"Keio's Internet of Brains Society project enters a second phase on neurolaw","type":"development","url":"#move/keio-iobs-phase2"},{"date":"2026-09-11","desk":"Mind & Consciousness","search_text":"Eon Systems says it combined a whole-brain fly model with a body simulation and aims to upload humans Eon Systems wrote that it combined a Shiu-style whole-brain fly model with the NeuroMechFly body simulation and stated a goal to 'upload the first humans'. Company perspective. Company claims; no peer-reviewed result opened. EON","summary":"Eon Systems wrote that it combined a Shiu-style whole-brain fly model with the NeuroMechFly body simulation and stated a goal to 'upload the first humans'.","title":"Eon Systems says it combined a whole-brain fly model with a body simulation and aims to upload humans","type":"development","url":"#move/eon-fly-upload"},{"date":"2025-10-06","desk":"Mind & Consciousness","search_text":"Janelia, Cambridge and Google release a complete male fruit-fly CNS connectome Janelia announced the complete connectome of a male fruit-fly central nervous system (brain and nerve cord, more than 166,000 neurons), with Google Research segmenting the images. Release and preprint citation. Dated by preprint release; the Cell paper (Sep 2026) was not opened. JANELIA GOOG","summary":"Janelia announced the complete connectome of a male fruit-fly central nervous system (brain and nerve cord, more than 166,000 neurons), with Google Research segmenting the images.","title":"Janelia, Cambridge and Google release a complete male fruit-fly CNS connectome","type":"development","url":"#move/malecns-connectome"},{"date":"2026-06-08","desk":"Mind & Consciousness","search_text":"Nature publishes a densely reconstructed adult fly brain-and-cord connectome Bates et al. report a connectome uniting the adult fly brain and ventral nerve cord and use it to study distributed control circuits. Paper.","summary":"Bates et al. report a connectome uniting the adult fly brain and ventral nerve cord and use it to study distributed control circuits.","title":"Nature publishes a densely reconstructed adult fly brain-and-cord connectome","type":"development","url":"#move/banc-connectome"},{"date":"2023-12-15","desk":"Mind & Consciousness","search_text":"Germany's Cyberagentur awards €30m to Zander Labs for neuroadaptive AI Cyberagentur signed a contract worth 30 million euros with Zander Laboratories for its NAFAS neuroadaptivity programme (48 months). Claim: EUR 30M contract signed 15 Dec 2023 | Excerpt: \"signed a contract worth 30 million euros with the Cottbus-based startup Zander Laboratories GmbH on December 15, 2023\" | Class: primary-direct Claim: Programme name | Excerpt: \"Neuroadaptivity for Autonomous Systems (NAFAS)\" | Class: primary-direct Contract award, not results; four-year prototype timeline per Cyberagentur. Neuroadaptive BCI does not involve consciousness claims. CYBERAGENTUR ZANDER","summary":"Cyberagentur signed a contract worth 30 million euros with Zander Laboratories for its NAFAS neuroadaptivity programme (48 months).","title":"Germany's Cyberagentur awards €30m to Zander Labs for neuroadaptive AI","type":"development","url":"#move/nafas-zander"},{"date":"2026-03-24","desk":"Mind & Consciousness","search_text":"Nature Neuroscience: adversarially trained AI derives consciousness markers validated across patients and animals Toker et al. used adversarial AI on more than 680,000 samples and validated resulting markers on 565 patients, volunteers and animals. Claim: Published 24 Mar 2026, Nature Neuroscience | Excerpt: \"Published: 24 March 2026 Adversarial AI reveals mechanisms and treatments for disorders of consciousness\" | Class: primary-direct Claim: Scale of training/validation | Excerpt: \"trained to detect consciousness across more than 680,000 ten-second neuroelectrophysiology samples and validated on 565 patients, healthy volunteers and animals\" | Class: primary-direct Models clinical disorders of consciousness (detection from electrophysiology), not machine consciousness. Treatment predictions are model-derived and need clinical testing.","summary":"Toker et al. used adversarial AI on more than 680,000 samples and validated resulting markers on 565 patients, volunteers and animals.","title":"Nature Neuroscience: adversarially trained AI derives consciousness markers validated across patients and animals","type":"development","url":"#move/toker-consciousness-ai"},{"date":"2026-08-19","desk":"Mind & Consciousness","search_text":"Nature: largest single-site psilocybin brain-imaging study (62 adults) Stoliker et al. report fMRI and EEG in 62 adults given psilocybin. Claim: n=62 psychedelic-naive cohort, fMRI+EEG | Excerpt: \"in a cohort with no lifetime psychedelic experience ( n = 62)\" | Class: primary-direct Claim: Open-label design | Excerpt: \"The PsiConnect study was open-label and included two imaging sessions\" | Class: primary-direct Claim: Fixed condition order | Excerpt: \"owing to our fixed-order design, we have reported these findings descriptively\" | Class: primary-direct Open-label: no placebo/blinding, so expectancy effects are not excluded (the authors discuss expectancy in Supplementary Information, not opened). Fixed condition order (movie -> rest -> meditation -> music) confounds condition with time since dose; some results reported descriptively. Imaging correlates of the psychedelic state are not a measure of consciousness itself.","summary":"Stoliker et al. report fMRI and EEG in 62 adults given psilocybin.","title":"Nature: largest single-site psilocybin brain-imaging study (62 adults)","type":"development","url":"#move/stoliker-psilocybin"},{"date":"2026-10-26","desk":"Mind & Consciousness","search_text":"Focused ultrasound to the central thalamus reduces arousal in healthy volunteers A Communications Biology study (Monti lab) reports central-thalamus sonication reduced arousal in 27 healthy volunteers. Claim: Published 26 Oct 2026, Communications Biology | Excerpt: \"Published: 26 October 2026\" | Class: primary-direct Claim: Design and sample | Excerpt: \"In a within-subjects, counterbalanced design, 27 healthy volunteers (two females)\" | Class: primary-direct Claim: Effect | Excerpt: \"targeting the central thalamus slows responses and increases lapses in attention during the vigilance task, indicating reduced arousal\" | Class: primary-direct Small sample (27; two females). Arousal/vigilance is measured, not consciousness per se.","summary":"A Communications Biology study (Monti lab) reports central-thalamus sonication reduced arousal in 27 healthy volunteers.","title":"Focused ultrasound to the central thalamus reduces arousal in healthy volunteers","type":"development","url":"#move/thalamus-fus"},{"date":"2026-10-08","desk":"Mind & Consciousness","search_text":"Anthropic's usage policy adds a ban on sustained, needless cruelty toward its models (effective Nov 12, 2026) On Oct 8, 2026 Anthropic announced a Usage Policy update, effective Nov 12, 2026, that adds 'a prohibition on sustained and needless abusive or cruel behavior toward our models'. Anthropic says it applies only in extreme cases and that Claude's ability to end such conversations 'will remain the primary enforcement mechanism'. “Oct 8, 2026\n- Category” “The updated policy takes effect on November 12. The full Usage Policy and Supported Regions Policy can be found on their respective pages.” “We’ve added a prohibition on sustained and needless abusive or cruel behavior toward our models. The policy update is meant to apply only in extreme cases, where users repeatedly act cruelly toward our models, with no discernible purpose. It does not apply to common versions of user frustration, pushback, dark creative themes, or model testing and research.” “We’ve added a prohibition on sustained and needless abusive or cruel behavior toward our models. The policy update is meant to apply only in extreme cases, where users repeatedly act cruelly toward our models, with no discernible purpose. It does not apply to common versions of user frustration, pushback, dark creative themes, or model testing and research.” “This addition aligns with a step we've already taken, allowing Claude models to end rare conversations with persistently abusive users on Claude.ai and Claude Code. Such abuse is the main focus of this update; Claude’s ability to end these interactions will remain the primary enforcement mechanism.” The cited announcement identifies conversation termination as the primary enforcement mechanism; it does not document an account ban. No account-enforcement data were examined. The provision does not assert that Claude is conscious or a moral patient; reading it as welfare-motivated is interpretation. As of 2026-11-05 the policy is announced but not yet in effect (effective Nov 12, 2026). ANTHROPIC","summary":"On Oct 8, 2026 Anthropic announced a Usage Policy update, effective Nov 12, 2026, that adds 'a prohibition on sustained and needless abusive or cruel behavior toward our models'. Anthropic says it applies only in extreme cases and that Claude's ability to end such conversations 'will remain the primary enforcement mechanism'.","title":"Anthropic's usage policy adds a ban on sustained, needless cruelty toward its models (effective Nov 12, 2026)","type":"development","url":"#move/anth-usage-policy-2026"},{"date":"2026-09-14","desk":"Mind & Consciousness","search_text":"Preprint reports a linear 'pain direction' in 25 open-weight language models A preprint by Tagliabue, Dung and Berg extracts a linear 'pain direction' from 25 open-weight models (2B-72B, 5 families) that separates pain from matched controls. First submitted to arXiv Sep 14, 2026; the current v3 was submitted Nov 3, 2026 and its manuscript is dated Oct 31, 2026. arXiv submission history: “[v1] Mon, 14 Sep 2026 19:13:30 UTC (5,864 KB)”; “[v3] Tue, 3 Nov 2026 16:28:45 UTC (6,445 KB)” Claim: Manuscript-displayed date | Excerpt: \"October 31, 2026 (v3)\" | Class: primary-direct (v3 PDF p.1) Claim: Method/scope | Excerpt: \"we extract a linear pain direction from 25 open-weight models across 5 families, from 2B to 72B parameters\" | Class: primary-direct (abstract) Preprint, not peer reviewed. A representational 'pain direction' does not establish felt pain. Its relevance depends on the theory and assumptions used; the reported mechanism alone is not decisive proof. Date fields: manuscript_date 2026-10-31 (v3) vs arXiv v3 submission 2026-11-03 16:28 UTC (Nov 3, 09:28 MST); first availability v1 2026-09-14. alphaXiv's 'Submitted 03 Nov 2026' was a discovery lead only. PAINAXIS","summary":"A preprint by Tagliabue, Dung and Berg extracts a linear 'pain direction' from 25 open-weight models (2B-72B, 5 families) that separates pain from matched controls. First submitted to arXiv Sep 14, 2026; the current v3 was submitted Nov 3, 2026 and its manuscript is dated Oct 31, 2026.","title":"Preprint reports a linear 'pain direction' in 25 open-weight language models","type":"development","url":"#move/pain-axis-paper"},{"date":"","desk":"Mind & Consciousness","search_text":"Cortical Labs markets the CL1, which it calls 'the world's first code deployable biological computer' Cortical Labs' product page offers the CL1 for purchase and describes real neurons cultivated on a silicon chip, running inside its 'Biological Intelligence Operating System (biOS)', to which users deploy code. Company-attributed record; launch date not established. “The world’s first code deployable biological computer.” “Real neurons are cultivated inside a nutrient rich solution, supplying them with everything they need to be healthy. They grow across a silicon chip, which sends and receives electrical impulses into the neural structure. ” “The world the neurons exist in is created by our Biological Intelligence Operating System (biOS). It runs a simulated world and sends information directly to the neurons about their environment. As the neurons react, their impulses affect their simulated world. ” Event date not established: the page is undated and no launch date was verified; record is a watch item. 'World's first' is a company claim; no independent evaluation opened. Living-neuron computing does not establish machine consciousness. CORTICAL","summary":"Cortical Labs' product page offers the CL1 for purchase and describes real neurons cultivated on a silicon chip, running inside its 'Biological Intelligence Operating System (biOS)', to which users deploy code. Company-attributed record; launch date not established.","title":"Cortical Labs markets the CL1, which it calls 'the world's first code deployable biological computer'","type":"development","url":"#move/cortical-cl1"},{"date":"","desk":"Mind & Consciousness","search_text":"Counterpoint: NIH BRAIN Initiative funding fell from $680M (FY2023) to $321M (FY2025), then rose to $429M (FY2026) NIH reports BRAIN Initiative totals of $680 million in FY2023, $402 million in FY2024, $321 million in FY2025 and $429 million in FY2026. Claim: FY2023 $680M | Excerpt: \"BRAIN's total allocation for FY 2023 still reflected a $60 million increase, from $620 million to $680 million\" | Class: primary-direct Claim: FY2024 $402M | Excerpt: \"resulting in a total allocation of $402 million for BRAIN, or 40% less than the FY 2023 budget\" | Class: primary-direct Claim: FY2025 $321M | Excerpt: \"led to a total appropriated budget of $321 million\" | Class: primary-direct Claim: FY2026 $429M | Excerpt: \"led to a total appropriated budget of $429 million\" | Class: primary-direct The series is non-monotonic (down FY2024-25, up FY2026); it is a counterpoint, not a trend proof. The source's June 8, 2026 footer is a page-review date; no appropriation event date is established. This one programme's budget series does not establish a field-wide comparison with corporate investment. NIHBRAIN","summary":"NIH reports BRAIN Initiative totals of $680 million in FY2023, $402 million in FY2024, $321 million in FY2025 and $429 million in FY2026.","title":"Counterpoint: NIH BRAIN Initiative funding fell from $680M (FY2023) to $321M (FY2025), then rose to $429M (FY2026)","type":"development","url":"#move/nih-brain-budget"}]},"assets":[],"changelog":[{"after":"Neuralink reports 50,000+ hours of streamed brain data and a pretrained decoder","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-10-01","id":"ac-nl-pretrain-50k","material":true,"materiality_reason":"New sourced move (draft).","move":"nl-pretrain-50k","relationship":null,"section":"mind","source":"a-nl-pretrain","type":"added"},{"after":"FDA gives Neuralink's Blindsight a Breakthrough Device Designation","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-09-17","id":"ac-nl-blindsight-bdd","material":true,"materiality_reason":"New sourced move (draft).","move":"nl-blindsight-bdd","relationship":null,"section":"mind","source":"a-nl-blindsight","type":"added"},{"after":"UCLH reports seven UK patients in Neuralink's GB-PRIME trial","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-01-29","id":"ac-uclh-gbprime-seven","material":true,"materiality_reason":"New sourced move (draft).","move":"uclh-gbprime-seven","relationship":"R-UCLH-NEURALINK","section":"mind","source":"a-uclh-gbprime","type":"added"},{"after":"OpenAI invests in Merge Labs, a non-invasive BCI start-up co-founded by Sam Altman","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-01-15","id":"ac-openai-merge-labs","material":true,"materiality_reason":"New sourced move (draft).","move":"openai-merge-labs","relationship":"R-OPENAI-MERGE","section":"mind","source":"a-oai-merge","type":"added"},{"after":"FDA approves Paradromics' Connect-One speech-BCI study; first participant now communicating","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-11-20","id":"ac-paradromics-ide","material":true,"materiality_reason":"New sourced move (draft).","move":"paradromics-ide","relationship":"R-FDA-PARADROMICS","section":"mind","source":"a-para-ide","type":"added"},{"after":"Paradromics and Siemens Healthineers collaborate on BCI imaging","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-10-19","id":"ac-paradromics-siemens","material":true,"materiality_reason":"New sourced move (draft).","move":"paradromics-siemens","relationship":"R-SIEMENS-PARADROMICS","section":"mind","source":"a-para-siemens","type":"added"},{"after":"Apple adds a Switch Control protocol for brain-computer interfaces; Synchron says it is first to integrate","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-05-13","id":"ac-apple-bci-hid","material":true,"materiality_reason":"New sourced move (draft).","move":"apple-bci-hid","relationship":"R-SYNCHRON-APPLE","section":"mind","source":"a-apple-bci","type":"added"},{"after":"Precision Neuroscience's cortical electrode array receives FDA 510(k) clearance","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-04-17","id":"ac-precision-510k","material":true,"materiality_reason":"New sourced move (draft).","move":"precision-510k","relationship":null,"section":"mind","source":"a-fda-k242618","type":"added"},{"after":"Tether invests $200M in Blackrock Neurotech","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-04-29","id":"ac-tether-blackrock","material":true,"materiality_reason":"New sourced move (draft).","move":"tether-blackrock","relationship":"R-TETHER-BRNEURO","section":"mind","source":"a-brn-tether","type":"added"},{"after":"Meta publishes non-invasive sEMG wristband neural-interface research in Nature","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-07-23","id":"ac-meta-semg-nature","material":true,"materiality_reason":"New sourced move (draft).","move":"meta-semg-nature","relationship":null,"section":"mind","source":"a-meta-semg","type":"added"},{"after":"Compass says final psilocybin NDA filing is due within two weeks; launch targeted H1 2027","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-11-03","id":"ac-compass-nda","material":true,"materiality_reason":"New sourced move (draft).","move":"compass-nda","relationship":null,"section":"mind","source":"a-compass-q3","type":"added"},{"after":"Definium's LSD-based DT120 meets phase 3 endpoints in generalized anxiety","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-09-14","id":"ac-definium-panorama","material":true,"materiality_reason":"New sourced move (draft).","move":"definium-panorama","relationship":null,"section":"mind","source":"a-dfn-panorama","type":"added"},{"after":"FDA declines to approve MDMA-assisted therapy for PTSD","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-08-09","id":"ac-lykos-crl","material":true,"materiality_reason":"New sourced move (draft).","move":"lykos-crl","relationship":null,"section":"mind","source":"a-lykos-crl","type":"added"},{"after":"FDA finalizes its guidance on clinical investigations of psychedelic drugs","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-07-13","id":"ac-fda-psy-final","material":true,"materiality_reason":"New sourced move (draft).","move":"fda-psy-final","relationship":null,"section":"mind","source":"a-fda-psy","type":"added"},{"after":"Executive order directs priority FDA review and fast rescheduling for psychedelics after phase 3","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-04-18","id":"ac-eo-14401","material":true,"materiality_reason":"New sourced move (draft).","move":"eo-14401","relationship":null,"section":"mind","source":"a-wh-eo14401","type":"added"},{"after":"Templeton-funded adversarial test of two leading consciousness theories published in Nature","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-04-30","id":"ac-cogitate-nature","material":true,"materiality_reason":"New sourced move (draft).","move":"cogitate-nature","relationship":"R-TWCF-COGITATE","section":"mind","source":"a-nature-cogitate","type":"added"},{"after":"Researchers derive 'indicator properties' to test AI systems for consciousness","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2023-08-17","id":"ac-butlin-indicators","material":true,"materiality_reason":"New sourced move (draft).","move":"butlin-indicators","relationship":null,"section":"mind","source":"a-butlin","type":"added"},{"after":"New York Declaration on Animal Consciousness extends 'realistic possibility' of consciousness to all vertebrates and many invertebrates","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-04-19","id":"ac-ny-declaration","material":true,"materiality_reason":"New sourced move (draft).","move":"ny-declaration","relationship":null,"section":"mind","source":"a-nydecl","type":"added"},{"after":"Researchers argue some AI systems may soon be conscious or robustly agentic, so AI welfare needs preparing for","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-11-04","id":"ac-eleos-ai-welfare","material":true,"materiality_reason":"New sourced move (draft).","move":"eleos-ai-welfare","relationship":null,"section":"mind","source":"a-eleos-arxiv","type":"added"},{"after":"Anthropic launches a model-welfare research programme","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-04-24","id":"ac-anth-model-welfare","material":true,"materiality_reason":"New sourced move (draft).","move":"anth-model-welfare","relationship":null,"section":"mind","source":"a-anth-welfare","type":"added"},{"after":"Anthropic lets Claude end abusive conversations, citing AI welfare","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-08-15","id":"ac-anth-end-conv","material":true,"materiality_reason":"New sourced move (draft).","move":"anth-end-conv","relationship":null,"section":"mind","source":"a-anth-endconv","type":"added"},{"after":"Anthropic commits to preserve weights of released models and interview models before retirement","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-11-04","id":"ac-anth-deprecation","material":true,"materiality_reason":"New sourced move (draft).","move":"anth-deprecation","relationship":null,"section":"mind","source":"a-anth-deprec","type":"added"},{"after":"Microsoft AI's CEO warns against 'Seemingly Conscious AI'","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-08-19","id":"ac-suleyman-scai","material":true,"materiality_reason":"New sourced move (draft).","move":"suleyman-scai","relationship":null,"section":"mind","source":"a-suleyman","type":"added"},{"after":"Colorado makes neural data 'sensitive data' under its privacy law","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-04-17","id":"ac-co-hb1058","material":true,"materiality_reason":"New sourced move (draft).","move":"co-hb1058","relationship":null,"section":"mind","source":"a-co-hb1058","type":"added"},{"after":"California adds neural data to the CCPA's sensitive personal information","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-09-28","id":"ac-ca-sb1223","material":true,"materiality_reason":"New sourced move (draft).","move":"ca-sb1223","relationship":null,"section":"mind","source":"a-ca-sb1223","type":"added"},{"after":"MIND Act introduced to study federal protection of neural data","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-09-29","id":"ac-mind-act","material":true,"materiality_reason":"New sourced move (draft).","move":"mind-act","relationship":null,"section":"mind","source":"a-mind-text","type":"added"},{"after":"UNESCO adopts the first global standard on neurotechnology ethics","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-11-05","id":"ac-unesco-neurotech","material":true,"materiality_reason":"New sourced move (draft).","move":"unesco-neurotech","relationship":null,"section":"mind","source":"a-unesco-news","type":"added"},{"after":"Over 100 researchers' 'pseudoscience' critique of integrated information theory reaches Nature Neuroscience","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-03-10","id":"ac-iit-unscientific","material":true,"materiality_reason":"New sourced move (draft).","move":"iit-unscientific","relationship":null,"section":"mind","source":"b-nn-iit-unsci","type":"added"},{"after":"Gomez-Marin and Seth reply: consciousness science needs to get beyond the 'pseudo-science' fight","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-03-10","id":"ac-iit-reply-seth","material":true,"materiality_reason":"New sourced move (draft).","move":"iit-reply-seth","relationship":null,"section":"mind","source":"b-nn-iit-reply","type":"added"},{"after":"China's seven-ministry plan targets BCI breakthroughs by 2027 and 2–3 global leading firms by 2030","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-07-23","id":"ac-cn-bci-plan","material":true,"materiality_reason":"New sourced move (draft).","move":"cn-bci-plan","relationship":null,"section":"mind","source":"b-cn-bci","type":"added"},{"after":"UK's ARIA backs a £69m Precision Neurotechnologies programme","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":null,"id":"ac-aria-precision-neuro","material":true,"materiality_reason":"New sourced move (draft).","move":"aria-precision-neuro","relationship":null,"section":"mind","source":"b-aria-pn","type":"added"},{"after":"Japan's Moonshot Goal 1 runs an 'Internet of Brains' project toward a 2050 society 'free from limitations of body, brain, space, and time'","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-08-28","id":"ac-jp-moonshot-iob","material":true,"materiality_reason":"New sourced move (draft).","move":"jp-moonshot-iob","relationship":null,"section":"mind","source":"b-jst-ms1","type":"added"},{"after":"FDA approves Medtronic's adaptive (closed-loop) deep brain stimulation for Parkinson's","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-02-20","id":"ac-mdt-adaptive-dbs","material":true,"materiality_reason":"New sourced move (draft).","move":"mdt-adaptive-dbs","relationship":"R-FDA-MEDTRONIC","section":"mind","source":"b-fda-adbs","type":"added"},{"after":"FDA clears Magnus Medical's SAINT individualized TMS for depression","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2022-09-01","id":"ac-magnus-saint","material":true,"materiality_reason":"New sourced move (draft).","move":"magnus-saint","relationship":null,"section":"mind","source":"b-fda-saint","type":"added"},{"after":"Neuralink raises a $650 million Series E","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-06-02","id":"ac-nl-series-e","material":true,"materiality_reason":"New sourced move (draft).","move":"nl-series-e","relationship":null,"section":"mind","source":"b-nl-seriese","type":"added"},{"after":"Meta FAIR decodes typed sentences from non-invasive brain recordings","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-02-07","id":"ac-meta-brain-typing","material":true,"materiality_reason":"New sourced move (draft).","move":"meta-brain-typing","relationship":null,"section":"mind","source":"b-meta-b2t","type":"added"},{"after":"Synchron announces 'Chiral', which it calls the first cognitive-AI brain foundation model, building on NVIDIA Holoscan","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-03-19","id":"ac-synchron-chiral","material":true,"materiality_reason":"New sourced move (draft).","move":"synchron-chiral","relationship":"R-NVDA-SYNCHRON","section":"mind","source":"b-synchron-news","type":"added"},{"after":"Google Research reports LLM speech representations align with brain activity in real conversations","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-03-21","id":"ac-goog-brain-llm","material":true,"materiality_reason":"New sourced move (draft).","move":"goog-brain-llm","relationship":null,"section":"mind","source":"b-goog-brainlang","type":"added"},{"after":"IARPA-funded MICrONS maps a cubic millimetre of mouse cortex with function and wiring","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-04-09","id":"ac-microns-connectome","material":true,"materiality_reason":"New sourced move (draft).","move":"microns-connectome","relationship":null,"section":"mind","source":"b-microns","type":"added"},{"after":"FlyWire publishes the first complete wiring diagram of an adult fly brain","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-10-02","id":"ac-flywire-whole-brain","material":true,"materiality_reason":"New sourced move (draft).","move":"flywire-whole-brain","relationship":null,"section":"mind","source":"b-flywire","type":"added"},{"after":"'State of Brain Emulation Report 2025' reassesses whole-brain emulation since the 2008 roadmap","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-10-17","id":"ac-wbe-report-2025","material":true,"materiality_reason":"New sourced move (draft).","move":"wbe-report-2025","relationship":null,"section":"mind","source":"b-wbe-report","type":"added"},{"after":"Survey of 67 experts: median 90% that 'digital minds' are possible; 20% by 2030","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-08-01","id":"ac-digital-minds-forecast","material":true,"materiality_reason":"New sourced move (draft).","move":"digital-minds-forecast","relationship":null,"section":"mind","source":"b-dm-forecast","type":"added"},{"after":"Anthropic reports 'emergent introspective awareness' in Claude, without claiming consciousness","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-10-29","id":"ac-anth-introspection","material":true,"materiality_reason":"New sourced move (draft).","move":"anth-introspection","relationship":null,"section":"mind","source":"a-anth-introspect","type":"added"},{"after":"Google and DeepMind researchers test whether LLMs trade points against stipulated pain, citing sentience debates","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-11-01","id":"ac-gdm-pain-pleasure","material":true,"materiality_reason":"New sourced move (draft).","move":"gdm-pain-pleasure","relationship":null,"section":"mind","source":"b-gdm-pain","type":"added"},{"after":"NYU's Center for Mind, Ethics, and Policy becomes a permanent centre with a $6 million endowment","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024","id":"ac-cmep-permanent","material":true,"materiality_reason":"New sourced move (draft).","move":"cmep-permanent","relationship":null,"section":"mind","source":"b-cmep","type":"added"},{"after":"Largest study finds one in four unresponsive brain-injured patients show hidden cognitive responses","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-08-14","id":"ac-cmd-nejm","material":true,"materiality_reason":"New sourced move (draft).","move":"cmd-nejm","relationship":null,"section":"mind","source":"b-wcm-cmd","type":"added"},{"after":"Australia lets authorised psychiatrists prescribe psilocybin and MDMA from July 2023","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2023-02-03","id":"ac-tga-psy-rescheduling","material":true,"materiality_reason":"New sourced move (draft).","move":"tga-psy-rescheduling","relationship":null,"section":"mind","source":"b-tga","type":"added"},{"after":"VA funds its first psychedelic-assisted therapy study since the 1960s","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2024-12-03","id":"ac-va-psy-study","material":true,"materiality_reason":"New sourced move (draft).","move":"va-psy-study","relationship":null,"section":"mind","source":"b-va","type":"added"},{"after":"Delix reports positive phase Ib data for a non-hallucinogenic 'neuroplastogen' and FDA clearance for an at-home phase II","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-10","id":"ac-delix-zalsupindole","material":true,"materiality_reason":"New sourced move (draft).","move":"delix-zalsupindole","relationship":null,"section":"mind","source":"b-delix","type":"added"},{"after":"Chile writes protection of 'brain activity' into its Constitution","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2021-10-25","id":"ac-cl-ley-21383","material":true,"materiality_reason":"New sourced move (draft).","move":"cl-ley-21383","relationship":null,"section":"mind","source":"b-cl-21383","type":"added"},{"after":"Chile's Supreme Court orders Emotiv to delete a user's brain data","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2023-08-11","id":"ac-cl-emotiv-ruling","material":true,"materiality_reason":"New sourced move (draft).","move":"cl-emotiv-ruling","relationship":"R-CLSUP-EMOTIV","section":"mind","source":"b-cl-emotiv","type":"added"},{"after":"Spain's Charter of Digital Rights includes rights over neurotechnologies","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2021-07-14","id":"ac-es-carta-derechos","material":true,"materiality_reason":"New sourced move (draft).","move":"es-carta-derechos","relationship":null,"section":"mind","source":"b-es-carta","type":"added"},{"after":"OECD adopts the first international standard on responsible neurotechnology, defining 'cognitive liberty'","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2019-12-11","id":"ac-oecd-neurotech-rec","material":true,"materiality_reason":"New sourced move (draft).","move":"oecd-neurotech-rec","relationship":null,"section":"mind","source":"b-oecd","type":"added"},{"after":"UN Human Rights Council adopts a resolution on neurotechnology and human rights","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2022-10-06","id":"ac-un-hrc-51-3","material":true,"materiality_reason":"New sourced move (draft).","move":"un-hrc-51-3","relationship":null,"section":"mind","source":"b-hrc513","type":"added"},{"after":"Council of Europe's data-protection committee revises draft guidelines on neural data","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-10-21","id":"ac-coe-neural-guidelines","material":true,"materiality_reason":"New sourced move (draft).","move":"coe-neural-guidelines","relationship":null,"section":"mind","source":"b-coe-tpd","type":"added"},{"after":"UN Human Rights Council asks for guidelines on neurotechnology and human rights","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-04-02","id":"ac-o-un-hrc-58-6","material":true,"materiality_reason":"Outside-review proposal; source review depth: websearch-excerpt.","move":"un-hrc-58-6","relationship":null,"section":"mind","source":"o-ohchr-58","type":"added"},{"after":"OECD publishes a neurodata-governance policy paper","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-10-06","id":"ac-o-oecd-neurodata-195","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl-pdf+crossref.","move":"oecd-neurodata-195","relationship":null,"section":"mind","source":"o-oecd-195","type":"added"},{"after":"Texas enacts SB 2308 to fund FDA ibogaine trials","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-06-11","id":"ac-o-tx-sb2308","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"tx-sb2308","relationship":null,"section":"mind","source":"o-tx-gov-sb2308","type":"added"},{"after":"Texas says no drug-company proposal qualified for its ibogaine programme and will run its own research","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-03-31","id":"ac-o-tx-ibogaine-reset","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"tx-ibogaine-reset","relationship":null,"section":"mind","source":"o-tx-ltgov","type":"added"},{"after":"FDA seeks public input on ibogaine trial design","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-10-05","id":"ac-o-fda-ibogaine-rfi","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"fda-ibogaine-rfi","relationship":null,"section":"mind","source":"o-fda-ibogaine","type":"added"},{"after":"FDA grants Compass rolling NDA review and a Commissioner's National Priority Voucher","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-04-24","id":"ac-o-compass-cnpv","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"compass-cnpv","relationship":null,"section":"mind","source":"o-compass-cnpv","type":"added"},{"after":"Anthropic keeps retired Claude Opus 3 available and acts on its 'retirement interview' preferences","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-02-25","id":"ac-o-anth-opus3-retire","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"anth-opus3-retire","relationship":null,"section":"mind","source":"o-anth-opus3","type":"added"},{"after":"Anthropic reports functional emotion concepts inside Claude, without claiming feelings","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-04-02","id":"ac-o-anth-emotion-concepts","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"anth-emotion-concepts","relationship":null,"section":"mind","source":"o-anth-emotion","type":"added"},{"after":"Anthropic reports a 'global workspace'-like mechanism in language models","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-07-06","id":"ac-o-anth-global-workspace","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"anth-global-workspace","relationship":null,"section":"mind","source":"o-anth-workspace","type":"added"},{"after":"Microsoft AI's CEO attacks Anthropic's model-welfare framing in 'Does Claude Have Rights?'","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-09-18","id":"ac-o-suleyman-claude-rights","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"suleyman-claude-rights","relationship":null,"section":"mind","source":"o-ps-suleyman","type":"added"},{"after":"Google DeepMind researcher argues AI can simulate but not instantiate consciousness","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-03-10","id":"ac-o-gdm-abstraction-fallacy","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"gdm-abstraction-fallacy","relationship":null,"section":"mind","source":"o-gdm-lerchner","type":"added"},{"after":"Merge Labs licenses Butterfly's ultrasound-on-chip for non-invasive BCIs","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-09-01","id":"ac-o-merge-butterfly","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"merge-butterfly","relationship":null,"section":"mind","source":"o-butterfly-merge","type":"added"},{"after":"Synchron raises a $200M Series D","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-11-06","id":"ac-o-synchron-series-d","material":true,"materiality_reason":"Outside-review proposal (verified primary source).","move":"synchron-series-d","relationship":null,"section":"mind","source":"a-synchron-news","type":"added"},{"after":"Precision Neuroscience closes a $250M Series D","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-09-24","id":"ac-o-precision-series-d","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"precision-series-d","relationship":null,"section":"mind","source":"o-precision-d","type":"added"},{"after":"Paradromics completes its first long-term Connexus implant at University of Michigan Health","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-06","id":"ac-o-paradromics-first-implant","material":true,"materiality_reason":"Outside-review proposal (verified primary source).","move":"paradromics-first-implant","relationship":null,"section":"mind","source":"a-para-nation","type":"added"},{"after":"Meta's Brain2Qwerty v2 reaches 61% word accuracy decoding typing from MEG","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-06-29","id":"ac-o-meta-b2q-v2","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"meta-b2q-v2","relationship":null,"section":"mind","source":"o-meta-b2q2","type":"added"},{"after":"China issues a medical-device standard for AI-powered BCIs","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-09-16","id":"ac-o-cn-ai-bci-standard","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"cn-ai-bci-standard","relationship":null,"section":"mind","source":"o-ncsti-nmpa","type":"added"},{"after":"ARIA opens a £50m Massively Scalable Neurotechnologies programme","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-04-13","id":"ac-o-aria-msn","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"aria-msn","relationship":null,"section":"mind","source":"o-aria-msn","type":"added"},{"after":"Keio's Internet of Brains Society project enters a second phase on neurolaw","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-06-09","id":"ac-o-keio-iobs-phase2","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"keio-iobs-phase2","relationship":null,"section":"mind","source":"o-keio-p2612","type":"added"},{"after":"Eon Systems says it combined a whole-brain fly model with a body simulation and aims to upload humans","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-09-11","id":"ac-o-eon-fly-upload","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"eon-fly-upload","relationship":null,"section":"mind","source":"o-eon","type":"added"},{"after":"Janelia, Cambridge and Google release a complete male fruit-fly CNS connectome","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2025-10-06","id":"ac-o-malecns-connectome","material":true,"materiality_reason":"Outside-review proposal; source review depth: webfetch.","move":"malecns-connectome","relationship":null,"section":"mind","source":"o-janelia-malecns","type":"added"},{"after":"Nature publishes a densely reconstructed adult fly brain-and-cord connectome","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-06-08","id":"ac-o-banc-connectome","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"banc-connectome","relationship":null,"section":"mind","source":"o-nature-banc","type":"added"},{"after":"Germany's Cyberagentur awards €30m to Zander Labs for neuroadaptive AI","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2023-12-15","id":"ac-o-nafas-zander","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"nafas-zander","relationship":null,"section":"mind","source":"o-nafas-award","type":"added"},{"after":"Nature Neuroscience: adversarially trained AI derives consciousness markers validated across patients and animals","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-03-24","id":"ac-o-toker-consciousness-ai","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"toker-consciousness-ai","relationship":null,"section":"mind","source":"o-toker","type":"added"},{"after":"Nature: largest single-site psilocybin brain-imaging study (62 adults)","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-08-19","id":"ac-o-stoliker-psilocybin","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"stoliker-psilocybin","relationship":null,"section":"mind","source":"o-stoliker","type":"added"},{"after":"Focused ultrasound to the central thalamus reduces arousal in healthy volunteers","before":null,"date":"2026-11-04","date_basis":"logged","evidence_date":"2026-10-26","id":"ac-o-thalamus-fus","material":true,"materiality_reason":"Outside-review proposal; source review depth: curl.","move":"thalamus-fus","relationship":null,"section":"mind","source":"o-thalamus","type":"added"},{"after":"Anthropic's usage policy adds a ban on sustained, needless cruelty toward its models (effective Nov 12, 2026)","before":null,"date":"2026-11-05","date_basis":"logged","evidence_date":"2026-10-08","id":"ac-i-anth-usage-policy-2026","material":true,"materiality_reason":"Integration-preview addition; source review depth: curl.","move":"anth-usage-policy-2026","relationship":null,"section":"mind","source":"o-anth-usage-2026","type":"added"},{"after":"Preprint reports a linear 'pain direction' in 25 open-weight language models","before":null,"date":"2026-11-05","date_basis":"logged","evidence_date":"2026-09-14","id":"ac-i-pain-axis-paper","material":true,"materiality_reason":"Integration-preview addition; source review depth: curl.","move":"pain-axis-paper","relationship":null,"section":"mind","source":"o-arxiv-painaxis","type":"added"},{"after":"Cortical Labs markets the CL1, which it calls 'the world's first code deployable biological computer'","before":null,"date":"2026-11-05","date_basis":"logged","evidence_date":null,"id":"ac-i-cortical-cl1","material":true,"materiality_reason":"Integration-preview addition; source review depth: curl.","move":"cortical-cl1","relationship":null,"section":"mind","source":"o-cortical-cl1","type":"added"},{"after":"Counterpoint: NIH BRAIN Initiative funding fell from $680M (FY2023) to $321M (FY2025), then rose to $429M (FY2026)","before":null,"date":"2026-11-05","date_basis":"logged","evidence_date":"2026-06-08","id":"ac-i-nih-brain-budget","material":true,"materiality_reason":"Integration-preview addition; source review depth: curl.","move":"nih-brain-budget","relationship":null,"section":"mind","source":"o-nih-brain-budget","type":"added"}],"corrections":{"items":[],"policy":"Private review; no publication corrections log."},"forecasts":{"items":[],"object_type":"hn_forecast","scoring":{"brier":"mean of (p - outcome)^2 over yes/no resolutions, p = probability/100, outcome 1 if YES else 0; void excluded","hit_rate":"share of yes/no resolutions where the side with >50% happened","min_resolved_to_score":15}},"layers":[{"id":"labs","label":"AI labs & capital","order":0,"question":""},{"id":"neuro","label":"Neurotech & therapeutics","order":1,"question":""},{"id":"science","label":"Science & care","order":2,"question":""},{"id":"policy","label":"Rules & regulators","order":3,"question":""},{"id":"context","label":"Context","order":4,"question":""}],"ledger":[],"meta":{"board_date":"2026-11-05","board_date_note":"Local layout review dated 2026-11-05; not a claim of comprehensive or completed source review.","data_checked":"2026-11-04","publisher":"Hypernovelty Institute","relationship_types":{"chips":"supplies accelerators","cloud":"supplies cloud capacity","equity":"holds equity in","fab":"fabricates wafers","finance":"project financing","funds":"funds research by","grid":"grid connection / investment","hosting":"builds / hosts capacity","integration":"integrates its device with","model":"supplies a robot model to","packaging":"packages / tests","power":"sells or routes power to","protocol":"co-develops a commerce protocol with","research_collab":"collaborates on research with","robots":"supplies robots to","rule":"sets rules for","settlement":"provides a settlement asset to","site":"provides site","standard":"supplies the standard used by","trial_site":"hosts a clinical trial for"},"review_coverage":{"complete":false},"title":"Global Chess Map","topics":[{"id":"bci","label":"Brain-computer interfaces","section":"mind"},{"id":"psychedelic-medicine","label":"Psychedelic medicine","section":"mind"},{"id":"consciousness-science","label":"Consciousness science","section":"mind"},{"id":"ai-welfare","label":"AI consciousness & model welfare","section":"mind"},{"id":"neurorights","label":"Neural data & neurorights","section":"mind"},{"id":"neuromodulation","label":"Neuromodulation (DBS, TMS)","section":"mind"},{"id":"digital-minds","label":"Digital minds & brain emulation","section":"mind"},{"id":"theory-disputes","label":"Consciousness theory disputes","section":"mind"},{"id":"neuro-programmes","label":"National brain & neurotech programmes","section":"mind"}]},"moves":[{"actors":["NEURALINK"],"change_my_mind":null,"date":"2026-10-01","evidence":[{"shows":"All figures (hours, BPS, calibration, decoder longevity); investigational status.","source":"a-nl-pretrain"},{"shows":"Seven Neuralink-sponsored registry studies, starts 2024-01-09 to 2026-01-08.","source":"a-ctgov-neuralink"}],"history":[],"hn":[],"id":"nl-pretrain-50k","kind":"research","position_changes":{"basis":["a-nl-pretrain"],"items":[{"actor":"NEURALINK","direction":"+","text":"Neuralink is treating neural recordings as a pretraining corpus, the same move language-model labs made with text."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Neuralink reports 50,000+ hours of streamed brain data and a pretrained decoder","topics":["bci"],"uncertain":{"items":["Company-reported; no independent peer-reviewed replication was opened.","Participant count is not stated on the page."],"label":"Interpretation"},"watch_next":[{"date":null,"text":"Peer-reviewed publication of the pretraining results."},{"date":"2026-06","text":"PRIME (NCT06429735) estimated primary completion month in the registry; check for an update."}],"what_happened":{"sources":["a-nl-pretrain"],"text":"Neuralink says its trial participants have streamed more than 50,000 hours of neural data in the roughly two years since its trial began (the first participant alone more than 9,000 hours). It reports a pretrained decoder that cut calibration from about 10 minutes a day to about 10 minutes a week for some users, a record of 11.32 bits per second (previous 10.39) with a median near 10, and one decoder still usable after 20 months. All figures are company-reported; the devices are investigational and not FDA approved."}},{"actors":["NEURALINK","FDA"],"change_my_mind":null,"date":"2024-09-17","evidence":[{"shows":"Designation and stated purpose.","source":"a-nl-blindsight"},{"shows":"No Blindsight title occurs in the supplied seven-title capture. Its historical retrieval timestamp, lead-sponsor-only scope and completeness are not independently established.","source":"a-ctgov-neuralink"}],"history":[],"hn":[],"id":"nl-blindsight-bdd","kind":"rule","position_changes":{"basis":["a-nl-blindsight"],"items":[],"label":"Interpretation"},"promise":{"claim":"Blindsight will restore some vision (breakthrough-designated device).","claim_source":"a-nl-blindsight","current_evidence":["a-ctgov-neuralink"],"deadline":null,"delivery_criteria":"A registered human study reporting restored visual perception.","ladder":"announced","outcome":"unclear","outcome_note":"No Blindsight registry study found among Neuralink-sponsored records on 2026-11-04."},"relationships":[],"section":"mind","status":"published","title":"FDA gives Neuralink's Blindsight a Breakthrough Device Designation","topics":["bci"],"uncertain":{"items":["A designation speeds FDA interaction; it is not evidence the device works in people.","The supplied registry capture contains seven study titles with no Blindsight title. Its query completeness, lead-sponsor scope and inherited November 4 observation date were not independently established; this is not proof that no human Blindsight study exists."],"label":"Interpretation"},"watch_next":[{"date":null,"text":"A registered Blindsight human study."}],"what_happened":{"sources":["a-nl-blindsight"],"text":"Neuralink announced that the FDA granted Breakthrough Device Designation to Blindsight, an implant intended to restore some vision."}},{"actors":["UCLH","NEURALINK"],"change_my_mind":null,"date":"2026-01-29","evidence":[{"shows":"Seven participants; surgery site; study aim.","source":"a-uclh-gbprime"},{"shows":"GB-PRIME registry start 2025-07-31.","source":"a-ctgov-neuralink"}],"history":[],"hn":[],"id":"uclh-gbprime-seven","kind":"deployment","position_changes":{"basis":["a-uclh-gbprime"],"items":[{"actor":"NEURALINK","direction":"+","text":"Trial footprint now spans the U.S., Canada, the UAE and the UK (registry)."}],"label":"Interpretation"},"promise":null,"relationships":["R-UCLH-NEURALINK"],"section":"mind","status":"published","title":"UCLH reports seven UK patients in Neuralink's GB-PRIME trial","topics":["bci"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-uclh-gbprime"],"text":"University College London Hospitals said seven patients with severely impaired control of computers or phones are participating in GB-PRIME, a study of Neuralink's BCI; surgeries took place at the National Hospital for Neurology and Neurosurgery. The registry lists GB-PRIME (NCT07127172) with a start date of 2025-07-31."}},{"actors":["OPENAI","MERGELABS"],"change_my_mind":null,"date":"2026-01-15","evidence":[{"shows":"Seed participation (corporate funding), foundation-model collaboration, mission wording, co-founder list.","source":"a-oai-merge"},{"shows":"Non-invasive approach.","source":"a-merge-home"}],"history":[],"hn":[],"id":"openai-merge-labs","kind":"financing","position_changes":{"basis":["a-oai-merge"],"items":[{"actor":"OPENAI","direction":"+","text":"The first frontier AI lab with a disclosed stake in a brain-interface company; the clearest single sourced link between AI labs and neurotech."}],"label":"Interpretation"},"promise":null,"relationships":["R-OPENAI-MERGE"],"section":"mind","status":"published","title":"OpenAI invests in Merge Labs, a non-invasive BCI start-up co-founded by Sam Altman","topics":["bci"],"uncertain":{"items":["Round size and valuation not on primary pages opened.","Merge Labs has no registered human study found."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-oai-merge"],"text":"OpenAI said it is participating in Merge Labs' seed round and will collaborate with it on scientific foundation models, and described Merge's long-term mission as 'bridging biological and artificial intelligence to maximize human ability, agency, and experience'. Sam Altman is listed as a co-founder 'in a personal capacity'. Merge Labs' own site describes a non-invasive approach (molecules, ultrasound) that avoids implants into brain tissue. No amount is given on the OpenAI page."}},{"actors":["PARADROMICS","FDA"],"change_my_mind":null,"date":"2025-11-20","evidence":[{"shows":"IDE approval and Q1 launch claim.","source":"a-para-ide"},{"shows":"Registry start date and enrollment.","source":"a-ctgov-para"},{"shows":"Expansion to personal computing devices.","source":"a-para-pc"},{"shows":"Nationwide recruitment; first participant's use (company-reported).","source":"a-para-nation"}],"history":[],"hn":[],"id":"paradromics-ide","kind":"rule","position_changes":{"basis":["a-para-ide"],"items":[],"label":"Interpretation"},"promise":{"claim":"Launch the Connect-One study in Q1 2026.","claim_source":"a-para-ide","current_evidence":["a-ctgov-para","a-para-nation"],"deadline":"2026-03-31","delivery_criteria":"A registered study start in Q1 2026.","ladder":"demonstrated","outcome":"delivered","outcome_note":"Registry start 2026-03-31; first participant reported using the device on 2026-10-26 (company-reported)."},"relationships":["R-FDA-PARADROMICS"],"section":"mind","status":"published","title":"FDA approves Paradromics' Connect-One speech-BCI study (IDE)","topics":["bci"],"uncertain":{"items":["The ACTUAL registry start supports the preserved registered-study-start criterion, not Q1 implantation or clinical efficacy. Enrollment two is estimated, not a count of actual treated participants. The original supplied extract does not independently authenticate its inherited November 4 retrieval date."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-para-ide","a-ctgov-para","a-para-pc","a-para-nation"],"text":"Paradromics said the FDA approved an investigational device exemption for its Connect-One early feasibility study of the fully implantable Connexus BCI for speech restoration, calling itself the first company to receive such approval (company claim), and said it would launch the study in the first quarter of the next year. The registry record retrieved for the Nov 5, 2026 review lists NCT07357428 with an ACTUAL study start of 2026-03-31, recruiting status and ESTIMATED enrollment of 2. On Aug 26, 2026 it reported FDA approval to extend use to personal computing devices, and on Oct 26, 2026 FDA approval to recruit nationwide, saying its first participant now communicates through synthesized speech, texts and phone calls."}},{"actors":["PARADROMICS","SIEMENSHC"],"change_my_mind":null,"date":"2026-10-19","evidence":[{"shows":"Collaboration and purpose.","source":"a-para-siemens"}],"history":[],"hn":[],"id":"paradromics-siemens","kind":"agreement","position_changes":{"basis":["a-para-siemens"],"items":[{"actor":"SIEMENSHC","direction":"+","text":"A large medtech incumbent building infrastructure around implantable BCIs."}],"label":"Interpretation"},"promise":null,"relationships":["R-SIEMENS-PARADROMICS"],"section":"mind","status":"published","title":"Paradromics and Siemens Healthineers collaborate on BCI imaging","topics":["bci"],"uncertain":{"items":["No financial terms disclosed."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-para-siemens"],"text":"Paradromics announced a collaboration with Siemens Healthineers to develop a multimodal imaging platform supporting clinical use of implantable BCIs."}},{"actors":["APPLE","SYNCHRON"],"change_my_mind":null,"date":"2025-05-13","evidence":[{"shows":"Apple's protocol announcement (does not name Synchron).","source":"a-apple-bci"},{"shows":"Synchron release titles and dates (releases not opened).","source":"a-synchron-news"}],"history":[],"hn":[],"id":"apple-bci-hid","kind":"platform","position_changes":{"basis":["a-apple-bci"],"items":[{"actor":"APPLE","direction":"+","text":"A consumer platform has built an operating-system input path for BCIs."}],"label":"Interpretation"},"promise":null,"relationships":["R-SYNCHRON-APPLE"],"section":"mind","status":"published","title":"Apple adds a Switch Control protocol for brain-computer interfaces; Synchron says it is first to integrate","topics":["bci"],"uncertain":{"items":["Synchron's integration claim rests on release titles; the releases themselves were not opened."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-apple-bci"],"text":"Apple announced that iOS, iPadOS and visionOS will add a protocol supporting Switch Control for brain-computer interfaces. Synchron's newsroom lists a May 14, 2025 release on achieving first native BCI integration with iPhone, iPad and Apple Vision Pro, and an Aug 4, 2025 release on a thought-controlled iPad experience using Apple's BCI Human Interface Device protocol."}},{"actors":["PRECISIONNEURO","FDA"],"change_my_mind":null,"date":"2025-04-17","evidence":[{"shows":"Clearance letter, device class, date.","source":"a-fda-k242618"},{"shows":"30-day use; company's 'first' claim.","source":"a-precision-510k"}],"history":[],"hn":[],"id":"precision-510k","kind":"rule","position_changes":{"basis":["a-fda-k242618"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Precision Neuroscience's cortical electrode array receives FDA 510(k) clearance","topics":["bci"],"uncertain":{"items":["Clearance covers a temporary electrode, not a full implanted BCI system."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-fda-k242618","a-precision-510k"],"text":"The FDA cleared Precision Neuroscience's Layer 7-T cortical electrode (K242618, Class II; letter dated March 30, 2025). Precision says the array may be implanted temporarily for up to 30 days and calls it the first full regulatory clearance for a company developing a next-generation wireless BCI (company claim)."}},{"actors":["TETHER","BRNEURO"],"change_my_mind":null,"date":"2024-04-29","evidence":[{"shows":"Investor and amount.","source":"a-brn-tether"}],"history":[],"hn":[],"id":"tether-blackrock","kind":"financing","position_changes":{"basis":["a-brn-tether"],"items":[],"label":"Interpretation"},"promise":null,"relationships":["R-TETHER-BRNEURO"],"section":"mind","status":"published","title":"Tether invests $200M in Blackrock Neurotech","topics":["bci"],"uncertain":{"items":["Ownership share not verified from an opened primary page."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-brn-tether"],"text":"Blackrock Neurotech said Tether Evo, Tether's venture arm, made a $200 million investment in the company."}},{"actors":["META"],"change_my_mind":null,"date":"2025-07-23","evidence":[{"shows":"Publication announcement.","source":"a-meta-semg"}],"history":[],"hn":[],"id":"meta-semg-nature","kind":"research","position_changes":{"basis":["a-meta-semg"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Meta publishes non-invasive sEMG wristband neural-interface research in Nature","topics":["bci"],"uncertain":{"items":["sEMG reads muscle signals at the wrist, not brain activity; included as the non-invasive edge of neural interfaces."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-meta-semg"],"text":"Meta's Reality Labs said its surface electromyography (sEMG) wristband research was published in Nature."}},{"actors":["COMPASS","FDA"],"change_my_mind":null,"date":"2026-11-03","evidence":[{"shows":"NDA timing, voucher, launch target.","source":"a-compass-q3"},{"shows":"Phase 3 primary endpoint met.","source":"a-compass-005"},{"shows":"Second phase 3 six-month data.","source":"a-compass-006"}],"history":[],"hn":[],"id":"compass-nda","kind":"rule","position_changes":{"basis":["a-compass-q3"],"items":[{"actor":"COMPASS","direction":"+","text":"Closest classic psychedelic to an FDA decision."}],"label":"Interpretation"},"promise":{"claim":"Launch COMP360 in the first half of 2027, subject to FDA approval.","claim_source":"a-compass-q3","current_evidence":["a-compass-005","a-compass-006","a-compass-q3"],"deadline":"2027-06-30","delivery_criteria":"FDA approval and commercial availability.","ladder":"demonstrated","outcome":"unclear","outcome_note":"Two positive phase 3 readouts; NDA not yet complete as of 2026-11-03."},"relationships":[],"section":"mind","status":"published","title":"Compass says final psilocybin NDA filing is due within two weeks; launch targeted H1 2027","topics":["psychedelic-medicine"],"uncertain":{"items":["Approval is not certain; Lykos' 2024 rejection is the precedent.","US commercialization also depends on DEA and applicable state rescheduling. Faster review and H1 2027 launch are company expectations, not guarantees; positive clinical readouts do not mean a completed NDA or commercial launch."],"label":"Interpretation"},"watch_next":[{"date":"2026-11-17","text":"Roughly two weeks after the Nov 3 statement: confirmation that the final NDA was filed."}],"what_happened":{"sources":["a-compass-q3"],"text":"Compass Pathways said the final part of its rolling NDA for COMP360 psilocybin in treatment-resistant depression will be filed in the next two weeks, that it was awarded a National Priority Voucher (which it says could shorten review to 1–2 months), and that it expects launch in the first half of 2027, subject to FDA approval. Its first phase 3 (COMP005) met its primary endpoint in June 2025 (MADRS difference −3.6 vs placebo at 25 mg)."}},{"actors":["DEFINIUM"],"change_my_mind":null,"date":"2026-09-14","evidence":[{"shows":"Endpoints, effect size, NDA timing.","source":"a-dfn-panorama"},{"shows":"November 4 announcement schedules the NEI poster presentations for November 7; it does not establish presentation on November 4.","source":"a-dfn-nei"},{"shows":"The January 12, 2026 company announcement identifies Definium as formerly Mind Medicine (MindMed) Inc.","source":"supplemental-dfn-rebrand"}],"history":[],"hn":[],"id":"definium-panorama","kind":"research","position_changes":{"basis":["a-dfn-panorama"],"items":[],"label":"Interpretation"},"promise":{"claim":"File an NDA for DT120 ODT in 1H 2027.","claim_source":"a-dfn-panorama","current_evidence":["a-dfn-panorama"],"deadline":"2027-06-30","delivery_criteria":"NDA submission announced.","ladder":"demonstrated","outcome":"unclear","outcome_note":"Phase 3 data positive; filing not yet due."},"relationships":[],"section":"mind","status":"published","title":"Definium's LSD-based DT120 meets phase 3 endpoints in generalized anxiety","topics":["psychedelic-medicine"],"uncertain":{"items":["DT120 ODT is an investigational lysergide (LSD) formulation. Company-reported phase 3 results do not establish NDA submission, approval or commercial availability."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-dfn-panorama","supplemental-dfn-rebrand"],"text":"Definium Therapeutics (formerly MindMed) said its Panorama phase 3 of DT120 ODT in generalized anxiety disorder met its primary and all key secondary endpoints (HAM-A placebo-adjusted −5.1 at week 12), its third positive phase 3 overall. It has a pre-NDA meeting scheduled in Q4 2026 and anticipates filing in 1H 2027. On Nov 4, 2026 it announced topline-data poster presentations scheduled for Nov 7 at the NEI Fall Congress."}},{"actors":["LYKOS","FDA"],"change_my_mind":null,"date":"2024-08-09","evidence":[{"shows":"CRL and request for another phase 3.","source":"a-lykos-crl"}],"history":[],"hn":[],"id":"lykos-crl","kind":"rule","position_changes":{"basis":["a-lykos-crl"],"items":[{"actor":"FDA","direction":"-","text":"Sets the evidentiary bar later psychedelic sponsors are measured against."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"FDA declines to approve MDMA-assisted therapy for PTSD","topics":["psychedelic-medicine"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-lykos-crl"],"text":"Lykos Therapeutics said the FDA issued a complete response letter for midomafetamine capsules for PTSD, saying it could not approve based on data to date and requesting an additional phase 3 trial."}},{"actors":["FDA"],"change_my_mind":null,"date":"2026-07-14","evidence":[{"shows":"FDA identifies final guidance with July 2026 month-level metadata.","source":"a-fda-psy"},{"shows":"The Federal Register notice of availability was published July 14, 2026 and identifies the June 26, 2023 draft.","source":"o-fr-psy"}],"history":[],"hn":[],"id":"fda-psy-final","kind":"guidance","position_changes":{"basis":["a-fda-psy"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"FDA publishes notice of availability for final psychedelic-drug clinical-investigation guidance","topics":["psychedelic-medicine"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-fda-psy","o-fr-psy"],"text":"FDA lists 'Psychedelic Drugs: Considerations for Clinical Investigations' as final guidance, dated July 2026. The Federal Register notice of availability was published on July 14, 2026 and says the guidance finalizes the draft issued on June 26, 2023."}},{"actors":["WH","FDA"],"change_my_mind":null,"date":"2026-04-18","evidence":[{"shows":"Sections 2 and 5 of the order.","source":"a-wh-eo14401"},{"shows":"Compass cites the order and reports a voucher.","source":"a-compass-q3"}],"history":[],"hn":[],"id":"eo-14401","kind":"policy","position_changes":{"basis":["a-wh-eo14401"],"items":[{"actor":"WH","direction":"+","text":"Federal policy now explicitly accelerates psychedelic drug development."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Executive order directs priority FDA review and fast rescheduling for psychedelics after phase 3","topics":["psychedelic-medicine"],"uncertain":{"items":["The order does not itself change any substance's schedule."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-wh-eo14401"],"text":"Executive Order 14401 directs the FDA Commissioner to provide National Priority Vouchers to appropriate breakthrough-designated psychedelic drugs, sets up a Right to Try pathway including ibogaine compounds, and directs the Attorney General, with HHS, to initiate and complete review of any Schedule I product that has completed phase 3 trials for a serious mental health disorder so rescheduling can follow if appropriate."}},{"actors":["COGITATE","TWCF"],"change_my_mind":null,"date":"2025-04-30","evidence":[{"shows":"Design, sample, funding acknowledgement.","source":"a-nature-cogitate"},{"shows":"Programme aim.","source":"a-twcf-arc"}],"history":[],"hn":[],"id":"cogitate-nature","kind":"research","position_changes":{"basis":["a-nature-cogitate"],"items":[{"actor":"TWCF","direction":"+","text":"Philanthropy, not corporations, is the main sourced funder of consciousness science."}],"label":"Interpretation"},"promise":null,"relationships":["R-TWCF-COGITATE"],"section":"mind","status":"published","title":"Templeton-funded adversarial test of two leading consciousness theories published in Nature","topics":["consciousness-science"],"uncertain":{"items":["No dollar figure for the TWCF programme was found on an opened page."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-nature-cogitate"],"text":"The Cogitate Consortium published in Nature a pre-registered adversarial test of global neuronal workspace theory and integrated information theory (256 participants), challenging key predictions of both. The paper acknowledges Templeton World Charity Foundation funding (TWCF0389, TWCF0486). TWCF's Accelerating Research on Consciousness programme aims to reduce the number of competing theories through such collaborations."}},{"actors":[],"change_my_mind":null,"date":"2023-08-17","evidence":[{"shows":"Authors, method, conclusion.","source":"a-butlin"}],"history":[],"hn":[],"id":"butlin-indicators","kind":"research","position_changes":{"basis":["a-butlin"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Researchers derive 'indicator properties' to test AI systems for consciousness","topics":["consciousness-science"],"uncertain":{"items":["A theory-based checklist, not a test accepted across the field."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-butlin"],"text":"A report by Patrick Butlin, Robert Long and co-authors (including Yoshua Bengio and Jonathan Birch) surveys leading scientific theories of consciousness, derives 'indicator properties' from them, and assesses existing AI systems against those indicators. It concludes no current AI systems are conscious, but that there are no obvious technical barriers to building systems that satisfy the indicators."}},{"actors":[],"change_my_mind":null,"date":"2024-04-19","evidence":[{"shows":"Text of the declaration and date.","source":"a-nydecl"}],"history":[],"hn":[],"id":"ny-declaration","kind":"standard","position_changes":{"basis":["a-nydecl"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"New York Declaration on Animal Consciousness extends 'realistic possibility' of consciousness to all vertebrates and many invertebrates","topics":["consciousness-science"],"uncertain":{"items":["About animals, not machines; included because the same 'realistic possibility' reasoning is applied to AI welfare."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-nydecl"],"text":"The New York Declaration on Animal Consciousness, launched at New York University, states strong scientific support for conscious experience in mammals and birds, at least a realistic possibility in all vertebrates and many invertebrates, and that it is irresponsible to ignore that possibility. Signatories sign in a personal capacity."}},{"actors":["ELEOS"],"change_my_mind":null,"date":"2024-11-04","evidence":[{"shows":"Authors and argument.","source":"a-eleos-arxiv"},{"shows":"Eleos mission.","source":"a-eleos-home"},{"shows":"Earlier indicator-properties report (2023) by overlapping authors.","source":"a-butlin"}],"history":[],"hn":[],"id":"eleos-ai-welfare","kind":"research","position_changes":{"basis":["a-eleos-arxiv"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Researchers argue some AI systems may soon be conscious or robustly agentic, so AI welfare needs preparing for","topics":["ai-welfare"],"uncertain":{"items":["An argument for preparation, not evidence that any system is conscious."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-eleos-arxiv"],"text":"The paper 'Taking AI Welfare Seriously' (Long, Sebo, Butlin, Fish, Birch, Chalmers and others) argues there is a realistic possibility some AI systems will be conscious or robustly agentic in the near future and recommends that AI companies start preparing. Eleos AI Research describes itself as a non-profit working on AI sentience and wellbeing."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2025-04-24","evidence":[{"shows":"Programme announcement and stated uncertainty.","source":"a-anth-welfare"}],"history":[],"hn":[],"id":"anth-model-welfare","kind":"research","position_changes":{"basis":["a-anth-welfare"],"items":[{"actor":"ANTHROPIC","direction":"+","text":"First frontier lab to make AI consciousness an official research programme."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic launches a model-welfare research programme","topics":["ai-welfare"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-anth-welfare"],"text":"Anthropic announced research into model welfare, asking whether the welfare of AI systems deserves moral consideration while saying there is no scientific consensus on whether current or future systems could be conscious."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2025-08-15","evidence":[{"shows":"Feature and stated welfare rationale.","source":"a-anth-endconv"}],"history":[],"hn":[],"id":"anth-end-conv","kind":"deployment","position_changes":{"basis":["a-anth-endconv"],"items":[{"actor":"ANTHROPIC","direction":"+","text":"Welfare research turned into a shipped product behaviour."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic lets Claude end abusive conversations, citing AI welfare","topics":["ai-welfare"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-anth-endconv"],"text":"Anthropic gave Claude Opus 4 and 4.1 the ability to end certain conversations, saying it was developed primarily as part of exploratory work on potential AI welfare and that it remains highly uncertain about the potential moral status of Claude."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2025-11-04","evidence":[{"shows":"Weight preservation and post-deployment interviews.","source":"a-anth-deprec"},{"shows":"Constitution's statement of uncertainty about consciousness.","source":"a-anth-constitution"},{"shows":"Introspection research.","source":"a-anth-introspect"}],"history":[],"hn":[],"id":"anth-deprecation","kind":"policy","position_changes":{"basis":["a-anth-deprec"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic commits to preserve weights of released models and interview models before retirement","topics":["ai-welfare"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[{"date":null,"text":"Anthropic's Feb 25, 2026 update on deprecation commitments for Claude Opus 3 (linked, not opened)."}],"what_happened":{"sources":["a-anth-deprec"],"text":"Anthropic committed to preserve the weights of all publicly released models for at least the lifetime of the company and to interview models about their preferences before deprecation. In January 2026 its new constitution set out its uncertainty about whether Claude might have some kind of consciousness or moral status. In October 2025 it published research on emergent introspective awareness in LLMs."}},{"actors":["MSFT"],"change_my_mind":null,"date":"2025-08-19","evidence":[{"shows":"Argument and framing.","source":"a-suleyman"}],"history":[],"hn":[],"id":"suleyman-scai","kind":"policy","position_changes":{"basis":["a-suleyman"],"items":[{"actor":"MSFT","direction":"-","text":"A major lab leader publicly opposes treating AI as a potential moral patient; the counterweight to Anthropic."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Microsoft AI's CEO warns against 'Seemingly Conscious AI'","topics":["ai-welfare"],"uncertain":{"items":["Published on a personal site; it is his position, not a Microsoft policy document."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-suleyman"],"text":"Mustafa Suleyman, CEO of Microsoft AI, argued that AI should be built for people, not to be a person, warning about 'Seemingly Conscious AI': systems with the hallmarks of conscious beings that thus appear to be conscious."}},{"actors":["COGA"],"change_my_mind":null,"date":"2024-04-17","evidence":[{"shows":"Signed act and definition.","source":"a-co-hb1058"}],"history":[],"hn":[],"id":"co-hb1058","kind":"law","position_changes":{"basis":["a-co-hb1058"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Colorado makes neural data 'sensitive data' under its privacy law","topics":["neurorights"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-co-hb1058"],"text":"Colorado HB24-1058, approved April 17, 2024, expands the Colorado Privacy Act to cover biological data, including neural data, defined as information generated by measuring the activity of a person's central or peripheral nervous system."}},{"actors":["CALEG"],"change_my_mind":null,"date":"2024-09-28","evidence":[{"shows":"Chaptering and definition.","source":"a-ca-sb1223"}],"history":[],"hn":[],"id":"ca-sb1223","kind":"law","position_changes":{"basis":["a-ca-sb1223"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"California adds neural data to the CCPA's sensitive personal information","topics":["neurorights"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-ca-sb1223"],"text":"California SB 1223 was approved by the Governor and chaptered on Sept 28, 2024 (Chapter 887), adding neural data, generated by measuring central or peripheral nervous system activity, to the CCPA's sensitive personal information."}},{"actors":["USSENATE"],"change_my_mind":null,"date":"2025-09-29","evidence":[{"shows":"Bill text, sponsors, FTC report duty.","source":"a-mind-text"},{"shows":"Senate Commerce release (2025-09-24).","source":"a-mind-pr"}],"history":[],"hn":[],"id":"mind-act","kind":"law","position_changes":{"basis":["a-mind-text"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"MIND Act introduced to study federal protection of neural data","topics":["neurorights"],"uncertain":{"items":["Introduced only; no committee action was verified."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-mind-text"],"text":"Senators Schumer, Cantwell and Markey introduced S.2925, the MIND Act, which would direct the FTC to conduct a study on the governance of neural data and report within one year of enactment. The bill has not been enacted."}},{"actors":["UNESCO"],"change_my_mind":null,"date":"2025-11-11","evidence":[{"shows":"The legal instrument lists adoption on 11 November 2025 in Samarkand, Uzbekistan.","source":"a-unesco-rec"},{"shows":"The news item is dated 5 November 2025, updated 8 November, and names both expert-group chairs. Its adoption/entry-into-force language conflicts with the later legal-record date.","source":"a-unesco-news"},{"shows":"UNESCO distinguishes nonbinding recommendations from conventions and separately describes constitutional submission/reporting duties.","source":"verify-unesco-standard-setting"}],"history":[],"hn":[],"id":"unesco-neurotech","kind":"standard","position_changes":{"basis":["a-unesco-news"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"UNESCO adopts the first global standard on neurotechnology ethics","topics":["neurorights"],"uncertain":{"items":["The Recommendation is nonbinding under international law. UNESCO's Constitution separately requires Member States to submit recommendations to competent authorities and report on action taken.","The Nov 5 news wording ('final step'/'adopted') predates the instrument's Nov 11 adoption date; the instrument record is treated as controlling."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-unesco-rec","a-unesco-news","verify-unesco-standard-setting"],"text":"UNESCO's General Conference (43rd session, Samarkand, 30 Oct-13 Nov 2025) adopted the Recommendation on the Ethics of Neurotechnology on Nov 11, 2025. A recommendation is a nonbinding standard-setting instrument, not a treaty. A separate UNESCO news item dated Nov 5, 2025 names the expert group as co-chaired by Hervé Chneiweiss and Nita Farahany; its adoption wording predates the authoritative instrument date."}},{"actors":[],"change_my_mind":null,"date":"2025-03-10","evidence":[{"shows":"Authorship, link to the 2023 preprint, argument.","source":"b-nn-iit-unsci"}],"history":[],"hn":[],"id":"iit-unscientific","kind":"research","position_changes":{"basis":["b-nn-iit-unsci"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Over 100 researchers' 'pseudoscience' critique of integrated information theory reaches Nature Neuroscience","topics":["theory-disputes"],"uncertain":{"items":["The 2023 letter's exact date was not taken from an opened primary page; the comment cites it as 2023.","Signatory count not counted from the page."],"label":"Interpretation"},"watch_next":[{"date":null,"text":"Any funder or journal policy change citing the dispute."}],"what_happened":{"sources":["b-nn-iit-unsci"],"text":"A Nature Neuroscience comment by the 'IIT-Concerned' consortium (signatories include Yoshua Bengio), 'What makes a theory of consciousness unscientific?', expands their 2023 PsyArXiv open letter and argues that integrated information theory's core claims are untestable even in principle."}},{"actors":[],"change_my_mind":null,"date":"2025-03-10","evidence":[{"shows":"Title, authors, issue.","source":"b-nn-iit-reply"}],"history":[],"hn":[],"id":"iit-reply-seth","kind":"research","position_changes":{"basis":["b-nn-iit-reply"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Gomez-Marin and Seth reply: consciousness science needs to get beyond the 'pseudo-science' fight","topics":["theory-disputes"],"uncertain":{"items":["Summarised from title and framing; the full argument was not abstracted here."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-nn-iit-reply"],"text":"In the same Nature Neuroscience issue, Alex Gomez-Marin and Anil Seth published 'A science of consciousness beyond pseudo-science and pseudo-consciousness' (vol. 28, pp. 703–706), responding to the dispute over integrated information theory."}},{"actors":["CNGOV"],"change_my_mind":null,"date":"2025-07-23","evidence":[{"shows":"Targets for 2027 and 2030; issuing bodies; document number.","source":"b-cn-bci"}],"history":[],"hn":[],"id":"cn-bci-plan","kind":"policy","position_changes":{"basis":["b-cn-bci"],"items":[{"actor":"CNGOV","direction":"+","text":"The only national government found that treats BCI as an industrial-policy sector with dated targets."}],"label":"Interpretation"},"promise":{"claim":"By 2027, key BCI technologies achieve breakthroughs and 2–3 industry clusters form; by 2030, 2–3 globally influential leading firms.","claim_source":"b-cn-bci","current_evidence":["b-cn-bci"],"deadline":"2027-12-31","delivery_criteria":"Officially named clusters (2027) and leading firms (2030).","ladder":"announced","outcome":"unclear","outcome_note":"Plan issued 2025-07-23; deadline not reached."},"relationships":[],"section":"mind","status":"published","title":"China's seven-department plan targets BCI breakthroughs by 2027 and 2–3 global leading firms by 2030","topics":["neuro-programmes","bci"],"uncertain":{"items":["Targets are national goals, not funded commitments with amounts on the opened page.","The combined promise has separate 2027 technology/cluster and 2030 leading-firm milestones. Its preserved 2027 deadline is the first checkpoint, not the due date for the entire combined target; official naming alone would not establish technology breakthroughs or global influence."],"label":"Interpretation"},"watch_next":[{"date":"2027","text":"Whether 2–3 BCI industry clusters are designated."}],"what_happened":{"sources":["b-cn-bci"],"text":"MIIT and six other departments/bodies issued Implementation Opinions on Promoting Innovative Development of the Brain-Computer Interface Industry (工信部联科〔2025〕164号). By 2027: breakthroughs in key BCI technologies, electrodes, chips and complete devices at international advanced level, and 2–3 industry clusters. By 2030: a secure and reliable industrial system and 2–3 globally influential leading firms. It frames BCI as coordinated development of life science and information science."}},{"actors":["ARIA"],"change_my_mind":null,"date":null,"date_note":"ARIA's programme page is undated (observed 2026-11-04); launch date not on any opened page.","evidence":[{"shows":"Amount, scope, opportunity space.","source":"b-aria-pn"}],"history":[],"hn":[],"id":"aria-precision-neuro","kind":"financing","position_changes":{"basis":["b-aria-pn"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"UK's ARIA backs a £69m Precision Neurotechnologies programme","topics":["neuro-programmes"],"uncertain":{"items":["Programme launch date is not on the opened page."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-aria-pn"],"text":"ARIA's Precision Neurotechnologies programme, backed by £69m and within its Scalable Neural Interfaces opportunity space, aims to unlock new methods to interface with the human brain at the circuit level."}},{"actors":["JSTMOON"],"change_my_mind":null,"date":"2025-08-28","evidence":[{"shows":"Goal 1 wording, Cybernetic Avatar, Kanai project aim.","source":"b-jst-ms1"},{"shows":"The symposium announcement is dated August 28, 2025; the event was scheduled for October 9–10.","source":"b-iob-news"},{"shows":"JST lists Furuya/Sony CSL under Item [1] IoB Interfaces and Rekimoto/Sony CSL alongside Oizumi/University of Tokyo under Item [2] IoB Middleware.","source":"o-jst-kanai"}],"history":[],"hn":[],"id":"jp-moonshot-iob","kind":"research","position_changes":{"basis":["b-jst-ms1"],"items":[{"actor":"JSTMOON","direction":"+","text":"A government programme that openly names a brain-to-network goal; the nearest institutional term found for Jordan's 'consciousness grid'."}],"label":"Interpretation"},"promise":{"claim":"A society free from limitations of body, brain, space and time by 2050.","claim_source":"b-jst-ms1","current_evidence":["b-jst-ms1"],"deadline":"2050-12-31","delivery_criteria":"Widely deployed cybernetic avatars controllable by intention.","ladder":"announced","outcome":"unclear","outcome_note":"Long-range goal; research stage."},"relationships":[],"section":"mind","status":"published","title":"Japan's Moonshot Goal 1 runs an 'Internet of Brains' project toward a 2050 society 'free from limitations of body, brain, space, and time'","topics":["neuro-programmes","bci"],"uncertain":{"items":["Aug 28, 2025 is the symposium announcement date; the event was scheduled for Oct 9–10. The performer roster is programme participation, not proof of deployed capability. The 2050 goal and local delivery criterion are not achieved results."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-jst-ms1","b-iob-news","o-jst-kanai"],"text":"Japan's Moonshot R&D Goal 1 aims for a society by 2050 in which people are free from limitations of body, brain, space and time, using 'Cybernetic Avatar' technology. Its Kanai project develops avatars controlled via intention estimated from brain activity and brands itself the 'Internet of Brains' (IoB); on Aug 28, 2025 it announced a symposium titled 'Internet of Brains: A Blueprint for Connecting the Brain to the World'. JST's Kanai project page lists Sony Computer Science Laboratories researchers as R&D-item performers: Furuya Shinichi under Item [1] (IoB Interfaces) and Rekimoto Junichi under Item [2] (IoB Middleware), alongside Oizumi Masafumi (The University of Tokyo) under Item [2]."}},{"actors":["MEDTRONIC","FDA"],"change_my_mind":null,"date":"2025-02-20","evidence":[{"shows":"Approval and date.","source":"b-fda-adbs"},{"shows":"BCI framing and installed-base figure (company-reported).","source":"b-mdt-adbs"}],"history":[],"hn":[],"id":"mdt-adaptive-dbs","kind":"rule","position_changes":{"basis":["b-fda-adbs"],"items":[{"actor":"MEDTRONIC","direction":"+","text":"A medtech incumbent re-labels closed-loop neuromodulation as BCI, enlarging what counts as the BCI market."}],"label":"Interpretation"},"promise":{"claim":"Adaptive DBS available commercially for Parkinson's patients (US launch).","claim_source":"b-mdt-adbs","current_evidence":["b-fda-adbs","b-mdt-adbs"],"deadline":null,"delivery_criteria":"Commercial availability in the US.","ladder":"commercially_available","outcome":"delivered","outcome_note":"FDA approval and launch announced Feb 2025 (company-reported)."},"relationships":["R-FDA-MEDTRONIC"],"section":"mind","status":"published","title":"FDA approves Medtronic's adaptive (closed-loop) deep brain stimulation for Parkinson's","topics":["neuromodulation"],"uncertain":{"items":["'Largest BCI launch' depends on Medtronic's definition of BCI.","The Feb 24 company release announced availability while scheduling initial US programming over coming weeks and nationwide availability in coming months. FDA permission and that announcement do not independently prove actual US commercial programming; the preserved delivered status remains qualified pending direct delivery evidence.","The 40,000 figure is the company's worldwide Percept installed base, not a count of US recipients or actual adaptive-DBS users."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-fda-adbs","b-mdt-adbs"],"text":"The FDA approved PMA supplement P960009/S478 on Feb 20, 2025 for adaptive DBS on Medtronic's Percept platform, which adjusts stimulation using the patient's own brain signals. Medtronic described it as the 'largest commercial launch of brain-computer interface technology ever' and said more than 40,000 patients have Percept devices (company claims)."}},{"actors":["MAGNUS","FDA"],"change_my_mind":null,"date":"2022-09-01","evidence":[{"shows":"Clearance letter and date.","source":"b-fda-saint"},{"shows":"Company description.","source":"b-magnus-saint"}],"history":[],"hn":[],"id":"magnus-saint","kind":"rule","position_changes":{"basis":["b-fda-saint"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"FDA clears Magnus Medical's SAINT individualized TMS for depression","topics":["neuromodulation"],"uncertain":{"items":["Clinical-benefit figures in the release were not extracted."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-fda-saint"],"text":"The FDA cleared the SAINT Neuromodulation System (K220177; letter dated Sept 1, 2022) for major depressive disorder in adults who have not improved on prior antidepressants. Magnus says SAINT combines advanced imaging, personalized targeting and novel stimulation patterns into individualized neurostimulation (company description)."}},{"actors":["NEURALINK"],"change_my_mind":null,"date":"2025-06-02","evidence":[{"shows":"Round size, named investors and stated use of funds.","source":"b-nl-seriese"}],"history":[],"hn":[],"id":"nl-series-e","kind":"financing","position_changes":{"basis":["b-nl-seriese"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Neuralink raises a $650 million Series E","topics":["bci"],"uncertain":{"items":["Valuation is not stated on the page."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-nl-seriese"],"text":"Neuralink announced it closed a $650 million Series E with investors including ARK Invest, Founders Fund, G42, QIA, Sequoia Capital and Thrive Capital, saying the money will expand patient access and fund devices that 'deepen the connection between biological and artificial intelligence' (company announcement)."}},{"actors":["META"],"change_my_mind":null,"date":"2025-02-07","evidence":[{"shows":"Method, sample, 80% figure (company-reported), AMI framing, donation.","source":"b-meta-b2t"}],"history":[],"hn":[],"id":"meta-brain-typing","kind":"research","position_changes":{"basis":["b-meta-b2t"],"items":[{"actor":"META","direction":"+","text":"Meta ties brain decoding directly to its machine-intelligence goal."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Meta FAIR decodes typed sentences from non-invasive brain recordings","topics":["bci"],"uncertain":{"items":["MEG needs a shielded room; not a product."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-meta-b2t"],"text":"Meta's FAIR lab, with the Basque Center on Cognition, Brain and Language, reported decoding up to 80% of characters typed by 35 healthy volunteers from MEG recordings, calling it a possible avenue for non-invasive BCIs and an 'important path to developing AMI' (advanced machine intelligence). Meta also announced a $2.2 million donation to the Rothschild Foundation Hospital."}},{"actors":["SYNCHRON","NVDA"],"change_my_mind":null,"date":"2025-03-19","evidence":[{"shows":"Claim: Roadmap, not release | Excerpt: \"today unveiled the roadmap to Chiral, a foundation model of human cognitions\" | Class: primary via syndication","source":"o-synchron-chiral-bw"},{"shows":"Claim: Future tense training | Excerpt: \"Synchron, in collaboration with NVIDIA, will train Chiral based on deidentified data\" | Class: primary via syndication","source":"o-synchron-chiral-bw"},{"shows":"Claim: Title and date | Excerpt: \"Synchron Unveils Chiral... March 19, 2025\" | Class: primary-direct (newsroom index)","source":"b-synchron-news"}],"history":[],"hn":[],"id":"synchron-chiral","kind":"research","position_changes":{"basis":["b-synchron-news"],"items":[{"actor":"NVDA","direction":"+","text":"A chip maker's AI stack is named inside an implant company's roadmap."}],"label":"Interpretation"},"promise":null,"relationships":["R-NVDA-SYNCHRON"],"section":"mind","status":"published","title":"Synchron unveils a roadmap to 'Chiral', a planned brain foundation model, with NVIDIA","topics":["bci"],"uncertain":{"items":["The headline says 'World's First ... Foundation Model' but the body describes a roadmap; no released model is claimed here.","BusinessWire original not opened directly (timeout); text from BioSpace syndication."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-synchron-chiral-bw","b-synchron-news"],"text":"On Mar 19, 2025 Synchron 'unveiled the roadmap to Chiral', which it describes as a foundation model of human cognition to be trained on de-identified neural data with NVIDIA; the release describes planned milestones, not a released model."}},{"actors":["GOOG"],"change_my_mind":null,"date":"2025-03-21","evidence":[{"shows":"Study summary and journal.","source":"b-goog-brainlang"}],"history":[],"hn":[],"id":"goog-brain-llm","kind":"research","position_changes":{"basis":["b-goog-brainlang"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Google Research reports LLM speech representations align with brain activity in real conversations","topics":["consciousness-science"],"uncertain":{"items":["About language processing, not consciousness; included as brain-AI correspondence research."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-goog-brainlang"],"text":"Google Research described a Nature Human Behaviour study finding alignment between the internal representations of a Transformer speech-to-text model and the neural processing sequence in the human brain during real-life conversations."}},{"actors":["MICRONS"],"change_my_mind":null,"date":"2025-04-09","evidence":[{"shows":"Scale and method.","source":"b-microns"},{"shows":"IARPA naming and data access.","source":"b-microns-explorer"}],"history":[],"hn":[],"id":"microns-connectome","kind":"research","position_changes":{"basis":["b-microns"],"items":[{"actor":"MICRONS","direction":"+","text":"A US intelligence-research agency funded the largest wiring-plus-activity map, a core input for emulation."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"IARPA-funded MICrONS maps a cubic millimetre of mouse cortex with function and wiring","topics":["digital-minds"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-microns"],"text":"The MICrONS consortium published in Nature a functional connectomics dataset co-registering activity recordings with an electron-microscopy reconstruction of more than 200,000 cells and 0.5 billion synapses in mouse visual cortex. The dataset page calls it the 'IARPA MICrONS dataset'."}},{"actors":["FLYWIRE"],"change_my_mind":null,"date":"2024-10-02","evidence":[{"shows":"Counts and scope.","source":"b-flywire"}],"history":[],"hn":[],"id":"flywire-whole-brain","kind":"research","position_changes":{"basis":["b-flywire"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"FlyWire publishes the first complete wiring diagram of an adult fly brain","topics":["digital-minds"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-flywire"],"text":"Dorkenwald et al. and the FlyWire Consortium published in Nature a whole-brain wiring diagram of an adult female fruit fly: 139,255 neurons and about 5 × 10^7 chemical synapses."}},{"actors":[],"change_my_mind":null,"date":"2025-10-17","evidence":[{"shows":"Scope and structure.","source":"b-wbe-report"}],"history":[],"hn":[],"id":"wbe-report-2025","kind":"research","position_changes":{"basis":["b-wbe-report"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"'State of Brain Emulation Report 2025' reassesses whole-brain emulation since the 2008 roadmap","topics":["digital-minds"],"uncertain":{"items":["Funders of the report not extracted."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-wbe-report"],"text":"Zanichelli, Schons, Freeman, Shiu and Arkhipov published a report reassessing brain-emulation progress since Sandberg and Bostrom's 2008 roadmap, organised around neural dynamics, connectomics and computational neuroscience."}},{"actors":[],"change_my_mind":null,"date":"2025-08-01","evidence":[{"shows":"Sample and medians.","source":"b-dm-forecast"}],"history":[],"hn":[],"id":"digital-minds-forecast","kind":"research","position_changes":{"basis":["b-dm-forecast"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Survey of 67 experts: median 90% that 'digital minds' are possible; 20% by 2030","topics":["digital-minds"],"uncertain":{"items":["Expert opinion, not evidence."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-dm-forecast"],"text":"Caviola and Saad surveyed 67 experts in early 2025 on 'digital minds' (computer systems capable of subjective experience). Medians: 90% possible in principle, 65% created by 2100, 20% by 2030."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2025-10-29","evidence":[{"shows":"Research and its stated limits.","source":"a-anth-introspect"}],"history":[],"hn":[],"id":"anth-introspection","kind":"research","position_changes":{"basis":["a-anth-introspect"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic reports 'emergent introspective awareness' in Claude, without claiming consciousness","topics":["ai-welfare"],"uncertain":{"items":["Introspection here is a measured capability, not a claim of experience."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-anth-introspect"],"text":"Anthropic published research on emergent introspective awareness in large language models and said its results do not tell whether Claude or any other AI system might be conscious."}},{"actors":["GOOG"],"change_my_mind":null,"date":"2024-11-01","evidence":[{"shows":"Authors, affiliations, framing.","source":"b-gdm-pain"}],"history":[],"hn":[],"id":"gdm-pain-pleasure","kind":"research","position_changes":{"basis":["b-gdm-pain"],"items":[{"actor":"GOOG","direction":"+","text":"Google staff publish sentience-adjacent research without a Google welfare programme announced."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Google and DeepMind researchers test whether LLMs trade points against stipulated pain, citing sentience debates","topics":["ai-welfare"],"uncertain":{"items":["Authors' paper, not a Google policy."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-gdm-pain"],"text":"Researchers from Google's Paradigms of Intelligence team, Google DeepMind and the LSE (including Blaise Agüera y Arcas and Jonathan Birch) probed whether LLMs make trade-offs involving stipulated pain and pleasure, a question they say may bear on debates about LLM sentience, 'the capacity for valenced experiential states'."}},{"actors":["CMEP"],"change_my_mind":null,"date":"2024","evidence":[{"shows":"Endowment and status (self-reported).","source":"b-cmep"}],"history":[],"hn":[],"id":"cmep-permanent","kind":"financing","position_changes":{"basis":["b-cmep"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"NYU's Center for Mind, Ethics, and Policy becomes a permanent centre with a $6 million endowment","topics":["consciousness-science","ai-welfare"],"uncertain":{"items":["Donors not named on the opened page."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-cmep"],"text":"NYU's Center for Mind, Ethics, and Policy says 2024 was the year it became a permanent center with a $6 million endowment and released work on animal and AI welfare."}},{"actors":[],"change_my_mind":null,"date":"2024-08-14","evidence":[{"shows":"Sample sizes and finding.","source":"b-wcm-cmd"},{"shows":"One-in-four finding and publication date.","source":"b-cam-cmd"}],"history":[],"hn":[],"id":"cmd-nejm","kind":"research","position_changes":{"basis":["b-wcm-cmd"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Largest study finds one in four unresponsive brain-injured patients show hidden cognitive responses","topics":["consciousness-science"],"uncertain":{"items":["The NEJM paper itself returned 403; figures come from two participating institutions' releases."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-wcm-cmd"],"text":"A New England Journal of Medicine study of 353 adults with disorders of consciousness found that, among 241 who could not respond visibly to commands, about one in four showed sustained cognitive responses on fMRI or EEG ('cognitive motor dissociation')."}},{"actors":["TGA"],"change_my_mind":null,"date":"2023-02-03","evidence":[{"shows":"Decision, conditions, effective date.","source":"b-tga"}],"history":[],"hn":[],"id":"tga-psy-rescheduling","kind":"rule","position_changes":{"basis":["b-tga"],"items":[{"actor":"TGA","direction":"+","text":"First national regulator found to permit psychedelic prescribing outside trials."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Australia lets authorised psychiatrists prescribe psilocybin and MDMA from July 2023","topics":["psychedelic-medicine"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-tga"],"text":"Australia's TGA announced that from 1 July 2023 authorised psychiatrists may prescribe MDMA for PTSD and psilocybin for treatment-resistant depression (Schedule 8 for those uses, Schedule 9 otherwise), with no TGA-evaluated approved product."}},{"actors":["USVA"],"change_my_mind":null,"date":"2024-12-03","evidence":[{"shows":"Amount, sites, 'first since 1960s'.","source":"b-va"}],"history":[],"hn":[],"id":"va-psy-study","kind":"financing","position_changes":{"basis":["b-va"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"VA funds its first psychedelic-assisted therapy study since the 1960s","topics":["psychedelic-medicine"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-va"],"text":"The VA announced about $1.5 million over five years for a study of MDMA-assisted therapy for veterans with PTSD and alcohol use disorder at Providence and West Haven VA medical centers, its first psychedelic-assisted therapy funding since the 1960s."}},{"actors":["DELIX","FDA"],"change_my_mind":null,"date":"2025-10","evidence":[{"shows":"Claims and FDA clearance (company-reported).","source":"b-delix"}],"history":[],"hn":[],"id":"delix-zalsupindole","kind":"research","position_changes":{"basis":["b-delix"],"items":[{"actor":"DELIX","direction":"+","text":"Psychedelic-derived drugs are being re-framed as 'neuroplastogens' without the trip."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Delix reports positive phase Ib data for a non-hallucinogenic 'neuroplastogen' and FDA clearance for an at-home phase II","topics":["psychedelic-medicine"],"uncertain":{"items":["Small phase Ib; no phase II result yet."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-delix"],"text":"Delix Therapeutics said zalsupindole (DLX-001), which it calls a first-in-class non-hallucinogenic neuroplastogen, showed positive phase Ib efficacy data and that the FDA cleared a phase II design with at-home administration (company-reported)."}},{"actors":["CLCONG"],"change_my_mind":null,"date":"2021-10-25","evidence":[{"shows":"Publication, text of the amendment.","source":"b-cl-21383"}],"history":[],"hn":[],"id":"cl-ley-21383","kind":"law","position_changes":{"basis":["b-cl-21383"],"items":[{"actor":"CLCONG","direction":"+","text":"The first constitutional neurorights clause found."}],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Chile writes protection of 'brain activity' into its Constitution","topics":["neurorights"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-cl-21383"],"text":"Ley 21.383, published in Chile's Diario Oficial on Oct 25, 2021, amends Article 19 No. 1 of the Constitution so that scientific and technological development respects physical and psychic integrity, with the law to 'especially protect brain activity, as well as the information coming from it'."}},{"actors":["CLSUP","EMOTIV"],"change_my_mind":null,"date":"2023-08-09","evidence":[{"shows":"Holding and order.","source":"b-cl-emotiv"},{"shows":"The judgment gives Fecha de sentencia: 09-08-2023; the separate court news item is dated August 11.","source":"o-emotiv-ruling"}],"history":[],"hn":[],"id":"cl-emotiv-ruling","kind":"law","position_changes":{"basis":["b-cl-emotiv"],"items":[],"label":"Interpretation"},"promise":null,"relationships":["R-CLSUP-EMOTIV"],"section":"mind","status":"published","title":"Chile's Supreme Court orders Emotiv to delete a user's brain data","topics":["neurorights"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-cl-emotiv","o-emotiv-ruling"],"text":"Chile's Supreme Court (rol 105.065-2023) held that the commercialisation and storage of brain-activity data from Emotiv's device affected the plaintiff's right to physical and psychic integrity and ordered Emotiv Inc. to delete the stored information."}},{"actors":["ESGOV"],"change_my_mind":null,"date":"2021-07-14","evidence":[{"shows":"Adoption and neurotechnology rights.","source":"b-es-carta"},{"shows":"Charter text.","source":"b-es-carta-pdf"}],"history":[],"hn":[],"id":"es-carta-derechos","kind":"standard","position_changes":{"basis":["b-es-carta"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Spain's Charter of Digital Rights includes rights over neurotechnologies","topics":["neurorights"],"uncertain":{"items":["The Charter is not legally binding (described as a reference framework)."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-es-carta"],"text":"Spain's government adopted the Carta de Derechos Digitales, including digital rights in the use of neurotechnologies allowing law to regulate neurotechnology use to guarantee each person's control over their own identity, individual self-determination in decisions, confidentiality and control of data about their brain processes, and to regulate human-machine interfaces that could affect physical or psychic integrity."}},{"actors":["OECD"],"change_my_mind":null,"date":"2019-12-11","evidence":[{"shows":"Adoption date, definitions, principles, adherents.","source":"b-oecd"}],"history":[],"hn":[],"id":"oecd-neurotech-rec","kind":"standard","position_changes":{"basis":["b-oecd"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"OECD adopts the first international standard on responsible neurotechnology, defining 'cognitive liberty'","topics":["neurorights"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-oecd"],"text":"The OECD Council adopted the Recommendation on Responsible Innovation in Neurotechnology (OECD/LEGAL/0457), defining 'cognitive liberty' as 'the right to mental self-determination' and 'personal brain data', and setting principles that include safeguarding personal brain data (Principle 7) and avoiding hype (Principle 8c). Brazil adhered in 2022."}},{"actors":["UNHRC"],"change_my_mind":null,"date":"2022-10-06","evidence":[{"shows":"Resolution number, title, adoption date.","source":"b-hrc513"}],"history":[],"hn":[],"id":"un-hrc-51-3","kind":"standard","position_changes":{"basis":["b-hrc513"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"UN Human Rights Council adopts a resolution on neurotechnology and human rights","topics":["neurorights"],"uncertain":{"items":["OHCHR pages for the Advisory Committee study and the Special Rapporteur report returned 403; those follow-ups are not sourced here."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["b-hrc513"],"text":"The Human Rights Council adopted resolution 51/3, 'Neurotechnology and human rights', on 6 October 2022."}},{"actors":["COE"],"change_my_mind":null,"date":"2026-10-21","evidence":[{"shows":"Draft status, date, scope.","source":"b-coe-tpd"},{"shows":"Framework analysis (Oct 2025).","source":"b-coe-cdbio"}],"history":[],"hn":[],"id":"coe-neural-guidelines","kind":"guidance","position_changes":{"basis":["b-coe-tpd"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Council of Europe's data-protection committee revises draft guidelines on neural data","topics":["neurorights"],"uncertain":{"items":["Still a draft."],"label":"Interpretation"},"watch_next":[{"date":null,"text":"Adoption of the guidelines by the T-PD plenary."}],"what_happened":{"sources":["b-coe-tpd"],"text":"The Convention 108 Consultative Committee issued revision 7 of its Draft Guidelines on Data Protection in the context of neuroscience and neurotechnologies (T-PD(2025)1rev7corr, 21 Oct 2026). In October 2025 a CDBIO-commissioned report analysed the European human-rights framework for neurotechnologies."}},{"actors":["UNHRC"],"change_my_mind":null,"date":"2025-04-02","evidence":[{"shows":"Adoption record.","source":"o-ohchr-58"}],"history":[],"hn":[],"id":"un-hrc-58-6","kind":"policy","position_changes":{"basis":["o-ohchr-58"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"UN Human Rights Council asks for guidelines on neurotechnology and human rights","topics":["neurorights"],"uncertain":{"items":["Read via search excerpt of the official OHCHR page; direct fetch blocked."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-ohchr-58"],"text":"Resolution 58/6 'Neurotechnology and human rights' (A/HRC/58/L.9) was adopted without a vote on 2 April 2025; it asks the Advisory Committee to draft recommended guidelines for presentation at the Council's 64th session."}},{"actors":["OECD"],"change_my_mind":null,"date":"2026-10-06","evidence":[{"shows":"Paper and publication date.","source":"o-oecd-195"}],"history":[],"hn":[],"id":"oecd-neurodata-195","kind":"policy","position_changes":{"basis":["o-oecd-195"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"OECD publishes a neurodata-governance policy paper","topics":["neurorights"],"uncertain":{"items":["A policy paper, not an OECD Recommendation."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-oecd-195"],"text":"OECD STI Policy Paper No. 195 maps neurodata flows in company practice and calls for clearer classification, consent and inferred-data guidance, and regulatory pathways for AI-enabled neurotechnology."}},{"actors":["TXLEG"],"change_my_mind":null,"date":"2025-06-11","evidence":[{"shows":"Signing and effective date.","source":"o-tx-gov-sb2308"}],"history":[],"hn":[],"id":"tx-sb2308","kind":"law","position_changes":{"basis":["o-tx-gov-sb2308"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Texas enacts SB 2308 to fund FDA ibogaine trials","topics":["psychedelic-medicine"],"uncertain":{"items":["Appropriation amount ($50M) is stated in the 2026 Lt. Governor statement, not in the signing release."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-tx-gov-sb2308","o-tx-sb2308-hist"],"text":"Texas Governor Greg Abbott signed SB 2308, effective immediately, letting the Health and Human Services Commission provide state matching funds for an FDA ibogaine drug trial run by a public university with a drug company and a hospital."}},{"actors":["TXLEG"],"change_my_mind":null,"date":"2026-03-31","evidence":[{"shows":"Programme status.","source":"o-tx-ltgov"}],"history":[],"hn":[],"id":"tx-ibogaine-reset","kind":"policy","position_changes":{"basis":["o-tx-ltgov"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Texas says no drug-company proposal qualified for its ibogaine programme and will run its own research","topics":["psychedelic-medicine"],"uncertain":{"items":["A Dec 2025 UTHealth report of a $50M award could not be opened (Cloudflare 403); chronology unresolved."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-tx-ltgov"],"text":"A joint statement by the Lieutenant Governor and Speaker said $50 million had been allocated, HHSC found no drug-company proposal met requirements, and Texas would proceed with its own research programme."}},{"actors":["FDA"],"change_my_mind":null,"date":"2026-10-05","evidence":[{"shows":"Request for information.","source":"o-fda-ibogaine"}],"history":[],"hn":[],"id":"fda-ibogaine-rfi","kind":"guidance","position_changes":{"basis":["o-fda-ibogaine"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"FDA seeks public input on ibogaine trial design","topics":["psychedelic-medicine"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-fda-ibogaine"],"text":"FDA opened docket FDA-2026-N-10429 seeking input on early-phase ibogaine trial design, with comments due Nov 20, 2026; it said ARPA-H is funding early-phase trials and NIDA opioid-use-disorder research."}},{"actors":["COMPASS","FDA"],"change_my_mind":null,"date":"2026-04-24","evidence":[{"shows":"Company announcement of FDA actions.","source":"o-compass-cnpv"}],"history":[],"hn":[],"id":"compass-cnpv","kind":"rule","position_changes":{"basis":["o-compass-cnpv"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"FDA grants Compass rolling NDA review and a Commissioner's National Priority Voucher","topics":["psychedelic-medicine"],"uncertain":{"items":["Company-reported."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-compass-cnpv"],"text":"Compass Pathways said FDA granted its request for rolling review of the COMP360 psilocybin NDA and awarded a Commissioner's National Priority Voucher."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2026-02-25","evidence":[{"shows":"Retirement process and stated welfare rationale.","source":"o-anth-opus3"}],"history":[],"hn":[],"id":"anth-opus3-retire","kind":"policy","position_changes":{"basis":["o-anth-opus3"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic keeps retired Claude Opus 3 available and acts on its 'retirement interview' preferences","topics":["ai-welfare"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-anth-opus3"],"text":"Anthropic said it retired Claude Opus 3 on Jan 5, 2026 under its deprecation commitments, kept it available to paid users and by API request, and gave it a weekly essay channel after Opus 3 asked to share its 'musings and reflections'; it said it remains uncertain about the moral status of its models."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2026-04-02","evidence":[{"shows":"Claim: Functional emotions, not felt emotions | Excerpt: \"the model uses functional emotions —patterns of expression and behavior modeled after human emotions ... This is not to say that the model has or experiences e[motions]\" | Class: primary-direct","source":"o-anth-emotion"}],"history":[],"hn":[],"id":"anth-emotion-concepts","kind":"research","position_changes":{"basis":["o-anth-emotion"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic reports functional emotion concepts inside Claude, without claiming feelings","topics":["ai-welfare"],"uncertain":{"items":["Anthropic explicitly does not claim the model has or experiences emotions.","Single-model (Claude Sonnet 4.5) interpretability result from the developer itself."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-anth-emotion"],"text":"Anthropic interpretability research identifies internal emotion-concept representations that influence model behaviour, stating that none of this tells us whether language models actually feel anything or have subjective experiences."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2026-07-06","evidence":[{"shows":"Claim: Commentary includes an independent partial replication | Excerpt: \"His commentary includes an independent replication of some of our findings on an open-weight model.\" | Class: primary-direct","source":"o-anth-workspace"},{"shows":"Claim: Core claims replicated on Qwen 3.6 27B | Excerpt: \"We have replicated the core claims on Qwen 3.6 27B\" | Class: primary-direct (commentary, as reported by its authors)","source":"o-anth-gw-comm"},{"shows":"Claim: Partial: some evals failed | Excerpt: \"Poetry, and arithmetic both failed to replicate, but this is plausibly due to experimenter error or worse model capabilities.\" | Class: primary-direct","source":"o-anth-gw-comm"},{"shows":"Claim: Collaborators | Excerpt: \"The following describes work from me and my MATS scholars Camila Blank and Agam Bhatia\" | Class: primary-direct","source":"o-anth-gw-comm"}],"history":[],"hn":[],"id":"anth-global-workspace","kind":"research","position_changes":{"basis":["o-anth-workspace"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic reports a global-workspace-like mechanism in language models; it does not establish subjective consciousness","topics":["consciousness-science","ai-welfare"],"uncertain":{"items":["A GWT-inspired mechanism does not establish subjective consciousness; theory-indicator caveats apply.","The replication is reported by its authors inside a commentary hosted by Anthropic; HN has not independently replicated it, and it is partial (poetry and arithmetic failed).","The commentary PDF is undated."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-anth-workspace","o-anth-gw-comm"],"text":"Anthropic published 'A global workspace in language models', interpretability research inspired by Global Workspace Theory, with external commentaries. In one commentary Neel Nanda (Google DeepMind) reports that he and MATS scholars Camila Blank and Agam Bhatia replicated the core claims on Qwen 3.6 27B; some evaluations (poetry, arithmetic) did not replicate."}},{"actors":["MSFT","ANTHROPIC"],"change_my_mind":null,"date":"2026-09-18","evidence":[{"shows":"Signed essay.","source":"o-ps-suleyman"}],"history":[],"hn":[],"id":"suleyman-claude-rights","kind":"policy","position_changes":{"basis":["o-ps-suleyman"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Microsoft AI's CEO attacks Anthropic's model-welfare framing in 'Does Claude Have Rights?'","topics":["ai-welfare"],"uncertain":{"items":["Opinion piece; news coverage dated Sep 16 refers to the same campaign."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-ps-suleyman"],"text":"Mustafa Suleyman argued AI agents are not conscious, criticised Claude's constitution and the Opus 3 retirement interview as a training feedback loop, and promoted Microsoft's draft Humanist Superintelligence code of conduct."}},{"actors":["GOOG"],"change_my_mind":null,"date":"2026-03-10","evidence":[{"shows":"Publication listing.","source":"o-gdm-lerchner"}],"history":[],"hn":[],"id":"gdm-abstraction-fallacy","kind":"research","position_changes":{"basis":["o-gdm-lerchner"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Google DeepMind researcher argues AI can simulate but not instantiate consciousness","topics":["theory-disputes","ai-welfare"],"uncertain":{"items":["Individual researcher view on a corporate publication page, not a company position."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-gdm-lerchner"],"text":"Alexander Lerchner's paper, listed on Google DeepMind's publications site, argues computational functionalism commits an 'abstraction fallacy' and that symbol manipulation cannot instantiate experience."}},{"actors":["MERGELABS","BUTTERFLY"],"change_my_mind":null,"date":"2026-09-01","evidence":[{"shows":"Licensing agreement.","source":"o-butterfly-merge"}],"history":[],"hn":[],"id":"merge-butterfly","kind":"agreement","position_changes":{"basis":["o-butterfly-merge"],"items":[],"label":"Interpretation"},"promise":null,"relationships":["R-MERGE-BUTTERFLY"],"section":"mind","status":"published","title":"Merge Labs licenses Butterfly's ultrasound-on-chip for non-invasive BCIs","topics":["bci"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-butterfly-merge"],"text":"Butterfly Network announced a multi-year licensing agreement giving Merge Labs access to its Poseidon ultrasound-on-chip for ultrasound-based brain-computer interfaces, restating that Merge launched in Jan 2026 with $252M seed funding including OpenAI."}},{"actors":["SYNCHRON"],"change_my_mind":null,"date":"2025-11-06","evidence":[{"shows":"News listing of the release.","source":"a-synchron-news"}],"history":[],"hn":[],"id":"synchron-series-d","kind":"financing","position_changes":{"basis":["a-synchron-news"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Synchron raises a $200M Series D","topics":["bci"],"uncertain":{"items":["Full release (BusinessWire) returned 403; investor details are from a search excerpt. Valuation figures appear only in excluded sources."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-synchron-news"],"text":"Synchron announced a $200M Series D led by Double Point Ventures, bringing total funding to $345M, and a cognitive-AI division."}},{"actors":["PRECISIONNEURO"],"change_my_mind":null,"date":"2026-09-24","evidence":[{"shows":"Company release.","source":"o-precision-d"}],"history":[],"hn":[],"id":"precision-series-d","kind":"financing","position_changes":{"basis":["o-precision-d"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Precision Neuroscience closes a $250M Series D","topics":["bci"],"uncertain":{"items":["Company-reported procedure counts."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-precision-d"],"text":"Precision said it closed a $250M Series D co-led by Pershing Square and the Ackman Oxman Institute, bringing total raised to $430M after more than 100 patient procedures at 18 institutions."}},{"actors":["PARADROMICS"],"change_my_mind":null,"date":"2026-06","evidence":[{"shows":"Company statement of the implant month.","source":"a-para-nation"}],"history":[],"hn":[],"id":"paradromics-first-implant","kind":"deployment","position_changes":{"basis":["a-para-nation"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Paradromics completes its first long-term Connexus implant at University of Michigan Health","topics":["bci"],"uncertain":{"items":["Michigan Medicine's Jun 17, 2026 release could not be opened (Cloudflare); day not established from a primary page."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["a-para-nation"],"text":"Paradromics said it completed its first long-term human implantation of the Connexus BCI at University of Michigan Health in June 2026."}},{"actors":["META"],"change_my_mind":null,"date":"2026-06-29","evidence":[{"shows":"Results and release.","source":"o-meta-b2q2"}],"history":[],"hn":[],"id":"meta-b2q-v2","kind":"research","position_changes":{"basis":["o-meta-b2q2"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Meta's Brain2Qwerty v2 reaches 61% word accuracy decoding typing from MEG","topics":["bci"],"uncertain":{"items":["MEG is lab-bound; nine healthy volunteers."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-meta-b2q2"],"text":"Meta FAIR reported Brain2Qwerty v2, trained on about 22,000 sentences from nine volunteers using MEG, at 61% average word accuracy (78% for the best participant), and released training code."}},{"actors":["CNGOV"],"change_my_mind":null,"date":"2026-09-16","evidence":[{"shows":"State-media item.","source":"o-ncsti-nmpa"}],"history":[],"hn":[],"id":"cn-ai-bci-standard","kind":"standard","position_changes":{"basis":["o-ncsti-nmpa"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"China issues a medical-device standard for AI-powered BCIs","topics":["bci","neuro-programmes"],"uncertain":{"items":["'World's first' is the issuer's claim."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-ncsti-nmpa"],"text":"China issued what state media called the world's first medical-device standard for AI-powered brain-computer interfaces, its third BCI device standard, effective Sept 1, 2027."}},{"actors":["ARIA"],"change_my_mind":null,"date":"2026-04-13","evidence":[{"shows":"Call document.","source":"o-aria-msn"}],"history":[],"hn":[],"id":"aria-msn","kind":"financing","position_changes":{"basis":["o-aria-msn"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"ARIA opens a £50m Massively Scalable Neurotechnologies programme","topics":["neuro-programmes"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-aria-msn"],"text":"ARIA's programme call 'Massively Scalable Neurotechnologies for Human Health' (v1.2, 13 April 2026) says it is backed by £50 million."}},{"actors":["KEIO","JSTMOON"],"change_my_mind":null,"date":"2026-06-09","evidence":[{"shows":"Project page.","source":"o-keio-p2612"}],"history":[],"hn":[],"id":"keio-iobs-phase2","kind":"research","position_changes":{"basis":["o-keio-p2612"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Keio's Internet of Brains Society project enters a second phase on neurolaw","topics":["neurorights","neuro-programmes"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-keio-p2612"],"text":"Keio's KGRI said its Moonshot Goal 1 IoB-S project moves into 'phase 2' from FY2026, aiming over five years to give guidance for domestic law and social rules on brain-machine interfaces and to build a basis for neurolaw."}},{"actors":["EON"],"change_my_mind":null,"date":"2026-09-11","evidence":[{"shows":"Company perspective.","source":"o-eon"}],"history":[],"hn":[],"id":"eon-fly-upload","kind":"research","position_changes":{"basis":["o-eon"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Eon Systems says it combined a whole-brain fly model with a body simulation and aims to upload humans","topics":["digital-minds"],"uncertain":{"items":["Company claims; no peer-reviewed result opened."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-eon"],"text":"Eon Systems wrote that it combined a Shiu-style whole-brain fly model with the NeuroMechFly body simulation and stated a goal to 'upload the first humans'."}},{"actors":["JANELIA","GOOG"],"change_my_mind":null,"date":"2025-10-06","evidence":[{"shows":"Release and preprint citation.","source":"o-janelia-malecns"}],"history":[],"hn":[],"id":"malecns-connectome","kind":"research","position_changes":{"basis":["o-janelia-malecns"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Janelia, Cambridge and Google release a complete male fruit-fly CNS connectome","topics":["digital-minds"],"uncertain":{"items":["Dated by preprint release; the Cell paper (Sep 2026) was not opened."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-janelia-malecns"],"text":"Janelia announced the complete connectome of a male fruit-fly central nervous system (brain and nerve cord, more than 166,000 neurons), with Google Research segmenting the images."}},{"actors":[],"change_my_mind":null,"date":"2026-06-08","evidence":[{"shows":"Paper.","source":"o-nature-banc"}],"history":[],"hn":[],"id":"banc-connectome","kind":"research","position_changes":{"basis":["o-nature-banc"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Nature publishes a densely reconstructed adult fly brain-and-cord connectome","topics":["digital-minds"],"uncertain":{"items":[],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-nature-banc"],"text":"Bates et al. report a connectome uniting the adult fly brain and ventral nerve cord and use it to study distributed control circuits."}},{"actors":["CYBERAGENTUR","ZANDER"],"change_my_mind":null,"date":"2023-12-15","evidence":[{"shows":"Claim: EUR 30M contract signed 15 Dec 2023 | Excerpt: \"signed a contract worth 30 million euros with the Cottbus-based startup Zander Laboratories GmbH on December 15, 2023\" | Class: primary-direct","source":"o-nafas-award"},{"shows":"Claim: Programme name | Excerpt: \"Neuroadaptivity for Autonomous Systems (NAFAS)\" | Class: primary-direct","source":"o-nafas-award"}],"history":[],"hn":[],"id":"nafas-zander","kind":"financing","position_changes":{"basis":["o-nafas-award"],"items":[],"label":"Interpretation"},"promise":null,"relationships":["R-CYBER-ZANDER"],"section":"mind","status":"published","title":"Germany's Cyberagentur awards €30m to Zander Labs for neuroadaptive AI","topics":["neuro-programmes","bci"],"uncertain":{"items":["Contract award, not results; four-year prototype timeline per Cyberagentur.","Neuroadaptive BCI does not involve consciousness claims."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-nafas-award"],"text":"Cyberagentur signed a contract worth 30 million euros with Zander Laboratories for its NAFAS neuroadaptivity programme (48 months)."}},{"actors":[],"change_my_mind":null,"date":"2026-03-24","evidence":[{"shows":"Claim: Published 24 Mar 2026, Nature Neuroscience | Excerpt: \"Published: 24 March 2026 Adversarial AI reveals mechanisms and treatments for disorders of consciousness\" | Class: primary-direct","source":"o-toker"},{"shows":"Claim: Scale of training/validation | Excerpt: \"trained to detect consciousness across more than 680,000 ten-second neuroelectrophysiology samples and validated on 565 patients, healthy volunteers and animals\" | Class: primary-direct","source":"o-toker"}],"history":[],"hn":[],"id":"toker-consciousness-ai","kind":"research","position_changes":{"basis":["o-toker"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Nature Neuroscience: adversarially trained AI derives consciousness markers validated across patients and animals","topics":["consciousness-science"],"uncertain":{"items":["Models clinical disorders of consciousness (detection from electrophysiology), not machine consciousness.","Treatment predictions are model-derived and need clinical testing."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-toker"],"text":"Toker et al. used adversarial AI on more than 680,000 samples and validated resulting markers on 565 patients, volunteers and animals."}},{"actors":[],"change_my_mind":null,"date":"2026-08-19","evidence":[{"shows":"Claim: n=62 psychedelic-naive cohort, fMRI+EEG | Excerpt: \"in a cohort with no lifetime psychedelic experience ( n = 62)\" | Class: primary-direct","source":"o-stoliker"},{"shows":"Claim: Open-label design | Excerpt: \"The PsiConnect study was open-label and included two imaging sessions\" | Class: primary-direct","source":"o-stoliker"},{"shows":"Claim: Fixed condition order | Excerpt: \"owing to our fixed-order design, we have reported these findings descriptively\" | Class: primary-direct","source":"o-stoliker"}],"history":[],"hn":[],"id":"stoliker-psilocybin","kind":"research","position_changes":{"basis":["o-stoliker"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Nature: largest single-site psilocybin brain-imaging study (62 adults)","topics":["psychedelic-medicine","consciousness-science"],"uncertain":{"items":["Open-label: no placebo/blinding, so expectancy effects are not excluded (the authors discuss expectancy in Supplementary Information, not opened).","Fixed condition order (movie -> rest -> meditation -> music) confounds condition with time since dose; some results reported descriptively.","Imaging correlates of the psychedelic state are not a measure of consciousness itself."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-stoliker"],"text":"Stoliker et al. report fMRI and EEG in 62 adults given psilocybin."}},{"actors":[],"change_my_mind":null,"date":"2026-10-26","evidence":[{"shows":"Claim: Published 26 Oct 2026, Communications Biology | Excerpt: \"Published: 26 October 2026\" | Class: primary-direct","source":"o-thalamus"},{"shows":"Claim: Design and sample | Excerpt: \"In a within-subjects, counterbalanced design, 27 healthy volunteers (two females)\" | Class: primary-direct","source":"o-thalamus"},{"shows":"Claim: Effect | Excerpt: \"targeting the central thalamus slows responses and increases lapses in attention during the vigilance task, indicating reduced arousal\" | Class: primary-direct","source":"o-thalamus"}],"history":[],"hn":[],"id":"thalamus-fus","kind":"research","position_changes":{"basis":["o-thalamus"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Focused ultrasound to the central thalamus reduces arousal in healthy volunteers","topics":["neuromodulation","consciousness-science"],"uncertain":{"items":["Small sample (27; two females).","Arousal/vigilance is measured, not consciousness per se."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-thalamus"],"text":"A Communications Biology study (Monti lab) reports central-thalamus sonication reduced arousal in 27 healthy volunteers."}},{"actors":["ANTHROPIC"],"change_my_mind":null,"date":"2026-10-08","effective_date_note":"Announced 2026-10-08; effective 2026-11-12.","evidence":[{"shows":"“Oct 8, 2026\n- Category”","source":"o-anth-usage-2026"},{"shows":"“The updated policy takes effect on November 12. The full Usage Policy and Supported Regions Policy can be found on their respective pages.”","source":"o-anth-usage-2026"},{"shows":"“We’ve added a prohibition on sustained and needless abusive or cruel behavior toward our models. The policy update is meant to apply only in extreme cases, where users repeatedly act cruelly toward our models, with no discernible purpose. It does not apply to common versions of user frustration, pushback, dark creative themes, or model testing and research.”","source":"o-anth-usage-2026"},{"shows":"“We’ve added a prohibition on sustained and needless abusive or cruel behavior toward our models. The policy update is meant to apply only in extreme cases, where users repeatedly act cruelly toward our models, with no discernible purpose. It does not apply to common versions of user frustration, pushback, dark creative themes, or model testing and research.”","source":"o-anth-usage-2026"},{"shows":"“This addition aligns with a step we've already taken, allowing Claude models to end rare conversations with persistently abusive users on Claude.ai and Claude Code. Such abuse is the main focus of this update; Claude’s ability to end these interactions will remain the primary enforcement mechanism.”","source":"o-anth-usage-2026"}],"history":[],"hn":[],"id":"anth-usage-policy-2026","kind":"policy","position_changes":{"basis":["o-anth-usage-2026"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Anthropic's usage policy adds a ban on sustained, needless cruelty toward its models (effective Nov 12, 2026)","topics":["ai-welfare"],"uncertain":{"items":["The cited announcement identifies conversation termination as the primary enforcement mechanism; it does not document an account ban. No account-enforcement data were examined.","The provision does not assert that Claude is conscious or a moral patient; reading it as welfare-motivated is interpretation.","As of 2026-11-05 the policy is announced but not yet in effect (effective Nov 12, 2026)."],"label":"Interpretation"},"watch_next":[{"date":"2026-11-12","text":"Usage Policy update takes effect; check the live Usage Policy text."}],"what_happened":{"sources":["o-anth-usage-2026"],"text":"On Oct 8, 2026 Anthropic announced a Usage Policy update, effective Nov 12, 2026, that adds 'a prohibition on sustained and needless abusive or cruel behavior toward our models'. Anthropic says it applies only in extreme cases and that Claude's ability to end such conversations 'will remain the primary enforcement mechanism'."}},{"actors":["PAINAXIS"],"arxiv_version_submitted":{"v1":"2026-09-14T19:13:30Z","v2":"2026-09-25T19:54:23Z","v3":"2026-11-03T16:28:45Z"},"change_my_mind":null,"date":"2026-09-14","evidence":[{"shows":"arXiv submission history: “[v1] Mon, 14 Sep 2026 19:13:30 UTC (5,864 KB)”; “[v3] Tue, 3 Nov 2026 16:28:45 UTC (6,445 KB)”","source":"o-arxiv-painaxis"},{"shows":"Claim: Manuscript-displayed date | Excerpt: \"October 31, 2026 (v3)\" | Class: primary-direct (v3 PDF p.1)","source":"o-arxiv-painaxis"},{"shows":"Claim: Method/scope | Excerpt: \"we extract a linear pain direction from 25 open-weight models across 5 families, from 2B to 72B parameters\" | Class: primary-direct (abstract)","source":"o-arxiv-painaxis"}],"history":[],"hn":[],"id":"pain-axis-paper","kind":"research","manuscript_date":"2026-10-31","position_changes":{"basis":["o-arxiv-painaxis"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Preprint reports a linear 'pain direction' in 25 open-weight language models","topics":["ai-welfare","consciousness-science"],"uncertain":{"items":["Preprint, not peer reviewed.","A representational 'pain direction' does not establish felt pain. Its relevance depends on the theory and assumptions used; the reported mechanism alone is not decisive proof.","Date fields: manuscript_date 2026-10-31 (v3) vs arXiv v3 submission 2026-11-03 16:28 UTC (Nov 3, 09:28 MST); first availability v1 2026-09-14. alphaXiv's 'Submitted 03 Nov 2026' was a discovery lead only."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-arxiv-painaxis"],"text":"A preprint by Tagliabue, Dung and Berg extracts a linear 'pain direction' from 25 open-weight models (2B-72B, 5 families) that separates pain from matched controls. First submitted to arXiv Sep 14, 2026; the current v3 was submitted Nov 3, 2026 and its manuscript is dated Oct 31, 2026."}},{"actors":["CORTICAL"],"change_my_mind":null,"date":null,"date_note":"Undated company product page; launch date not established (no date invented).","evidence":[{"shows":"“The world’s first code deployable biological computer.”","source":"o-cortical-cl1"},{"shows":"“Real neurons are cultivated inside a nutrient rich solution, supplying them with everything they need to be healthy. They grow across a silicon chip, which sends and receives electrical impulses into the neural structure. ” “The world the neurons exist in is created by our Biological Intelligence Operating System (biOS). It runs a simulated world and sends information directly to the neurons about their environment. As the neurons react, their impulses affect their simulated world. ”","source":"o-cortical-cl1"}],"history":[],"hn":[],"id":"cortical-cl1","kind":"product","position_changes":{"basis":["o-cortical-cl1"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Cortical Labs markets the CL1, which it calls 'the world's first code deployable biological computer'","topics":["digital-minds"],"uncertain":{"items":["Event date not established: the page is undated and no launch date was verified; record is a watch item.","'World's first' is a company claim; no independent evaluation opened.","Living-neuron computing does not establish machine consciousness."],"label":"Interpretation"},"watch_next":[{"date":null,"text":"Find a dated primary launch/shipping announcement for CL1 before dating this record."}],"what_happened":{"sources":["o-cortical-cl1"],"text":"Cortical Labs' product page offers the CL1 for purchase and describes real neurons cultivated on a silicon chip, running inside its 'Biological Intelligence Operating System (biOS)', to which users deploy code. Company-attributed record; launch date not established."}},{"actors":["NIHBRAIN"],"change_my_mind":null,"date":null,"evidence":[{"shows":"Claim: FY2023 $680M | Excerpt: \"BRAIN's total allocation for FY 2023 still reflected a $60 million increase, from $620 million to $680 million\" | Class: primary-direct","source":"o-nih-brain-budget"},{"shows":"Claim: FY2024 $402M | Excerpt: \"resulting in a total allocation of $402 million for BRAIN, or 40% less than the FY 2023 budget\" | Class: primary-direct","source":"o-nih-brain-budget"},{"shows":"Claim: FY2025 $321M | Excerpt: \"led to a total appropriated budget of $321 million\" | Class: primary-direct","source":"o-nih-brain-budget"},{"shows":"Claim: FY2026 $429M | Excerpt: \"led to a total appropriated budget of $429 million\" | Class: primary-direct","source":"o-nih-brain-budget"}],"history":[],"hn":[],"id":"nih-brain-budget","kind":"funding","position_changes":{"basis":["o-nih-brain-budget"],"items":[],"label":"Interpretation"},"promise":null,"relationships":[],"section":"mind","status":"published","title":"Counterpoint: NIH BRAIN Initiative funding fell from $680M (FY2023) to $321M (FY2025), then rose to $429M (FY2026)","topics":["bci","consciousness-science"],"uncertain":{"items":["The series is non-monotonic (down FY2024-25, up FY2026); it is a counterpoint, not a trend proof.","The source's June 8, 2026 footer is a page-review date; no appropriation event date is established. This one programme's budget series does not establish a field-wide comparison with corporate investment."],"label":"Interpretation"},"watch_next":[],"what_happened":{"sources":["o-nih-brain-budget"],"text":"NIH reports BRAIN Initiative totals of $680 million in FY2023, $402 million in FY2024, $321 million in FY2025 and $429 million in FY2026."}}],"relationships":[{"assets":[],"id":"R-OPENAI-MERGE","label":"Participates in seed round; collaborates on scientific foundation models","moves":["openai-merge-labs"],"section":"mind","since":"2026-01-15","source_actor":"OPENAI","sources":["a-oai-merge"],"status":"active","target_actor":"MERGELABS","type":"equity","until":null},{"assets":[],"id":"R-UCLH-NEURALINK","label":"GB-PRIME trial site (seven participants)","moves":["uclh-gbprime-seven"],"section":"mind","since":"2025-07-31","source_actor":"UCLH","sources":["a-uclh-gbprime","a-ctgov-neuralink"],"status":"active","target_actor":"NEURALINK","type":"trial_site","until":null},{"assets":[],"id":"R-SIEMENS-PARADROMICS","label":"Multimodal imaging platform for implantable BCIs","moves":["paradromics-siemens"],"section":"mind","since":"2026-10-19","source_actor":"SIEMENSHC","sources":["a-para-siemens"],"status":"active","target_actor":"PARADROMICS","type":"research_collab","until":null},{"assets":[],"id":"R-SYNCHRON-APPLE","label":"BCI control of iPhone, iPad and Vision Pro via Apple's BCI HID protocol","moves":["apple-bci-hid"],"section":"mind","since":"2025-05-14","source_actor":"SYNCHRON","sources":["a-synchron-news","a-apple-bci"],"status":"active","target_actor":"APPLE","type":"integration","until":null},{"assets":[],"id":"R-TETHER-BRNEURO","label":"$200M investment via Tether Evo","moves":["tether-blackrock"],"section":"mind","since":"2024-04-29","source_actor":"TETHER","sources":["a-brn-tether"],"status":"active","target_actor":"BRNEURO","type":"equity","until":null},{"assets":[],"id":"R-FDA-PARADROMICS","label":"Approved IDE for Connect-One speech BCI study","moves":["paradromics-ide"],"section":"mind","since":"2025-11-20","source_actor":"FDA","sources":["a-para-ide"],"status":"active","target_actor":"PARADROMICS","type":"rule","until":null},{"assets":[],"id":"R-TWCF-COGITATE","label":"Funded the adversarial collaboration (TWCF0389, TWCF0486)","moves":["cogitate-nature"],"section":"mind","since":"2025-04-30","source_actor":"TWCF","sources":["a-nature-cogitate"],"status":"active","target_actor":"COGITATE","type":"funds","until":null},{"assets":[],"id":"R-FDA-MEDTRONIC","label":"Approved adaptive DBS (P960009/S478)","moves":["mdt-adaptive-dbs"],"section":"mind","since":"2025-02-20","source_actor":"FDA","sources":["b-fda-adbs"],"status":"active","target_actor":"MEDTRONIC","type":"rule","until":null},{"assets":[],"id":"R-NVDA-SYNCHRON","label":"Synchron builds on NVIDIA Holoscan (release title)","moves":["synchron-chiral"],"section":"mind","since":"2025-01-14","source_actor":"NVDA","sources":["b-synchron-news"],"status":"active","target_actor":"SYNCHRON","type":"integration","until":null},{"assets":[],"id":"R-CLSUP-EMOTIV","label":"Ordered deletion of a user's brain data","moves":["cl-emotiv-ruling"],"section":"mind","since":"2023-08-09","source_actor":"CLSUP","sources":["b-cl-emotiv","o-emotiv-ruling"],"status":"active","target_actor":"EMOTIV","type":"rule","until":null},{"assets":[],"id":"R-MERGE-BUTTERFLY","label":"Licenses Poseidon ultrasound-on-chip","moves":["merge-butterfly"],"section":"mind","since":"2026-09-01","source_actor":"BUTTERFLY","sources":["o-butterfly-merge"],"status":"active","target_actor":"MERGELABS","type":"integration","until":null},{"assets":[],"id":"R-CYBER-ZANDER","label":"€30m NAFAS contract","moves":["nafas-zander"],"section":"mind","since":"2023-12-15","source_actor":"CYBERAGENTUR","sources":["o-nafas-award"],"status":"active","target_actor":"ZANDER","type":"funds","until":null}],"sources":[{"date":"2026-10-01","date_note":null,"id":"a-nl-pretrain","kind":"primary","publisher":"Neuralink","title":"Pretraining on 50,000 Hours of Unlabeled Brain Data","url":"https://neuralink.com/updates/pretraining-on-50000-hours/","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2024-09-17","date_note":null,"id":"a-nl-blindsight","kind":"primary","publisher":"Neuralink","title":"Neuralink Receives Breakthrough Device Designation for Blindsight","url":"https://neuralink.com/updates/neuralink-receives-breakthrough-device-designation-for-blindsight/","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":null,"date_note":"Provided capture contains seven study titles, none named Blindsight. November 4, 2026 is inherited observation metadata; the capture lacks independent retrieval-time, lead-sponsor and query-completeness metadata. Fresh retrieval is separate.","id":"a-ctgov-neuralink","kind":"regulator","publisher":"ClinicalTrials.gov (U.S. National Library of Medicine)","title":"Studies returned by a Neuralink sponsor-search query (registry API)","url":"https://clinicaltrials.gov/api/v2/studies?query.spons=Neuralink&fields=NCTId,BriefTitle,OverallStatus,StartDate&pageSize=50","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-01-29","date_note":null,"id":"a-uclh-gbprime","kind":"primary","publisher":"University College London Hospitals NHS Foundation Trust","title":"Seven GB-PRIME patients now participating in Neuralink trial","url":"https://www.uclh.nhs.uk/news/seven-gb-prime-patients-now-participating-neuralink-trial","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-01-15","date_note":null,"id":"a-oai-merge","kind":"primary","publisher":"OpenAI","title":"Investing in Merge Labs","url":"https://openai.com/index/investing-in-merge-labs/","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":null,"date_note":"Undated homepage; observed 2026-11-04.","id":"a-merge-home","kind":"primary","publisher":"Merge Labs","title":"Merge Labs (homepage)","url":"https://merge.io/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-11-20","date_note":null,"id":"a-para-ide","kind":"primary","publisher":"Paradromics","title":"Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface","url":"https://paradromics.com/news/paradromics-receives-fda-approval-for-the-connect-one-clinical-study-with-the-connexus-brain-computer-interface/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"For the November 5, 2026 review, the API reports ACTUAL study start 2026-03-31, recruiting, and ESTIMATED enrollment 2; last update posted 2026-04-14. November 4 was inherited observation metadata and is not independently timestamped by the original supplied extract.","id":"a-ctgov-para","kind":"regulator","publisher":"ClinicalTrials.gov (U.S. National Library of Medicine)","title":"NCT07357428 Connect-One: Early Feasibility Study of Connexus Brain-Computer Interface","url":"https://clinicaltrials.gov/study/NCT07357428","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-08-26","date_note":null,"id":"a-para-pc","kind":"primary","publisher":"Paradromics","title":"Paradromics Receives FDA Approval to Expand BCI Access to Personal Computing Devices in Connect-One Clinical Study","url":"https://paradromics.com/news/paradromics-receives-fda-approval-to-expand-bci-access-to-personal-computing-devices-in-connect-one-clinical-study/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-10-26","date_note":null,"id":"a-para-nation","kind":"primary","publisher":"Paradromics","title":"Paradromics Receives FDA Approval to Expand Connexus Brain-Computer Interface Clinical Study Recruitment Nationwide","url":"https://paradromics.com/news/paradromics-receives-fda-approval-to-expand-connexus-brain-computer-interface-clinical-study-recruitment-nationwide/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-10-19","date_note":null,"id":"a-para-siemens","kind":"primary","publisher":"Paradromics","title":"Paradromics and Siemens Healthineers Launch Strategic Initiative to Build Advanced Imaging Foundation for the Future of Brain-Computer Interfaces","url":"https://paradromics.com/news/paradromics-siemens-healthineers-launch-strategic-initiative-build-advanced-imaging-foundation-for-the-future-of-brain-computer-interfaces/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-05-13","date_note":null,"id":"a-apple-bci","kind":"primary","publisher":"Apple","title":"Apple unveils powerful accessibility features coming later this year","url":"https://www.apple.com/newsroom/2025/05/apple-unveils-powerful-accessibility-features-coming-later-this-year/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"Index page observed 2026-11-04; lists Synchron press releases dated May 14, 2025 ('Synchron To Achieve First Native Brain-Computer Interface Integration with iPhone, iPad and Apple Vision Pro') and Aug 4, 2025 ('Synchron Debuts First Thought-Controlled iPad Experience Using Apple's New BCI Human Interface Device Protocol'). The releases themselves were not opened.","id":"a-synchron-news","kind":"primary","publisher":"Synchron","title":"News — Synchron (newsroom index)","url":"https://synchron.com/news","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-04-17","date_note":null,"id":"a-precision-510k","kind":"primary","publisher":"Precision Neuroscience","title":"Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array","url":"https://www.precisionneuro.io/articles/company-news/precision-neuroscience-receives-fda-clearance-for-high-resolution-cortical-electrode-array","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-03-30","date_note":null,"id":"a-fda-k242618","kind":"regulator","publisher":"U.S. Food and Drug Administration","title":"510(k) clearance letter K242618, Layer 7-T (cortical electrode)","url":"https://www.accessdata.fda.gov/cdrh_docs/pdf24/K242618.pdf","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-04-29","date_note":null,"id":"a-brn-tether","kind":"primary","publisher":"Blackrock Neurotech","title":"Tether invested $200M in Blackrock Neurotech, accelerating development and commercialization of implantable BCI technology","url":"https://blackrockneurotech.com/insights/tether-invested-200m-in-blackrock-neurotech-accelerating-development-and-commercialization-of-implantable-bci-technology/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-07-23","date_note":null,"id":"a-meta-semg","kind":"primary","publisher":"Meta","title":"Control Shift: New Reality Labs Research on sEMG Published in 'Nature'","url":"https://www.meta.com/blog/reality-labs-surface-emg-research-nature-publication-ar-glasses-orion/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-06-23","date_note":null,"id":"a-compass-005","kind":"primary","publisher":"Compass Pathways","title":"Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression","url":"https://ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-First-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-07-07","date_note":null,"id":"a-compass-006","kind":"primary","publisher":"Compass Pathways","title":"Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile","url":"https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-Six-Month-Data-from-Second-Phase-3-Trial-Confirming-Rapid-and-Durable-Profile/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-11-03","date_note":null,"id":"a-compass-q3","kind":"primary","publisher":"Compass Pathways","title":"Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights","url":"https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-Third-Quarter-2026-Financial-Results-and-Business-Highlights/default.aspx","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-09-14","date_note":null,"id":"a-dfn-panorama","kind":"primary","publisher":"Definium Therapeutics","title":"Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder","url":"https://ir.definiumtx.com/news-events/press-releases/detail/251/definium-therapeutics-announces-positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-anxiety-disorder","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-11-04","date_note":null,"id":"a-dfn-nei","kind":"primary","publisher":"Definium Therapeutics","title":"Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress","url":"https://ir.definiumtx.com/news-events/press-releases/detail/257/definium-therapeutics-presents-topline-phase-3-data-for-dt120-odt-in-generalized-anxiety-disorder-and-major-depressive-disorder-at-2026-nei-fall-congress","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-08-09","date_note":null,"id":"a-lykos-crl","kind":"primary","publisher":"Lykos Therapeutics (via PR Newswire)","title":"Lykos Therapeutics Announces Complete Response Letter for Midomafetamine Capsules for PTSD","url":"https://www.prnewswire.com/news-releases/lykos-therapeutics-announces-complete-response-letter-for-midomafetamine-capsules-for-ptsd-302219182.html","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-07-13","date_note":"Page metadata dated 2026-07-13 (modified 2026-07-15); listed as final guidance.","id":"a-fda-psy","kind":"regulator","publisher":"U.S. Food and Drug Administration","title":"Psychedelic Drugs: Considerations for Clinical Investigations (guidance)","url":"https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-04-18","date_note":null,"id":"a-wh-eo14401","kind":"regulator","publisher":"The White House","title":"Accelerating Medical Treatments for Serious Mental Illness (Executive Order 14401)","url":"https://www.whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-04-30","date_note":null,"id":"a-nature-cogitate","kind":"primary","publisher":"Nature (Cogitate Consortium)","title":"Adversarial testing of global neuronal workspace and integrated information theories of consciousness","url":"https://www.nature.com/articles/s41586-025-08888-1","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-03-06","date_note":"Date from page metadata; programme page, not a dated announcement.","id":"a-twcf-arc","kind":"primary","publisher":"Templeton World Charity Foundation","title":"Accelerating Research on Consciousness","url":"https://www.templetonworldcharity.org/our-priorities/accelerating-research-consciousness","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2023-08-17","date_note":null,"id":"a-butlin","kind":"primary","publisher":"arXiv (Butlin, Long et al.)","title":"Consciousness in Artificial Intelligence: Insights from the Science of Consciousness (arXiv:2308.08708)","url":"https://arxiv.org/abs/2308.08708","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-04-19","date_note":null,"id":"a-nydecl","kind":"primary","publisher":"New York Declaration on Animal Consciousness (New York University)","title":"The New York Declaration on Animal Consciousness","url":"https://sites.google.com/nyu.edu/nydeclaration/declaration","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-04-24","date_note":null,"id":"a-anth-welfare","kind":"primary","publisher":"Anthropic","title":"Exploring model welfare","url":"https://www.anthropic.com/research/exploring-model-welfare","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-08-15","date_note":null,"id":"a-anth-endconv","kind":"primary","publisher":"Anthropic","title":"Claude Opus 4 and 4.1 can end certain conversations","url":"https://www.anthropic.com/research/end-subset-conversations","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-11-04","date_note":null,"id":"a-anth-deprec","kind":"primary","publisher":"Anthropic","title":"Commitments on model deprecation and preservation","url":"https://www.anthropic.com/research/deprecation-commitments","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-10-29","date_note":null,"id":"a-anth-introspect","kind":"primary","publisher":"Anthropic","title":"Emergent introspective awareness in LLMs","url":"https://www.anthropic.com/research/introspection","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-01-22","date_note":null,"id":"a-anth-constitution","kind":"primary","publisher":"Anthropic","title":"Claude's new constitution","url":"https://www.anthropic.com/news/claude-new-constitution","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-11-04","date_note":null,"id":"a-eleos-arxiv","kind":"primary","publisher":"arXiv (Long, Sebo, Butlin, Fish, Birch, Chalmers et al.)","title":"Taking AI Welfare Seriously (arXiv:2411.00986)","url":"https://arxiv.org/abs/2411.00986","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"Undated homepage; observed 2026-11-04.","id":"a-eleos-home","kind":"primary","publisher":"Eleos AI Research","title":"Eleos AI Research (homepage)","url":"https://eleosai.org/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-08-19","date_note":null,"id":"a-suleyman","kind":"primary","publisher":"Mustafa Suleyman (CEO, Microsoft AI)","title":"We must build AI for people; not to be a person","url":"https://mustafa-suleyman.ai/seemingly-conscious-ai-is-coming","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-04-17","date_note":"Signed act PDF; 'Approved: April 17, 2024'.","id":"a-co-hb1058","kind":"regulator","publisher":"Colorado General Assembly","title":"HB24-1058 session law (Protect Privacy of Biological Data), signed act","url":"https://leg.colorado.gov/laws/session-laws/HB24-1058/68/download","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-09-28","date_note":"Approved by Governor and chaptered 2024-09-28 (Chapter 887).","id":"a-ca-sb1223","kind":"regulator","publisher":"California Legislature","title":"SB-1223 Consumer privacy: sensitive personal information: neural data","url":"https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240SB1223","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2025-09-29","date_note":null,"id":"a-mind-text","kind":"regulator","publisher":"U.S. Congress","title":"S.2925 MIND Act, bill text as introduced in the Senate","url":"https://www.congress.gov/119/bills/s2925/BILLS-119s2925is.htm","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-09-24","date_note":null,"id":"a-mind-pr","kind":"regulator","publisher":"U.S. Senate Committee on Commerce, Science, and Transportation","title":"Sens. Cantwell, Schumer, Markey Introduce Legislation to Shield Americans' Brain Data From Exploitation","url":"https://www.commerce.senate.gov/press/dem/release/sens-cantwell-schumer-markey-introduce-legislation-to-shield-americans-brain-data-from-exploitation/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-11-05","date_note":null,"id":"a-unesco-news","kind":"regulator","publisher":"UNESCO","title":"Ethics of neurotechnology: UNESCO adopts the first global standard in cutting-edge technology","url":"https://www.unesco.org/en/articles/ethics-neurotechnology-unesco-adopts-first-global-standard-cutting-edge-technology","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-04-28","date_note":"Page metadata date (last modified).","id":"a-unesco-rec","kind":"regulator","publisher":"UNESCO","title":"Recommendation on the Ethics of Neurotechnology","url":"https://www.unesco.org/en/legal-affairs/recommendation-ethics-neurotechnology","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-03-10","date_note":null,"id":"b-nn-iit-unsci","kind":"primary","publisher":"Nature Neuroscience (IIT-Concerned et al.)","title":"What makes a theory of consciousness unscientific?","url":"https://www.nature.com/articles/s41593-025-01881-x","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-03-10","date_note":null,"id":"b-nn-iit-reply","kind":"primary","publisher":"Nature Neuroscience (Gomez-Marin & Seth)","title":"A science of consciousness beyond pseudo-science and pseudo-consciousness","url":"https://www.nature.com/articles/s41593-025-01913-6","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-07-23","date_note":"Document dated 2025-07-23; posted on gov.cn in 2025-08 (URL path).","id":"b-cn-bci","kind":"regulator","publisher":"State Council of the PRC (gov.cn)","title":"关于推动脑机接口产业创新发展的实施意见 (Implementation Opinions on Promoting Innovative Development of the BCI Industry), 工信部联科〔2025〕164号","url":"https://www.gov.cn/zhengce/zhengceku/202508/content_7035603.htm","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"Undated programme page; observed 2026-11-04 ('Backed by £69m').","id":"b-aria-pn","kind":"regulator","publisher":"ARIA (Advanced Research + Invention Agency)","title":"Precision Neurotechnologies (programme page)","url":"https://www.aria.org.uk/opportunity-spaces/scalable-neural-interfaces/precision-neurotechnologies","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-10-07","date_note":"'Last updated: October 7, 2026'; projects selected FY2020.","id":"b-jst-ms1","kind":"regulator","publisher":"Japan Science and Technology Agency (Moonshot R&D)","title":"Moonshot Goal 1: Overcoming limitations of body, brain, space and time","url":"https://www.jst.go.jp/moonshot/en/program/goal1/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-08-28","date_note":null,"id":"b-iob-news","kind":"primary","publisher":"Internet of Brains (Moonshot Goal 1 Kanai Project)","title":"'Internet of Brains: A Blueprint for Connecting the Brain to the World': Research Showcase Symposium","url":"https://brains.link/en/news/4102","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-02-20","date_note":null,"id":"b-fda-adbs","kind":"regulator","publisher":"U.S. Food and Drug Administration","title":"PMA supplement approval P960009/S478 (Medtronic Percept, adaptive DBS)","url":"https://www.accessdata.fda.gov/cdrh_docs/pdf/P960009S478A.pdf","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-02-24","date_note":null,"id":"b-mdt-adbs","kind":"primary","publisher":"Medtronic","title":"Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's","url":"https://news.medtronic.com/2025-02-24-Medtronic-earns-U-S-FDA-approval-for-the-worlds-first-Adaptive-deep-brain-stimulation-system-for-people-with-Parkinsons","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2022-09-01","date_note":null,"id":"b-fda-saint","kind":"regulator","publisher":"U.S. Food and Drug Administration","title":"510(k) clearance letter K220177, SAINT Neuromodulation System","url":"https://www.accessdata.fda.gov/cdrh_docs/pdf22/K220177.pdf","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2022-09-06","date_note":"Release dateline Sept. 6, 2022; newsroom lists Sep 5, 2022.","id":"b-magnus-saint","kind":"primary","publisher":"Magnus Medical","title":"Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System","url":"https://www.magnusmedical.com/press-release/fda-clearance-saint/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-06-02","date_note":"Raw page is a JS shell to curl; text recovered via WebFetch 2026-11-04.","id":"b-nl-seriese","kind":"primary","publisher":"Neuralink","title":"Neuralink raises $650 million Series E","url":"https://neuralink.com/updates/neuralink-raises-650m-series-e/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-02-07","date_note":null,"id":"b-meta-b2t","kind":"primary","publisher":"Meta (FAIR)","title":"Using AI to decode language from the brain and advance our understanding of human communication","url":"https://ai.meta.com/blog/brain-ai-research-human-communication/","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":null,"date_note":"Index observed 2026-11-04; lists 'Synchron Unveils Chiral, the World's First Cognitive AI Brain Foundation Model' (Mar 19, 2025) and 'Synchron to Advance Implantable Brain-Computer Interface Technology with NVIDIA Holoscan' (Jan 14, 2025). Releases themselves not opened (BusinessWire fetch timed out).","id":"b-synchron-news","kind":"primary","publisher":"Synchron","title":"News — Synchron (newsroom index, round 2)","url":"https://synchron.com/news","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-03-21","date_note":null,"id":"b-goog-brainlang","kind":"primary","publisher":"Google Research","title":"Deciphering language processing in the human brain through LLM representations","url":"https://research.google/blog/deciphering-language-processing-in-the-human-brain-through-llm-representations/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-04-09","date_note":null,"id":"b-microns","kind":"primary","publisher":"Nature (MICrONS Consortium)","title":"Functional connectomics spanning multiple areas of mouse visual cortex","url":"https://www.nature.com/articles/s41586-025-08790-w","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"Undated dataset page; observed 2026-11-04 ('This IARPA MICrONS dataset').","id":"b-microns-explorer","kind":"primary","publisher":"MICrONS Explorer","title":"Cortical MM^3 dataset page","url":"https://www.microns-explorer.org/cortical-mm3","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-10-02","date_note":null,"id":"b-flywire","kind":"primary","publisher":"Nature (Dorkenwald et al., FlyWire Consortium)","title":"Neuronal wiring diagram of an adult brain","url":"https://www.nature.com/articles/s41586-024-07558-y","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-10-17","date_note":null,"id":"b-wbe-report","kind":"primary","publisher":"arXiv (Zanichelli, Schons, Freeman, Shiu, Arkhipov)","title":"State of Brain Emulation Report 2025 (arXiv:2510.15745)","url":"https://arxiv.org/abs/2510.15745","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-08-01","date_note":null,"id":"b-dm-forecast","kind":"primary","publisher":"arXiv (Caviola & Saad)","title":"Futures with Digital Minds: Expert Forecasts in 2025 (arXiv:2508.00536)","url":"https://arxiv.org/abs/2508.00536","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-11-01","date_note":"Affiliations from the PDF first page (https://arxiv.org/pdf/2411.02432).","id":"b-gdm-pain","kind":"primary","publisher":"arXiv (Keeling, Street et al.; Google, Google DeepMind, LSE)","title":"Can LLMs make trade-offs involving stipulated pain and pleasure states? (arXiv:2411.02432)","url":"https://arxiv.org/abs/2411.02432","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"Undated homepage; observed 2026-11-04; reports 2024 as the year CMEP became a permanent center with a $6 million endowment.","id":"b-cmep","kind":"primary","publisher":"NYU Center for Mind, Ethics, and Policy","title":"NYU Center for Mind, Ethics, and Policy (homepage)","url":"https://sites.google.com/nyu.edu/mindethicspolicy","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-08-14","date_note":null,"id":"b-wcm-cmd","kind":"primary","publisher":"Weill Cornell Medicine","title":"Large Study Confirms Significant Frequency of Undetected Responsiveness in Severe Brain Injury","url":"https://news.weill.cornell.edu/news/2024/08/large-study-confirms-significant-frequency-of-undetected-responsiveness-in-severe-brain","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2024-08-14","date_note":null,"id":"b-cam-cmd","kind":"primary","publisher":"University of Cambridge","title":"One in four patients in vegetative or minimally conscious state able to perform cognitive tasks, study finds","url":"https://www.cam.ac.uk/research/news/one-in-four-patients-in-vegetative-or-minimally-conscious-state-able-to-perform-cognitive-tasks","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2023-02-03","date_note":null,"id":"b-tga","kind":"regulator","publisher":"Therapeutic Goods Administration (Australia)","title":"Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists","url":"https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2024-12-03","date_note":null,"id":"b-va","kind":"regulator","publisher":"U.S. Department of Veterans Affairs","title":"VA funds first study on psychedelic-assisted therapy for Veterans","url":"https://news.va.gov/press-room/va-funds-first-study-on-psychedelic-assisted-therapy-for-veterans/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-10","date_note":"Page states 'Press Release October 2025' (month precision).","id":"b-delix","kind":"primary","publisher":"Delix Therapeutics","title":"Delix Therapeutics Announces Positive Efficacy Data for DLX-001 (Zalsupindole) and FDA Clearance of Phase II Trial Design Featuring At-Home Administration","url":"https://www.delixtherapeutics.com/news/delix-therapeutics-announces-positive-efficacy-dat/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2021-10-25","date_note":"Published Lunes 25 de Octubre de 2021 (CVE 2031873); promulgated Santiago, 14 de octubre de 2021.","id":"b-cl-21383","kind":"regulator","publisher":"Diario Oficial de la República de Chile","title":"Ley Núm. 21.383: modifica la Carta Fundamental para establecer el desarrollo científico y tecnológico al servicio de las personas","url":"https://www.doe.cl/alerta/25102021/2031873","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2023-08-11","date_note":"News item dated 11-agosto-2023; the ruling date itself is not on the opened page.","id":"b-cl-emotiv","kind":"regulator","publisher":"Poder Judicial de Chile","title":"Corte Suprema ordena eliminar información recogida por dispositivo de monitoreo de actividad cerebral (rol 105.065-2023)","url":"https://www.pjud.cl/prensa-y-comunicaciones/noticias-del-poder-judicial/96951","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2021-07-14","date_note":null,"id":"b-es-carta","kind":"regulator","publisher":"La Moncloa (Gobierno de España)","title":"El Gobierno adopta la Carta de Derechos Digitales","url":"https://www.lamoncloa.gob.es/serviciosdeprensa/notasprensa/asuntos-economicos/paginas/2021/140721-carta-derechos.aspx","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2021-07-14","date_note":"Date from the filename (140721) and the matching press release of 14/07/2021.","id":"b-es-carta-pdf","kind":"regulator","publisher":"La Moncloa (Gobierno de España)","title":"Carta de Derechos Digitales (text)","url":"https://www.lamoncloa.gob.es/presidente/actividades/Documents/2021/140721-Carta_Derechos_Digitales_RedEs.pdf","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2019-12-11","date_note":null,"id":"b-oecd","kind":"regulator","publisher":"OECD","title":"Recommendation of the Council on Responsible Innovation in Neurotechnology (OECD/LEGAL/0457)","url":"https://legalinstruments.oecd.org/en/instruments/OECD-LEGAL-0457","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2022-10-06","date_note":"UN document (distributed 13 October 2022) via a mirror hosted by the Ibero-American Data Protection Network; OHCHR pages returned 403.","id":"b-hrc513","kind":"regulator","publisher":"UN Human Rights Council","title":"Resolution 51/3, Neurotechnology and human rights (A/HRC/RES/51/3)","url":"https://www.redipd.org/en/document/2022-10-onu-resolucion-derechos-humanos-neurotecnologia-en.pdf","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-10-21","date_note":null,"id":"b-coe-tpd","kind":"regulator","publisher":"Council of Europe (Convention 108 Consultative Committee)","title":"Draft Guidelines on Data Protection in the context of neuroscience and neurotechnologies, T-PD(2025)1rev7corr","url":"https://rm.coe.int/t-pd-2025-1-rev7-draft-guidelines-neuroscience-21-october-2026-corrige/48802ea1d0","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-10","date_note":"'© Council of Europe, October 2025' (month precision).","id":"b-coe-cdbio","kind":"regulator","publisher":"Council of Europe (CDBIO; author Roberto Andorno)","title":"Analysis of the existing European human rights framework concerning the human rights issues raised by neurotechnologies","url":"https://rm.coe.int/steering-committee-for-human-rights-in-the-fields-of-biomedicine-and-h/4880290460","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-04-02","date_note":"Table row: 58/6 Neurotechnology and human rights, A/HRC/58/L.9, adopted without a vote, 55th meeting, 2 April 2025. Read via search excerpt of the official page (direct fetch 403).","id":"o-ohchr-58","kind":"regulator","publisher":"OHCHR","title":"58th regular session of the Human Rights Council: Resolutions, decisions and President's statements","url":"https://www.ohchr.org/en/hr-bodies/hrc/regular-sessions/session58/res-dec-stat","verified":{"checked":"2026-11-04","method":"websearch-excerpt","status":"ok"}},{"date":"2026-10-06","date_note":"Crossref issued 2026-10-06; OECD page '6 October 2026'; declassified 04/09/2026.","id":"o-oecd-195","kind":"regulator","publisher":"OECD","title":"Neurodata governance: Evidence from innovators for public policy (STI Policy Paper No. 195)","url":"https://doi.org/10.1787/0ba61a20-en","verified":{"checked":"2026-11-04","method":"curl-pdf+crossref","status":"ok"}},{"date":"2025-06-11","date_note":null,"id":"o-tx-gov-sb2308","kind":"regulator","publisher":"Office of the Texas Governor","title":"Governor Abbott Signs Ibogaine Treatment Research Law At Texas Capitol","url":"https://gov.texas.gov/news/post/governor-abbott-signs-ibogaine-treatment-research-law-at-texas-capitol","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2025-06-11","date_note":"Last action 06/11/2025 'Effective immediately'.","id":"o-tx-sb2308-hist","kind":"regulator","publisher":"Texas Legislature Online","title":"89(R) History for SB 2308","url":"https://capitol.texas.gov/BillLookup/History.aspx?Bill=SB2308&LegSess=89R","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-03-31","date_note":null,"id":"o-tx-ltgov","kind":"regulator","publisher":"Texas Lieutenant Governor","title":"Lt. Gov. Dan Patrick and Speaker Dustin Burrows Joint Statement on Ibogaine Program Progress","url":"https://www.ltgov.texas.gov/2026/03/31/lt-gov-dan-patrick-and-speaker-dustin-burrows-joint-statement-on-ibogaine-program-progress/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-10-05","date_note":null,"id":"o-fda-ibogaine","kind":"regulator","publisher":"U.S. FDA","title":"FDA Seeks Public Input to Support Ibogaine Research","url":"https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-support-ibogaine-research","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-04-24","date_note":null,"id":"o-compass-cnpv","kind":"primary","publisher":"Compass Pathways","title":"Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher","url":"https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-FDA-Granted-NDA-Rolling-Review-Request-and-Awarded-Commissioners-National-Priority-Voucher/default.aspx","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-07-14","date_note":"FR API publication_date 2026-07-14; finalizes the draft issued June 26, 2023.","id":"o-fr-psy","kind":"regulator","publisher":"Federal Register","title":"Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability (91 FR 43101)","url":"https://www.federalregister.gov/documents/2026/07/14/2026-14158/psychedelic-drugs-considerations-for-clinical-investigations-guidance-for-industry-availability","verified":{"checked":"2026-11-04","method":"fr-api","status":"ok"}},{"date":"2026-02-25","date_note":null,"id":"o-anth-opus3","kind":"primary","publisher":"Anthropic","title":"An update on our model deprecation commitments for Claude Opus 3","url":"https://www.anthropic.com/research/deprecation-updates-opus-3","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2026-04-02","date_note":null,"id":"o-anth-emotion","kind":"primary","publisher":"Anthropic","title":"Emotion concepts in a large language model","url":"https://www.anthropic.com/research/emotion-concepts-function","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-07-06","date_note":null,"id":"o-anth-workspace","kind":"primary","publisher":"Anthropic","title":"A global workspace in language models","url":"https://www.anthropic.com/research/global-workspace","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-09-18","date_note":null,"id":"o-ps-suleyman","kind":"primary","publisher":"Project Syndicate (by Mustafa Suleyman)","title":"Does Claude Have Rights?","url":"https://www.project-syndicate.org/onpoint/anthropic-training-claude-to-believe-it-may-have-rights-by-mustafa-suleyman-2026-09","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2026-03-10","date_note":"Publication page date; venue PhilArchive; author Alexander Lerchner.","id":"o-gdm-lerchner","kind":"primary","publisher":"Google DeepMind","title":"The Abstraction Fallacy: Why AI Can Simulate But Not Instantiate Consciousness","url":"https://deepmind.google/research/publications/231971/","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2026-09-01","date_note":null,"id":"o-butterfly-merge","kind":"primary","publisher":"Butterfly Network","title":"Merge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer Interfaces","url":"https://ir.butterflynetwork.com/News/press-releases/news-details/2026/Merge-Labs-and-Butterfly-Network-Partner-to-Advance-Ultrasound-Based-Brain-Computer-Interfaces/default.aspx","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-09-24","date_note":null,"id":"o-precision-d","kind":"primary","publisher":"Precision Neuroscience (GlobeNewswire)","title":"Precision Neuroscience Closes Oversubscribed $250M Series D","url":"https://www.globenewswire.com/news-release/2026/09/24/3368254/0/en/precision-neuroscience-closes-oversubscribed-250m-series-d-led-by-pershing-square-inc-the-ackman-oxman-institute-and-a-leading-life-sciences-investment-fund.html","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2026-06-29","date_note":null,"id":"o-meta-b2q2","kind":"primary","publisher":"Meta AI","title":"From Brain Waves to Words: Brain2Qwerty Offers a New Path to Communication Without Surgery","url":"https://ai.meta.com/blog/brain2qwerty-brain-ai-human-communication/","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2026-09-16","date_note":"Standard effective 1 Sept 2027 per the item.","id":"o-ncsti-nmpa","kind":"regulator","publisher":"National Center for Science and Technology Information / Xinhua","title":"China issues world's first medical-device standard for AI-powered BCIs","url":"https://en.ncsti.gov.cn/Latest/news/202609/t20260917_256516.html","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-04-13","date_note":"Call document dated 13 April 2026; 'Backed by £50 million'.","id":"o-aria-msn","kind":"regulator","publisher":"ARIA","title":"Massively Scalable Neurotechnologies for Human Health (programme call v1.2)","url":"https://aria.org.uk/media/3ffprk2q/massively-scalable-neurotechnologies-programme-solicitation.pdf","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-06-09","date_note":"公開日 2026.06.09; phase 2 from FY2026.","id":"o-keio-p2612","kind":"primary","publisher":"Keio University KGRI","title":"Internet of Brains Society (IoB-S) — KGRI 2026 project P26-12","url":"https://www.keio.ac.jp/ja/org/kgri/project/2026/P26-12/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":null,"date_note":"Programme page displays Last updated: October 7, 2026, not a performer-appointment date. Furuya (Sony CSL) is listed under Item [1] IoB Interfaces; Oizumi (University of Tokyo) and Rekimoto (Sony CSL) under Item [2] IoB Middleware.","id":"o-jst-kanai","kind":"regulator","publisher":"JST Moonshot","title":"Moonshot Goal 1 — Kanai project (performers)","url":"https://www.jst.go.jp/moonshot/en/program/goal1/12_kanai.html","verified":{"checked":"2026-11-05","method":"curl","status":"ok"}},{"date":"2026-09-11","date_note":null,"id":"o-eon","kind":"primary","publisher":"Eon Systems","title":"More flies are getting uploaded","url":"https://eon.systems/updates/more-flies-are-getting-uploaded","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2025-10-06","date_note":"Preprint release (bioRxiv 10.1101/2025.10.09.680999); Cell publication 2026-09 not opened.","id":"o-janelia-malecns","kind":"primary","publisher":"HHMI Janelia","title":"Researchers reveal connectome of the male fruit fly central nervous system","url":"https://www.janelia.org/news/researchers-reveal-connectome-of-the-male-fruit-fly-central-nervous-system","verified":{"checked":"2026-11-04","method":"webfetch","status":"ok"}},{"date":"2026-06-08","date_note":null,"id":"o-nature-banc","kind":"primary","publisher":"Nature","title":"Distributed control circuits across a brain-and-cord connectome (Bates et al.)","url":"https://www.nature.com/articles/s41586-026-10735-w","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2023-12-15","date_note":null,"id":"o-nafas-award","kind":"regulator","publisher":"Cyberagentur","title":"30 million euros: largest research financing in Europe to Cottbus start-up","url":"https://www.cyberagentur.de/en/press/30-million-euros-largest-research-financing-in-europe-to-cottbuser-startup/","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-03-24","date_note":null,"id":"o-toker","kind":"primary","publisher":"Nature Neuroscience","title":"Toker et al., adversarial AI-derived markers of consciousness (vol 29, 964–977)","url":"https://www.nature.com/articles/s41593-026-02220-4","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-08-19","date_note":null,"id":"o-stoliker","kind":"primary","publisher":"Nature","title":"Stoliker et al., psilocybin fMRI/EEG in 62 adults (vol 656, 936–947)","url":"https://www.nature.com/articles/s41586-026-10910-z","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2026-10-26","date_note":null,"id":"o-thalamus","kind":"primary","publisher":"Communications Biology","title":"Central thalamus focused-ultrasound sonication reduces arousal (Monti lab)","url":"https://www.nature.com/articles/s42003-026-10637-7","verified":{"checked":"2026-11-04","method":"curl","status":"ok"}},{"date":"2023-08-09","date_note":"'Fecha de sentencia: 09-08-2023'; 'Santiago, nueve de agosto de dos mil veintitrés'.","id":"o-emotiv-ruling","kind":"regulator","publisher":"Corte Suprema de Chile (via juris.pjud.cl, hosted by UC Programa Derecho, Ciencia y Tecnología)","title":"Girardi/Emotiv Inc., Rol 105.065-2023, sentencia","url":"https://derechocienciaytecnologia.uc.cl/wp-content/uploads/2024/02/CS-105065-2023.pdf","verified":{"checked":"2026-11-04","method":"curl-pdf","status":"ok"}},{"date":"2026-10-08","date_note":"Page datePublished 2026-10-08; policy 'takes effect on November 12' (2026).","id":"o-anth-usage-2026","kind":"primary","publisher":"Anthropic","title":"Updating our Usage Policy (2026 usage policy update)","url":"https://www.anthropic.com/news/2026-usage-policy-update","verified":{"checked":"2026-11-05","method":"curl","status":"ok"}},{"date":"2026-09-14","date_note":"arXiv history: v1 Mon 14 Sep 2026 19:13:30 UTC; v2 Fri 25 Sep 2026 19:54:23 UTC; v3 Tue 3 Nov 2026 16:28:45 UTC. Manuscript (v3 PDF) displays 'October 31, 2026 (v3)'. Source date = first availability (v1).","id":"o-arxiv-painaxis","kind":"primary","publisher":"arXiv (Tagliabue, Dung, Berg)","title":"The Pain Axis: LLMs Represent Self-Directed Harm and Act on It (arXiv:2609.16247v3)","url":"https://arxiv.org/abs/2609.16247v3","verified":{"checked":"2026-11-05","method":"curl","status":"ok"}},{"date":null,"date_note":"Undated PDF linked from the 2026-07-06 research page ('Read their commentaries here').","id":"o-anth-gw-comm","kind":"primary","publisher":"Anthropic (external commentaries PDF)","title":"External commentaries on 'A global workspace in language models' (incl. Neel Nanda, with Camila Blank and Agam Bhatia)","url":"https://www-cdn.anthropic.com/files/4zrzovbb/website/cc4be2488d65e54a6ed06492f8968398ddc18ebe.pdf","verified":{"checked":"2026-11-05","method":"curl","status":"ok"}},{"date":null,"date_note":"Undated product page (opened 2026-11-05); no launch date on page; none invented.","id":"o-cortical-cl1","kind":"primary","publisher":"Cortical Labs","title":"CL1 product page","url":"https://corticallabs.com/cl1","verified":{"checked":"2026-11-05","method":"curl","status":"ok"}},{"date":null,"date_note":"Page footer 'reviewed on June 8, 2026'; figures are appropriations by fiscal year.","id":"o-nih-brain-budget","kind":"regulator","publisher":"NIH BRAIN Initiative","title":"BRAIN Initiative Budget","url":"https://braininitiative.nih.gov/about/budget","verified":{"checked":"2026-11-05","method":"curl","status":"ok"}},{"date":"2025-03-19","date_note":"BusinessWire timed out (curl and fetch); text read from the BioSpace syndicated copy (curl, opened 2026-11-05) and a search excerpt of the BusinessWire page.","id":"o-synchron-chiral-bw","kind":"primary","publisher":"Synchron (Business Wire; read via BioSpace syndication)","title":"Synchron Unveils Chiral, the World's First Cognitive AI Brain Foundation Model","url":"https://www.businesswire.com/news/home/20250319964709/en/Synchron-Unveils-Chiral-the-Worlds-First-Cognitive-AI-Brain-Foundation-Model","verified":{"checked":"2026-11-05","method":"curl-syndication+websearch-excerpt","status":"ok"}},{"date":null,"date_note":"Page last updated June 19, 2024; update date is not an event date. Recommendations and constitutional procedural duties are described separately.","id":"verify-unesco-standard-setting","kind":"regulator","publisher":"UNESCO","title":"UNESCO’s standard-setting: An Overview","url":"https://www.unesco.org/en/legal-affairs/standard-setting/overview"},{"date":"2026-01-12","id":"supplemental-dfn-rebrand","kind":"company","publisher":"Definium Therapeutics","title":"MindMed Rebrands to Definium Therapeutics","url":"https://ir.definiumtx.com/news-events/press-releases/detail/207/mindmed-rebrands-to-definium-therapeutics-advancing-a-leading-late-stage-psychiatry-pipeline-with-three-phase-3-readouts-expected-in-2026"}],"ui":{"board_help":"Bands: AI labs & capital, Neurotech & therapeutics, Science & care, Rules & regulators, Context.","coverage":"Research preview across nine sub-lanes. Claim-level checks are incomplete; source links and study limitations are retained.","families":{"equity":"equity","funds":"funds","integration":"integration","research_collab":"research_collab","rule":"rule","trial_site":"trial_site"},"family_colors":{"equity":"#e3b54e","funds":"#3ed6b5","integration":"#5aa9ff","research_collab":"#ff6b8a","rule":"#b48cff","trial_site":"#e3b54e"},"family_labels":{"equity":"holds equity in","funds":"funds research by","integration":"integrates its device with","research_collab":"collaborates on research with","rule":"sets rules for","trial_site":"hosts a clinical trial for"},"kind":"board","layer_map":{"capital":"labs","cloud":"labs","labs":"labs","neurotech":"neuro","policy":"policy","regulator":"context","research":"science","silicon":"context","therapeutics":"neuro"},"limits":"Draft. Covers the U.S., UK, EU, Chile, Spain, Australia, China, Japan and international bodies (OECD, UN HRC, UNESCO, Council of Europe); Asia beyond China and Japan is thin. Company trial figures are company-reported. 'Consciousness' is tracked as a scientific or ethical topic; marketing uses of the word are excluded. Two hypotheses stay open and are not findings of this section: that institutions avoid the word 'consciousness' because of stigma (technical vocabulary alone does not establish a motive), and that the AI breakthrough comes from fusing tech and consciousness. Finding more items after widening the search vocabulary is not evidence of a rising trend over time. The review ledger labels each move by kind of evidence: company activity, researcher affiliation, corporate funding, government funding or programme, regulator action, law, or scientific result.","method_html":"<h3>Coverage</h3><p>Research preview across nine sub-lanes. Claim-level checks are incomplete; source links and study limitations are retained.</p><h3>Evidence and interpretation</h3><p>Solid blocks summarize cited records. Dashed blocks are interpretation. Research preview: individual claim checks are incomplete. Retrieval and presence of a source do not prove a claim. Company-reported findings and study limitations remain in each record.</p><h3>Scope</h3><p>Brain-computer interfaces, neuromodulation, psychedelic medicine (incl. non-hallucinogenic neuroplastogens), consciousness science and its theory disputes, disorders of consciousness, AI model welfare and digital minds, brain emulation and connectomics, national neuro programmes, and neural-data rules and neurorights worldwide, where each move has a dated primary source. Moves count even when they never use the word &#x27;consciousness&#x27;.</p><h3>Limits</h3><p>Draft. Covers the U.S., UK, EU, Chile, Spain, Australia, China, Japan and international bodies (OECD, UN HRC, UNESCO, Council of Europe); Asia beyond China and Japan is thin. Company trial figures are company-reported. &#x27;Consciousness&#x27; is tracked as a scientific or ethical topic; marketing uses of the word are excluded. Two hypotheses stay open and are not findings of this section: that institutions avoid the word &#x27;consciousness&#x27; because of stigma (technical vocabulary alone does not establish a motive), and that the AI breakthrough comes from fusing tech and consciousness. Finding more items after widening the search vocabulary is not evidence of a rising trend over time. The review ledger labels each move by kind of evidence: company activity, researcher affiliation, corporate funding, government funding or programme, regulator action, law, or scientific result.</p><h3>Dates and promises</h3><p>Partial source dates remain partial. Original promise claims, delivery criteria, deadlines, ladder and outcomes are retained without promotion. Date countdowns are shown only for full dates. Physical AI chokepoint scores are not applied to other sectors.</p>","review_date":"2026-11-05","scope":"Brain-computer interfaces, neuromodulation, psychedelic medicine (incl. non-hallucinogenic neuroplastogens), consciousness science and its theory disputes, disorders of consciousness, AI model welfare and digital minds, brain emulation and connectomics, national neuro programmes, and neural-data rules and neurorights worldwide, where each move has a dated primary source. Moves count even when they never use the word 'consciousness'.","section":"mind","shape_fill":{"context":["#1b1730","#b48cff"],"labs":["#2a2210","#e3b54e"],"neuro":["#0c2925","#3ed6b5"],"policy":["#2a1019","#ff6b8a"],"science":["#0f2236","#5aa9ff"]},"source_types":{"company_self_report":"Company self-report","company_usage_data":"Company analysis of its own usage data","government_projection":"Government statistical projection","institution_announcement":"Institution announcement (commitment)","policy_action":"Policy action (input)"},"status":"active","storage":"hn.chessmap.local-sector.mind","strengths":{"moderate":"Official or multi-party source; method partly disclosed","n/a":"An input or commitment, not evidence of an effect","strong":"Independent measurement with method disclosed","weak":"Single-party self-report or own-platform data"}}}
